SlideShare a Scribd company logo
1 of 65
Download to read offline
NLN Pharmacology Study Guide
There is no official study guide for the NLN Pharmacology Exam. This guide is not meant to be all-inclusive of the information
you will need to know to successfully pass the NLN Pharmacology exam. You should utilize other resources as necessary to
prepare for the exam. Please note that after taking the exam, NLN provides access to review resources on-line.
The test is composed of 100 scored questions plus some trial questions (about 25). You will not know which are which. All are
multiple choice questions, including calculations.
Content is divided in three areas on the exam: calculations, principles of medication administration and medication effects. They
are pretty evenly divided. The questions are very similar to the NCLEX questions. You should also use traditional NCLEX testtaking tips to prepare for this exam also.
References:
Pearson nurses’s drug guide. (2013). Upper Saddle River, NJ: Pearson.
Silvestri, L. A. (2011). Saunders comprehensive review for the NCLEX-RN® examination. St. Louis, MO: Mosby.
Adams, M. P. & Urban, C. Q. (2013). Pharmacology: Connections to nursing practice (2nd ed.). Upper Saddle River, NJ: Pearson.

Calculations
Please remember this is about 1/3 of the pharmacology exam. It may be beneficial for you to practice calculations and/or review
a nursing math book to help prep. You may not have used all the calculation methods recently. Questions may include one or
more type of calculation.
Tips:
1. READ CAREFULLY. Always be sure you know what the end result should be (mg, pills, ml, etc.). This can help you select
the correct formula and eliminate unnecessary information.
2. Double (and triple) check actual math. Did you clear the calculator correctly?
3. Does the answer make sense?
4. There are both adult and pediatric calculations.
5. Watch ‘per dose’, ‘per day’.
6. How you calculate the answer does not matter (desired over have, ratio : proportion, etc.); accuracy does.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

1
2Common calculations include (but are not limited to):
1. Kg to mg to mcg conversion (any which way)
L
K
H
D
M
D
C
M
mcg
G
liter
(kilo – hecto – deca – meter – deci – centi – milli – skip – skip – micro)
gram
2. Dosage calculations
a. Tablets
b. mg. to tablets
c. mg. to ml
d. units to ml
e. kg to ml
f. Half-life calculation
g. IV rate calculation (hourly infusion rate) AND adjustment
h. IV rate dosage calculation (based on units per ml, etc.)
i. Macro- vs. micro-drop tubing
j. Calculating drops/minute (gtts/min)
Examples: (abbreviated to type of question; exam will add extra information)
1. Have 5 mg tablets; ordered dose 2.5 mg. How many tablets will the nurse administer?
2. Have 2 mg/2 ml; order is 1 mg. How many milliliters will the nurse administer?
3. Prepare a 20 mEq dose of a medication. Available solution is 40 mEq/10 ml. How many ml will be administered?
Note: calculation method is not different in examples 1 - 3, just the unit of measure (mg, units, mEq, etc.). BE SURE AVAILABLE
AND HAVE ARE THE SAME UNIT OF MEASURE.
4. Half-life conversion: Half-life is known to be 2 hours. What percentage will be left in the body after six hours?
5. A person weighs 165 lbs. How many kg does the person weigh?

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

2
6. The available medication has been reconstituted to 250 mg/5 ml. The order is 5 mg/kg/daily in two evenly divided doses.
Child weight 44 pounds. How many milliliters will be administered per dose? NOTE: More than one calculation method
must be used to answer this question.
7. IV was ordered at 1000 ml over 8 hour period. After two hours, only 900 ml has infused. Calculate the new infusion rate
for the medication to be administered within the original 8 hour period.
8. Order is for 3000 cc over a 24-hour period. What is the hourly flow rate? OR: What will the pump be set at per hour?
9. Order is for antibiotic to be mixed in 50 ml NS and administered over 45 minutes. What is the hourly flow rate? OR:
What will the pump be set at per hour?
10. Volume is 1000 ml. Ordered infusion time is 8 hours. Have tubing of 15 drops/ml. How many drops need to be counted to
deliver the identified milliliters per minute?
11. Available solution = 25,000 units in 250 ml NS. Order is to administer at 22 ml/hour. How many units will be given per
hour?
12. Available solution = 25,000 units in 250 ml NS. Administer at 2000 units/hour. How many ml will be given be hour? OR:
What will the pump be set at per hour?
Principles of Pharmacology
These include the basics! Review:
1. Routes of administration – benefits and problems
2. Sizes of needles and syringes for injections
3. Six Rights of Medication Administration; Three Checks
4. Side effects; adverse effects; paradoxical reactions; toxicity; antagonists
5. Half-life calculation
6. Allergic or hypersensitivity reactions
7. Absorption, metabolism, distribution and excretion
8. There may be questions on lab values as relevant.
9. There are pediatric and adult questions.
10. Immunosuppression precautions (due to meds for cancer, HIV/AIDS, etc.)

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

3
Administration routes: some key points
Sublingual administration
□ absorbed in mucosa of oral cavities
□ rapid onset of action
□ Place tablet on floor of mouth, close mouth. Do not swallow, hold under tongue until dissolve.
□ Use spray on floor of mouth under tongue and close mouth.
Buccal
□ place tablet between gum and cheek near back of mouth, close mouth and keep in place until dissolve
□ slower to dissolve and absorb than sublingual
Intramuscular injections
□ Given in the vastus lateralis in children up to 3
□ Spread skin taught to bring muscle near surface of skin, with dart-like motion insert needle at 90 degrees
□ Aspirate to determine if needle enter a blood vessel. If there is blood return discard the needle and meds and start
procedure over.
NGtube / Gtube
□ NG usually temporary; G-tube for longer term
□ Follow instructions re crushing, dissolving medication – no sustained release meds
Eye drop administration
□ Clean exudates from eye; (2) tilt head toward side of affected eye; (3) pull lower eyelid down; (4) have pt. look up; (5)
instill drops in conjunctival sac formed by lower lid (not onto the eye); (6) Apply gentle pressure for 30 sec to 1 min over
inner cantus next to nose (this prevents absorption through the tear duct and drainage of the medication). Close eyes
gently massage the eyes to distribute the meds.
□ Slow absorption except in infants where they readily absorb
EYE OINTMENT
□ Same as eye drop except it is expressed directly into the conjunctival sac from the inner canthus to the outer canthus. Close
eyes and gently massage to distribute the medication

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

4
Definitions:
Agranulocytosis / Neutropenia / agranulocytopenia
□ Definition: Acute decrease in the number of granulocytes/leukopenia (WBC) in peripheral blood
□ Causes include: treatment with broad spectrum PCN, sulfonamides or cephalosporin (piperacillin, tazobactam, cetazidime,
ticarcillin, gentamycin), bone marrow transplant, chemotherapy, radiation.
□ Generally is impaired resulting from bone marrow depression by drugs and chemicals or replacement by a neoplasm(oral
lesion, ulcer necrotic, gingivitis, buccal mucosa
□ Lymphadenopathy, lymphadenitis may be prevalent.
□ Could lead to respiratory infection, ulceration of mouth colon, high fever, UTI. But may be asymptomatic
Chelating agents
□ A form of detoxification
□ Chelating therapy involves an injection or oral administration of ethylene diamine Tetra acetic avide (a synthetic amino acid
which attaches to toxic substance such as lead, cadmium, aluminum and other metal in the blood to facilitate their removal
from the body.)
□ May be used to treat hardening of the arteries, heart attack, stroke, arthritis and gangrene because of its ability to remove
excess calcium from the body.
EDTA: Ethylenediaminetetraacetic acid
□ Use in children with lead level between 45&70 micron/dl.
□ EDTA binds to lead in blood and excreted by the bowel and kidney. EDTA may be toxic to kidney. Monitor urine output.
□ Give this by IV. Dose depends on weight of child, severity of the poison. Agent is given every 4 hours for 5 days. A second
course may be needed if there is a rebound in the blood level. Give oral and IV fluid to enhance excretion
□ Do not use EDTA with hypocalcemia or hypokalemia.
OTHER AGENTS
□ British antiLewisite (BAL) does not give with iron supplement and avoid in pt. with plant allergy. Give this by IM
□ Succimer (Chemer)
□ Chemet – oral medication - Do not give in pt. with encephalopathy
Epistaxis
□ Nose bleed. Can be anterior or posterior. Posterior is more serious.
□ due to rupture of blood vessels within richly perfuse nasal mucosa spontaneous or initiated by trauma
□ blood can come up through the eye, can also flow down the stomach causing nausea, vomiting

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

5
Treat epistaxis
□ cauterization with silver nitrate, calcium alginate mesh, nasal cavity packed with sterile dressing ribbon gauze, absorbent
dressing or saline sprayed into the nose
□ Ice pack to forehead or back of the neck
□ pinch septum of nose for 5 minutes
□ Do not pack nose with tissue or gauze
Half-life
□ The time it takes for a medication to lose half of its pharmacologic or physiologic effect
□ To calculate half-life: There is a formula but the easiest way to decrease count.
□ Example: half- life is 1 hour.
Start 100%
1 hr.
50%
2 hrs. 25%
3 hrs. 12.5%
4 hrs.
6.25%
Question – Half-life of ‘xyz’ medication is 1 hour. After 3 hours, what percentage of the medication will be left? A = 12.5%
Osmotic agent - see entry under Mannitol
Paradoxical reaction
□ A response to a drug (or medical treatment) that is the opposite to the usual response, such as agitation produced in an
individual patient by a drug which is ordered to sedate or calm a person.
Sustained release / time released / extended release / controlled release
□ Pills or capsule formulated to dissolve slowly and release drug over time.
□ They can often be taken less frequently, keep steadier levels of the drug in the bloodstream
□ Contain in a matrix of insoluble substance (e.g. Acrylics) the drug swells up to form a gel so that the drug has first to dissolve
in matrix then exit through the outer surface.
□ Cannot be crushed, dissolved or opened

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

6
Medication Effects
There is a bit of an overlap here with Principles of Pharmacology. These questions tend to be medication (or classification)
specific. There are many medications on the test and many could be. As applicable, both brand and generic names are used.
We recognize the attached grid is very lengthy, but have included some of the key components as identified below. Most
medications addressed are either high usage or high risk. Please note that auto-corrections will change generic names to
starting with caps. In the grid, we have tried to list generic first, then brand names.
Areas to know:
1. Use, dose, side effects, contraindications
2. Since there are a limited number of questions, not all medications are addressed. You may be asked to select which
medication would be given for a particular diagnosis. When studying, focus on the classifications – this may enable you
to answer without knowing the actual medication.
3. Focus on what are the major side effects of a medication or class? What makes it high risk? Why might one particular
med be used other than another?
4. Patient teaching is a major focus. What would you tell the patient about the medication? What would indicate
understanding? What would indicate need for further teaching?
Common classification of medications
Note letters in medication name and look for those letters that identify a particular classification:
◊

Androgens: end with –terone: testosterone (Testoderm)

◊

ACE Inhibitors: end with –pril: enalapril (Vasotec)

◊

Antidiuretic hormones: end with –pressin: desmopressin (DDAVP)

◊

Antilipidemic: end with –statin: atorvastatin (Lipitor)

◊

Antiviral: contain -vir: ritonavir (Norvir)

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

7
◊

Benzodiazepines: include alprazolam (Xanax), chlordiazepoxide (Librium), clorazepate (Tranxene),
estazolam (ProSom), and triazolam (Halcion). Most others end with –pam: diazepam (Valium)

◊

Beta Blockers: end with –lol: atenolol (Tenormin)

◊

CCB: end with –pine: amlodipine (Norvasc); some exceptions include diltiazem (Cardizem), verapamil
(Isoptin)

◊

Carbonic anhydrase inhibitors: end with –mide: acetazolamide (Diamox)

◊

Estrogens: contain est: conjugated estrogen (Premarin)

◊

Glucocorticoids and corticosteroids: end with –sone: prednisone (Deltasone)

◊

Histamine H2 receptor antagonists: end with –dine: cimetidine (Tagamet)

◊

Nitrates: contain nitr: nitroglycerin (Nitrostat)

◊

Pancreatic enzyme replacements: contain pancre: pancrelipase (Pancrease)

◊

Phenothiazines: end with –zine: chlorpromazine (Thorazine)

◊

Proton Pump Inhibitors: end with –zole: lansoprazole (Prevacid)

◊

Sulfonamides: include –sulf: sulfasalazine (Azulfidine)

◊

Thiazide diuretics: end with –zide: hydrochlorothiazide (HydroDIURIL)

◊

Thrombolytics: end with -ase: alteplase (Activase)

◊

Thyroid hormones: contain –thy: levothyroxine (Synthroid)

◊

Xanthine bronchodialators: end with –line: theophylline

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

8
Specific Diseases or treatments:
Aminoglycoside
□ antibiotics - Treats serious life threatening gram negative (and some positive) infections
All aminoglycoside ends Mycin but not all drugs that ends in Mycin are aminoglycosides such as (Erythromycin and
azithromycin)
Examples:
□ Gentamycin
□ Tobramycin
□ Vancomycin
□ Neomycin
□ Generally IM or IV.
□ Oral route is not recommended. It is only use for bowel prep prior to surgery (see Neomycin)
Adverse effects/toxicity:
Two most common MAJOR adverse effects: Nephrotoxicity and ototoxicity.
Also:
□ Photosensitivity
□ risk for superinfections
□ Pseudomembranous colitis (c-diff): stop med and treat with PO Flagyl
Peak level:
□ Drawn 15-30 min after the infusion is completed.
□ Peak concentration determines that toxic level does not occur.
□ If peak is too high, may reduce dose.
Trough level:
□ Drawn immediately (within 30 minutes) before next IV dose
□ Assures that therapeutic level of drug is maintained. Trough level is 1-2 g/ml between doses.
□ Dose will be adjusted if level is not sustained
□
WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

9
Blood administration
□ Start blood transfusion slow 2 ml/min. Remain with pt. for the first 15-30 min. if there is no sign of side effect, increase rate
to the desired rate
□ Administer using largest gauge IV access as possible.
□ Observe for acute reaction such as: allergic s/s – rash, itching, localized edema; febrile (even low grade); septic; air embolism;
circulatory overload.
□ Observe for delayed reaction: Graft vs. host; hepatitis; hemolysis
Crack abuse effect on newborns
□ Crack crosses the placenta and enters the fetus.
□ Common presentation: Infant may appear normal or develop neurological problem. Child may develop depression or
excitability, they may be lethargy, have poor suck; weak cry and difficulty in arousing, hypotonicity, rigidity, irritability,
inability to console and intolerance to change, small head, decreased birth length
□ Late symptoms: Some infant showed late symptoms 2-8 wks. There may be growth retardation - head growth is one of the
best indication
Diabetes treatment in children
□ Hypoglycemic reaction takes place most time before meals or when insulin effect is peaking.
□ First teaching: (1) let child wear bracelet or tag; (2) Teach how to give injection. Inject at 90 degree angle.
□ Teach only the essentials on the first few visits and intense later. Keep session for children to 14-20 min and adult may go up
to 45-60
□ Have same meal as normal child time intake of food. Eat at the same time each day.
□ Children can start learn to assume responsibility for self-management as soon as age 4-5. At age 9, they can start giving
their own insulin with supervision.
□ Exercise: do not restrict exercise. Have extra snack before and after exercise. Exercise very regularly as it decreases the
need for insulin
□ Carry a source of glucose at all times (hard candy, sugar cubes glucose tablets, insta glucose). The rapid releasing sugar is
followed by complex CHO and protein such as slice of bread or cracker spread with peanut butter
□ After glucagon injection, vomiting may occur. Place child on the side to prevent aspiration.
□ Preferred way of treating ketoacidosis is by insulin IV of low dosing. Note. Run a mixture of insulin through the tubing
before starting the drip because the insulin can chemically bind to plastic. Replace fluid over 24-48 hrs.
WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

10
Diabetes – Intravenous insulin administration
□ Can only be done with regular insulin in management of DKA, HHNK.
□ Premature discontinuation can cause prolongation of DKA.
□ Begin SQ insulin therapy before stopping the infusion. If not, there might be prolonged hyperglycemia.
Hepatitis – see below
HIV treatment – antiretinoviral therapy
Side effects:
START therapy:
Common meds:
(1) all symptomatic HIV people
□ Assess for opportunistic infection
(presenting with a AIDS-defining illness)
□ abacavir (ziagen)
(cancer, neurological disease); HA,
or
fatigue, nausea, vomiting, diarrhea,
□ stavudine (Zerit)
abdominal discomfort, anemia, taste (2) with a CD4 count less than 350 mm3.
□ zidovudine (AZT)
(3) also start pregnant women (AZT is
perversion, asthenia, circumoral
used to prevent maternal transmission
paresthesia with ritonivair,
Antiviral protease inhibitor. End in AVIR
of HIV)
Adverse/toxicity
□ Use prophylactically.
STOP if severe rash or other
□ Hepatoxicity, Hepatotoxicity: AST,
□ Use in combination to decrease viral
hypersensitivity reaction occurs.
ALT, bilirubin; observe for nausea,
load and increase CD4.
Excluding reaction to medications
vomiting jaundice upper right
Reverse transcriptase inhibitors: Ends in
and/or ineffectiveness of medication,
abdominal quad enlargement and
INE
treatment will be long-term.
tenderness. Reduce dose in liver
□ Stop replication/growth. Reduces
dysfunction.
viral load.
TEACH
□ One major advantage is that they do □ Nephrotoxicity; creatinine, BUN,
creatinine clearance, urinalysis, keep □ Use neutropenic precautions
not affect adversely affect
□ Eat small frequent meals with
accurate I& O, monitor for SE of
development of blood cells.
complete or complementary proteins
neutropenic, observe occult signs of
□ Use in combination with other meds
infection. (lower back, flank or
because resistant strains may rapidly
suprapubic pain, normal temp or low
evolve if used as single agent
grade fever related to UTI
therapy.
□ Inhibit cell protein synthesis that
interfere with viral replication; block
protease activity in HIV.
□ Treat AIDS and AIDS-related complex
to decrease viral load

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

11
Inotropic medications:
Positive inotropic meds increase cardiac contractility – examples: epinephrine, norepinephrine, dopamine
Negative inotropic meds decrease cardiac contractility, lower BP: examples – quinidine; betablockers (most end in ‘olol”)
Sulfonamides
Side effects:
CAUTION: do not use:
□ Rash common; most are urticaria and □ known allergies to sulfa drugs
□ Anti-infective.
maculopapular.
□ In polyuria, advanced renal or hepatic
□ Bacteriostatic which action on
□ GI symptoms
dysfunction
bacteria results from interference
□ Bone marrow depression
□ with intestinal and urinary blockage,
with the functioning of enzyme
□ Headache, dizziness, vertigo, ataxia,
□ asthma
systems necessary for normal
convulsion, depression
metabolism, growth and
Adverse effects/toxicity:
□ Take adequate amount to fluid 3000multiplication
□ Hepatotoxicity
4000ml/day to promote urinary
□ Treat: UTI, Chlamydia causing
output, at least 1500ml/d to prevent
□ Nephrotoxicity
blindness, pneumonia, brain abscess, □ Stevens Johnson syndrome (an
crystalluria/stone formation
ulcerative colitis, active Crohn’s
□ May be taken after meals to prolong
adverse reaction of skin that
disease, rheumatoid arthritis
time in intestine.
resembles appearance of partial
Examples:
□ Collect C&S prior to beginning
thickness burns)
□ Bactrim
therapy
Thiazide diuretics:
Side effects:
□ Take early in the day to avoid
Examples:
□ Dizziness, vertigo, HA, weakness,
nocturia
chlorothiazide (Hydrodiuril),
dehydration, orthostatic hypotension □ Take with food to avoid GI upset.
hydrochlorothiazide (HCTZ, Diuril)
□ N/V, abdominal pain, diarrhea,
□ Thiazide is ineffective if creatinine
Name ends in ZIDE
constipation, frequent urination
clearance is < 30ml/min
□ non-potassium sparing diuretic.
□ dermatitis and rash
□ Eat foods high in potassium, restrict
□ Acts on distal tubes, blocks
□ Electrolyte imbalance
sodium, do not use salt substitute if
reabsorption of sodium, chloride and □ impaired glucose tolerance
taking potassium supplement
water. Leads to increased loss of
Adverse effects/toxicity:
□ weigh self daily, report sudden
Potassium.
weight gains or losses
□ Renal failure,
□ Use for edema and mild to moderate □ aplastic anemia, agranulocytosis,
Avoid use with:
hypertension
□ Children
thrombocytopenia
□ will see effect of within 1-4 wks.
□ anuria
□ anaphylactic reaction
WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

12
Tricyclic Antidepressants
□ Initial mechanism of TCA takes 1-3
weeks to develop.
□ Maximum response is achieved in 6-8
wks.
□ Has long half-life.
Most Tricyclics ends in INE
□ nortriptyline (Pamelor)
□ amitriptyline (Elavil)
□ doxepin (sinequan)
□ imipramine (tofranil)

□ Block the reuptake of norepinephrine
or serotonins or both, leaving more
available in the CNS. It intensifies
the effect of norepinephrine and
serotonin which can elevate mood,
increase activity and alertness,
decrease preoccupation with
morbidity, improve appetite and
regulate sleep pattern.
□ It is used to treat insomnia, attention
deficit/hyperactivity and panic
disorder.
Side effects:
□ orthostatic hypotension,
□ sedation and anticholinergic effects.
Adverse effects/toxicity:
□ Most serious adverse effect is cardiac
toxicity; in the absence of overdose
or preexisting cardiac impairment,
serious cardiotoxicity is rare.
□ URINARY RETENTION IS URGENT
□ Overdose may cause convulsions

□ Take at nights, it causes sedation.
□ Do not take with MAO it will cause
hypertensive crisis from excessive
adrenergic stimulation of the heart
and blood vessels,
□ monitor orthostatic BP of pt. in
hospital

Use with caution:
□ Glaucoma
□ Elderly
□ constipation, prostatic hyperplasia,
as they are more sensitive to
anticholinergic effect
Avoid use with:
□ hypersensitivity,
□ MI, Cardiovascular disease

Vesicant – Chemotherapy
□ See precautions under “Vincristine”
Hepatitis: inflammation of liver caused by virus, bacteria or exposure to meds or hepatotoxins
Stages of viral hepatitis:
(1) Pre-icteric – precedes appearance of jaundice, may have flulike symptoms
(2) Icteric – appearance of jaundice, elevated bilirubin, dark or tea colored urine, clay-colored stools
(3) Post-icteric – convalescent stage; jaundice improves; color of urine and stool returns to normal

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

13
Hepatitis A (formerly
“infectious hepatitis”)
Cause: enterovirus
At risk:
□ Young children
□ Institutionalized
people
□ Health care
personnel
Transmission:
□ fecal-oral
□ ingestion of food or
liquids
contaminated with
the virus.
□ person by person
contact
Incubation: 3-5 wks.
Infectious: usually 2
wks. before the onset
of jaundice and 1 wk.
after onset of jaundice.
s/s: May have no
symptoms initially.
Complications:
□ Fulminant hepatitis

Hepatitis B.

Hepatitis C

Hepatitis D

Hepatitis E

At risk:
□ IV drug users
□ People on
Hemodialysis
□ Health care
personnel

At risk:
□ IV drug users
□ People receiving
frequent
transfusions
□ Healthcare
personnel

Cause: Occurs only with
Hepatitis B and only
causes problems with
an acute HepB
infection.

Cause: waterborne
virus

Transmission:
□ blood and body
fluids
□ contaminated
needles, parenteral
□ sexual activity
Incubation: 6-24 weeks
s/s:
□ progression of
symptoms is more
insidious and
prolonged than
Hep A virus.
□ Initially may be
asymptomatic.
□ 1 week -2 months of
Prodromal
symptoms: fatigue,
anorexia, transient
fever, abdominal

Transmission:
□ Same as Hep B
□ Blood and body
fluids
Incubation period: 5-10
weeks
s/s: similar to HBV but
often less severe.
Complications:
□ chronic liver disease
□ Cirrhosis.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

At risk:
□ common in Middle
east, south Africa
and Mediterranean
□ same as HepB
Transmission:
□ same as Hepatitis B.
Incubation period: 7-8
weeks
HepD along with HepB
causes superinfection
and worsening of
condition and rapid
progression of cirrhosis
Complications:
As per Hep B

At risk:
□ Travel to areas
where sewage
disposal is
inadequate and/or
people bathe in
contaminated rivers
□ At higher risk with
higher mortality:
women in third
trimester of
pregnancy
Transmission:
□ Same as HepA
Incubation: 2-9 weeks
Complications:
□ Maternal and fetal
demise

14
□ death

discomfort N/V, HA.
□ Then expanding to:
Hepatic S/S,
photophobia,
angioedema, rash,
vasculitis, jaundice
in Icteric phase
Complication:
□ Cirrhosis
□ Fulminant hepatitis

A grid follows with a listing of medications that may be on the exam.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

15
Drug
Acetylsalicylic acid
(Aspirin)
□ Non-narcotic
analgesic
□ Antipyretic
□ Antiplatelets

Activated charcoal
(Actidose)
□ Antidote
□ Adsorbent

Use and dosage
□ Blocks pain impulse
in peripheral and
some CNS;
□ antipyretic result;
□ inhibit platelets
aggregation
□

□

□

□

□

□

Side effect
□ Increases
coagulation times
□ Reye’s syndrome
(encephalopathy
and fatty liver),
□ GI bleed,
□ tinnitus,
Treat TIA, Post MI, □ liver toxicity (dark
Stroke, angina
urine, clay stool,
itching, yellowing
sclera and skin),
□ visual changes
Treat poison and
□ Vomiting with rapid
overdose following
administration
oral ingestion.
□ pulmonary
Binds to poison and
aspiration
prevent its
absorption by the
GI tract and then
eliminates in the
feces.
Administer within
60 minutes of
ingestion.
Give once or twice
depending on the
level of toxin.
May come premixed with water
12.5-25 grams

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ Monitor coagulation
studies
□ Take with full glass
of water, milk for
food to prevent
stomach upset
□ Do not crush enteric
coated
□ given daily (81-325
mg) for cardiac
prophylaxis post MI,
stents, strokes, etc.
□ Binding is
irreversible so
cathartic such as
sorbitol may be
added as well.
□ It allows certain
drugs/toxins to be
drawn out of the
blood and bind to
charcoal in the
intestine a kind of
“gut dialysis”
□ Stools will be black
□ Charcoal does not
change the stomach
PH.

contraindication
Do not use with:
□ children under 12
and/or children or
teenagers with
chicken pox or flu
like symptoms
(because of risk of
Reye’s syndrome);
□ pregnancy in 3rd
trimester; and
□ vitamin K deficiency
Do not administer with
Ingestion of:
□ caustic alkali agent,
□ high viscosity
petroleum products
OR when:
□ convulsions are
occurring,
□ cardiac
dysrhythmias are
present, or
□ there is emesis of
blood
Implement antidote
supportive care and
prevent aspiration are
if gastric lavage is not
to be performed.

16
Drug
Acyclovir
(Zovirax)
□ Antiviral
- Herpes simplex
virus – HSV
- Herpes zoster
- varicella

Alteplase recombinant
(Activase)
Streptokinase is similar.
Urokinase is given
mostly in emergency
situation.
□ Thrombolytic agent
Cath-flo Activase – is
for occluded catheters

Use and dosage
□ Used for herpes
simplex. Does not
eradicate latent
herpes. It reduces
viral shedding and
formation of new
lesions and speeds
healing time.
(oral, IV and topical)
□ To decrease
symptoms with
varicella zoster
(chicken pox/
shingles).
□ Dissolves or break
down clots to
reestablish
perfusion.
□ Indicated for clients
at risk for
developing
thrombus with
resultant ischemia
such as MI,
ischemic stroke,
arterial thrombosis,
DVT, PE
□ occlusion of IV
catheters.

Side effect
Side effects:
□ Headache, dizziness
□ seizure
□ nausea, vomiting,
diarrhea
□ acute renal failure
□ thrombocytopenia
□ purpura hemolytic
□ uremia syndrome

Teaching and labs
□ Even after HSV
infection is
controlled, latent
virus can be
activated by stress,
trauma, fever
exposure to
sunlight, sexual
intercourse.
□ Refrain from sex if
S/S of herpes.
Adverse effects/toxicity:
□ nephrotoxicity

contraindication

□
□
□
□

Do not give with:
□ pregnancy,
□ active bleeding,
□ recent Hx of CVA,
□ Uncontrolled HTN,

Hemorrhage,
N/V,
hypotension
cardiac
dysrhythmias.

□ Dose related is the
highest problem

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

□ Watch for s/s
bleeding; VS
changes, s/s of
impending shock
□ If bleeding is
occurring stop
treatment and
notify doctor. May
start on FFP and
PRBC.
□ Aminocaprionic acid
(Amicar) may be
ordered for
overdose or
excessive bleeding.

IM medication route is
contraindicated when
using thrombolytics.
□ Do not take NSAIDs
or Aspirin because
of enhanced
bleeding.

17
Drug
Aluminum hydroxide
(Amphogel)
□ Antacid

Ampicillin (Ampicin)
IV, PO, IM.
□ Antibiotic
□ Aminopenicillin

Similar side effects,
allergic reaction, etc.
for all Penicillins (PCN)

Use and dosage
□ Neutralizes gastric
acid,
□ antflatulent to
alleviate symptoms
of gas and bloating

Treat bacterial
infection
Commonly used with:
□ Shigella,
□ salmonella,
Escherichia coli,
□ haemophilus
influenza,
□ Neisseria
gonorrhea,
□ Neisseria
meningitis,
□ gram positive
organism

Side effect
□ Increases gastric pH,
□
□ Decreases
absorption of other
drugs such as dig, □
antibiotic, iron
supplement.
□ Toxicity causes
dementia,
Hypercalcemia,
□
metabolic alkalosis,
worsening of HTN,
heart failure from
increased intake.
□ allergic reaction:
Skin rash, urticaria,
swelling, pruritus,
angioedema.
□ Severe allergy:
hives, wheezing,
anaphylactic
reaction. Medical
emergency requires
immediate tx or can
lead to death.
□ side effects: GI, N/V,
diarrhea, abdominal
pain.
□ Pruritic rash like
measles is not a true
allergic reaction

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
Given 2 hrs. apart from
other drugs where
interaction may occur.
Observe for signs and
symptoms of altered
phosphate levels;
anorexia, muscle
weakness and malaise.
Increase fluid, exercise
and fiber to prevent
constipation.

contraindication
Do not use:
□ abdominal pain,
N/V, diarrhea,
□ severe renal
dysfunction,
□ fecal impaction,
rectal bleeding,
□ colostomy,
ileostomy
□ dehydration
□ hypercalcemia and
hypercalciuria

□ Do not give with
fruit juice, milk or
carbonated
beverages because
of poor absorption.
□ Watch for
hypokalemia
□ Take on empty
stomach.
□ May not be
necessary to stop
treatment if mild
diarrhea develops.
□ Give yogurt or
buttermilk to
restore normal flora
(or probiotics)

Avoid with:
□ Hypersensitivity to
any penicillins; use
cautiously if history
of hypersensitivity
to cephalosporins;
□ Exfoliated
dermatitis
□ Loop diuretic may
exacerbate
hypokalemia and
rash.
□ Potassium-sparing
diuretic may
contribute to
hyperkalemia

18
Drug
Atropine Sulfate.

Use and dosage
□ Use to increase
heart rate (not
Two different uses:
necessarily first
drug of choice).
□ Anticholinergic
□ Decreases
(such as for
involuntary
Parkinson’s disease)
movement and
□ For ophthalmic use
rigidity in
Parkinson’s disease
□ Pre-op to decrease
secretions and
prevent aspiration
Systemic effect is more
of secretions while
pronounced in infant
under anesthesia
and children with blue
eyes and blond hair.
□ Use for
Also increased risk of
inflammation of the
toxicity with Down
iris and uveal tract.
syndrome

Side effect
□ Dry mouth,
constipation, urinary
retention or
hesitancy headache,
dizziness
Adverse effects/toxicity:
□ Paralytic ileus.
□ Treat overdose
(resp. depression
and circulatory
collapse)
symptomatically.
Adverse effect when
used for the eye
□ Transient stinging,
□ increase IOP,
photophobia,

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
contraindication
□ Monitor dosage of
□ Increased
meds carefully, even
anticholinergic
slight overdose can
effect with
lead to toxicity.
phenothiazine,
antidepressant,
□ Assess for
MAO’s amantadine.
constipation and
urinary retention;
increase fluids, bulk □ Contraindicated in
and exercise, assess
pt. with narrow
bowel sound to rule
angle glaucoma,
out paralytic ileus,
myasthenia gravis,
or GI obstruction.
□ Avoid driving or
other hazardous
activities,
drowsiness may
occur.
For the Eye
□ Acute glaucoma can
be precipitated by
papillary dilation; if
not recognized and
treat, acute
glaucoma can result
in blindness.
□ Wear dark sunglass
and avoid bright
light for
photophobia,
□ Monitor intraocular
pressure and vision

19
Drug
Beclomethasone
diproprionate
(Beclovent)
□ inhaled
corticosteroid
medication

note: also nasal
inhalant as Beconase

Use and dosage
□ Used in bronchial
asthma, allergic
rhinitis

Side effect
Side Effects:
□ Pharyngeal irritation
and sore throat,
coughing, dry mouth,
oral fungal infections,
and sinusitis.

Teaching and labs
□ Decrease dose if pt.
is on systematic
corticosteroid.
□ Assess for impaired
bone growth in
children receiving
inhaled
□ Increased
corticosteroid
susceptibility to
Considerations:
infection,
□ Monitor for
dermatologic effects
hyperglycemia
and osteoporosis,
□ Rinse mouth after
diarrhea, N/V, HA,
use for medication;
fever, dizziness
oropharyngeal
angioedema rash
candidiasis and/or
urticaria and
hoarseness can
paradoxical
occur.
bronchospasm
□ Use bronchodilator
inhalant before
Adverse effects/toxicity
corticosteroid when
□ Adrenocortical
both are ordered.
insufficiency
□ Do not abruptly
□ fluid and electrolyte
stop meds taper
disturbances,
over 2 weeks.
□ nervous system
□ Be aware of steroids
effects and
symptoms - Moon
endocrine effects if
face, acne, edema,
absorbed
increased fat pads
systemically.
- notify doctor.
□ Report weight gain

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Do not use with:
□ children under
□ Clients with known
allergy
□ May require
adjustment of
antidiabetic agent
as there is a
potential for
elevated blood
glucose levels with
corticosteroids are
administered orally.
□ Not use in
bronchospasm or
status asthmaticus.

20
Drug
Benztropine mesylate
(Cogentin)
□ Anticholinergic
(cholinergic
receptor
antagonist)
□ Anti-Parkinson

Use and dosage
□ Treat Parkinson
symptoms:
Suppresses
tremors and
rigidity, not tardive
dyskinesia
□ Decreases
hypersalivation and
irregular
movement related
to Parkinson
disease.
□ Reduces extrapyramidal side
effects

Buspirone (Buspar)

□ Anxiety

□ anxiolytic

□ Desired response 710 days; Make take
3-4 weeks for full
effect

Side effect
Side effects:
□ dry mouth,
□ urinary
retention/hesitancy,
□ HA,
□ dizziness.

Teaching and labs
□ Monitor dose
carefully; even slight
overdose can lead
to toxicity.
Nursing considerations:
□ Monitor I&O’s,

Adverse effects/toxicity:
Education:
□ paralytic ileus
□ Avoid driving, or
other hazardous
activities;
drowsiness may
occur.
□ Avoid cough
OTC medication
unless
prescribed.
Side effects:
□ When switching to
□ Dizziness
Buspar, taper off
benzodiazepines
□ headache
□ Less likely to have
□ drowsiness
cognitive
impairment than
other CNS meds
□ Does not cause
withdrawal s/s and
thus does not need
to be tapered off
when stopping

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Avoid use with:
□ narrow-angle
glaucoma,
□ myasthenia gravis,
□ GI obstruction

Avoid use with:
□ MAO Inhibitors
□ Lactation
□ Caution with:
moderate to severe
renal impairment

21
Drug
Chlordiazepoxide
hydrochloride
(Librium)
□ Anxiolytic
□ Sedative-hypnotic
benzodiazepine
IM & tablet form
Peak:
□ 1-4 hours PO,
□ 15-30 min IM.
Half-life 5-30hr

Use and dosage
□ To relieve tension
and/or anxiety
□ To manage alcohol
withdrawal

Side effect
Adverse effect:
□ respiratory distress,
drowsy, dizziness,
lethargy, orthostatic
hypotension
□ photosensitivity

□ do not to stop
taking drug
abruptly – will have
withdrawal
symptoms (usually
in 5-7 days)

Suicidal tendencies may
be present and
protective measures
may be necessary.
□ Monitor closely for
paradoxical
reactions –
excitement,
stimulation, acute
rage – usually early
in tx – withhold
drug and notify dr.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ Give with milk or
food to prevent GI
upset.
□ Check BP and pulse
early in tx. If BP falls
delay medication
and notify dr.
□ Labs: Monitor CBC,
renal and hepatic
enzyme levels
□ watch for
dependency
Education:
□ Avoid alcohol
□ no OTC meds unless
prescribed
□ Avoid driving and
other hazardous
activities until
effects known.

contraindication
Avoid use with:
□ Narrow angle
glaucoma,
□ under 12 year old
□ lactation
Use cautiously with:
□ impending
depression,
□ impaired hepatic or
renal function,
□ COPD

22
Drug
Chloramphenicol
(Chloromycetin)
Oral, injection,
ophthalmic drops and
ointment
□ Anti-bacterial

Chlorothiazide (Diuril)
□ Thiazide diuretic,
non-Potassium
sparing
□ Anti-hypertensive

Use and dosage
□ severe infection for
susceptible
organisms when
other anti-infective
are ineffective.
□ Sty, conjunctivitis,
uveitis

Side effect
Side effects:
dermatitis, itching,
stinging, swelling
Adverse effects/toxicity
(oral and injection)
□ edema
□ super infection,
□ aplastic anemia.
□ Stevens-Johnson
syndrome

Teaching and labs
□ obtain culture
specimen from eye
before initiation of
treatment
□ remove exudates.
□ Monitor for pain,
drainage, redness,
swelling.
□ Monitor for
bleeding or bruising

contraindication
Avoid use with:
□ hypersensitivity

□ Increases urinary
excretion sodium
and water by
inhibiting sodium
reabsorption.
□ Use for edema and
HTN, HF, cirrhosis,
corticosteroid and
estrogen therapy,
diabetes insipidus,

Side effects:
□ Dizziness, vertigo,
frequent urination,
electrolyte
imbalance, impaired
glucose tolerance,
hyperuricemia,
photosensitivity
Adverse effects/toxicity:
□ Renal failure,
aplastic anemia, and
anaphylaxis

□ Take early in the
morning to avoid
nocturia.
□ Give with food,
□ allow for 3-4 weeks
for maximum effect,
□ Will not be effective
if creatinine
clearance Is less
than 30ml/min

Avoid use:
□ Client with anuria.
□ Use cautiously with
impaired renal or
hepatic function.
□ If pregnant.
□ Will increase serum
lithium level

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

23
Drug
Chlorpromazine
hydrochloride
(Thorazine)
□
□
□

□

Use and dosage
□ Block dopamine
receptor in CNS to
□ Use: treat
psychotic disorder
phenothiazine
(schizophrenia,
Antipsychotic
bipolar, and other
medication
mental illnesses);
prevent acute
Anti-emetic
exacerbation and
maintain highest
possible level of
function
Give bromocripitine
□ Use to control
(Parlodel) and
manic phase
dantrolene
(bipolar)
(Dantrium) for
□ intractable hiccups
NMS.
□ nausea/vomiting
□ Low potency antipsychotic which
can reduce the risk
of EPSE (extrapyramidal side
effects)

Side effect
Side effects:
□ Sedation,
orthostatic
hypotension,
□ anticholinergic
effect (dry mouth,
blurred vision,
urinary retention,
photophobia,
constipation,
tachycardia)
□ liver damage,
tremor are two
major side effects.
□ photosensitivity
Adverse effects/toxicity:
□ Neuroleptic
malignant
syndrome (NMS),
catatonia, rigidity,
stupor, unstable
blood pressure
profuse sweating,
dyspnea. Can be
toxic effect and
MAY last for 5-10
days after
discontinuation of
the med.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ get baseline ECG,
thorough baseline
evaluation lab tests
before treatment.
□ Give bromocripitine
(Parlodel) and
dantrolene
(Dantrium) for
NMS.
□ Withdrawal of drug
is necessary
□ Take measures to
protect eyes
exposed to sunlight

contraindication
□ Monitor diabetics
closely for glucose
intolerance

24
Drug
Cimetidine (Tagamet)
□ GI meds,
□ H2 receptor
antagonist

Cisplatin (Platinol)
Half-life 20-30 minutes
□ Antineoplastic
medication
□ Alkylating agent
** Major allergic
reaction can occur
within first 15 mins. of
administration.
Anaphylaxis may occur
within minutes of drug
initiation.

Use and dosage
□ Works against
histamine
receptors,
decreases gastric
secretion.
□ Use short term for
duodenal ulcer,
benign gastric
ulcer, acute upper
GI bleed
□ Treat ovarian and
testicular cancer by
interfering with
DNA replication

Side effect
Side effects:
□ Cardiac dysrhythmia,
diarrhea, dry mouth,
constipation
Adverse effects/toxicity:
□ Rare but may
include
agranulocytosis
neutropenia ,
thrombocytopenia
aplastic anemia,
anaphylaxis
Side effects:
□ anorexia,
uncontrolled N/V,
fluid retention,
weight gain
Adverse effects/toxicity:
□ Major toxicities
occur in the blood,
GI, and reproductive
system.
□ Watch urine output
and specific gravitynephrotoxicity may
occur within 2 wks.
□ ototoxicity (tinnitus
or difficulty hearing
in the high
frequency range)

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ May be given with
meals and at
bedtime
□ Avoid smoking
which cause gastric
stimulation
□ Avoid antacid use
within one hour of
dose

contraindication
Avoid use:
□ hypersensitivity
Use caution:
□ impaired renal or
hepatic function

□ maintain fluid at
least 3000 ml in 24
hr. ; report reduced
urine output
□ Avoid food high in
thiamine (beer,
wine cheese,
brewer’s yeast,
chicken liver &
banana) - may lead
to hypertension &
intracranial
hemorrhage

Avoid use:
□ Hx of sensitivity to
platinum-containing
compounds,
□ impaired renal
function and
hearing,
□ Hx of gout, renal
stones.
Incompatible with
□ dextrose and
Reglan, Vanco
□ Lasix may increase
otoxicity
□ other nephrotoxic
drugs may increase
nephrotoxicity and
renal failure.

25
Drug
Codeine sulfate
□ Opioid analgesic
(agonist)
□ Antitussive (cough
suppressant)

Use and dosage
□ To treat mild to
severe pain
□ most oral
preparations
combined with ASA
or acetaminophen
□ hyperactive cough

Rapid onset if IM or IV.
Peak 1-2 hrs.,
Duration up to 7 hours.

Cyanocobalamin
(Vitamin B12)
Half- life: 6 days

□ Vitamin B12 helps in
the formation of
red blood cells
essential for the
proper production
of blood platelets
and red and white
blood cells and the
nervous system
□ Malabsorption
syndrome
□ Pernicious anemia

Side effect
Side effects:
□ Constipation, urinary
retention, dizziness,
lightheadedness.
Adverse effects/toxicity:
□ Respiratory
depression,
respiratory arrest,
circulatory
depression, ICP.
□ Long term use may
cause withdrawal
symptoms when
stopped
Adverse effects/toxicity:
□ Anaphylactic shock,
sudden death,
□ severe optic nerve
atrophy (may
develop after years
of use or with
Leber’s disease)

□ water-soluble
vitamin that is
stored in the liver.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
Assess for:
□ respiration and
usually hold <12
breaths per minute,
□ CNS changes (LOC),
□ allergic reaction
TEACH:
□ no alcohol
□ no OTC pain meds
unless ordered
□ Avoid driving until
drug response is
known.

contraindication
Do not use:
□ Hypersensitivity
□ Increased ICP, head
injury
□ Acute alcoholism
□ labor

Teach:
□ Injection is once per
month for life with
pernicious anemia .
□ Oral preps may be
mixed with fruit
juice but give
immediately since
ascorbic acid (Vit. C)
affects stability of
B12.
□ Dietary B12: best are
organ meats, egg
yolk, clams, oysters,
crabs, sardines,
salmon

Do not use:
□ Hypersensitivity
□ Lactation

26
Drug
Cyclosporine
(Sandimmune)
□ Immunosuppressant
medication
Metabolized in the
liver.
Peak 4-5hr,
Duration 20-54 hrs.
Half-life 19-27 hrs.

Use and dosage
□ Inhibit T helper and
T suppressor cells.
□ Prevent rejection of
kidney, liver and
heart transplants.
□ Treat chronic
rejection in people
who have received
immunosuppressive agent,
rheumatoid
arthritis,
recalcitrant plaque
psoriasis

Side effect
Side effects:
□ Hypertension,
□ increased risk of
infection
□ Tremor is an
expected side effect

Teaching and labs
□ Monitor labs: AST,
ALT, BUN, creat,
platelet count, K,
TEACH:
□ Take with food to
reduce GI upset
□ mix with milk,
Adverse effects/toxicity:
chocolate milk or
orange juice but not
□ Renal toxicity,
with Grapefruit juice
□ hepatotoxicity
□ Mix in glass, not
plastic
□ Avoid use of live
vaccine
□ Prevention of
infection and report
signs of infections

contraindication
□ Do not use:
Pregnant/lactating
mom,
□ Use cautiously in
renal and hepatic
impairment
□ Antiepileptic
medications
decrease
cyclosporine levels
□ oral contraceptive
increase levels

□ Immunosuppressed
precautions

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

27
Drug
Debrox drops
□ Ear drops to dewax

Use and dosage
□ used to soften and
loosen ear wax,
making it easier to
remove.

Side effect
Side effects:
□ temporary decrease
in hearing after
using the ear drops
□ mild feeling of
fullness in the ear
□ mild itching inside
the ear.
Adverse effects/toxicity:
□ Get emergency
medical help if you
have any of these
signs of an allergic
reaction: hives;
difficulty breathing;
swelling of your
face, lips, tongue, or
throat

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
Use:
□ Tilt head with ear
facing upward. Pull
back on ear to open
up the ear canal.
Drop the correct
number of ear drops
into the ear.
□ After using the ear
drops, stay lying
down or with your
head tilted for at
least 5 minutes. You
may use a small
piece of cotton ball
to plug the ear and
keep the medicine
from draining out.
□ A bubbling sound
inside may be heard
after putting in the
drops. This is caused
by the foaming
action of carbamide
peroxide, which
helps break up the
wax
□ May come with bulb
syringe.

contraindication
Do not use:
□ With a ruptured ear
drum.
□ any signs of ear
infection or injury
□ Do not use this
medication in a
child younger than
12 years old without
the advice of a
doctor.
□ Do not use for
longer than 4 days
in a row.

28
Drug
Diazepam (Valium)
□ Benzodiazepine
(have zep and zap
in them)
□ minor tranquilizers,
□ anticonvulsant,
□ anxiolytic
□ Absorbed from GI,
metabolize in liver
Onset 30 min IM, 60
PO, 15 IV. Works
quickly.
Peak 1-2hr PO,
Duration 15 min to 1hr
IV; up to 3 hrs. PO.
Half-life 20-50 min

Use and dosage
□ Relieve pain and
discomfort from
musculoskeletal
disorders,
□ manage anxiety,
□ Manage acute
alcohol withdrawal
Maximum effect will
be seen in 1-2 weeks.
Can take 2-4 wks. It has
addictive effect.

Side effect
Side effects: ABCD.
□ Anticholinergic (dry
mouth),
□ Blurred vision,
□ Constipation, &
□ Drowsiness,

Teaching and labs
□ Watch for CNS
effect.
□ Monitor CBC WBC
with diff.
□ notify dr. if drop in
BP of 20 mm Hg
□ Assess for allergic
reaction including
□ cardiovascular
idiosyncratic
collapse,
reaction,
laryngospasm,
anaphylaxis, rash
dizzy, weakness,
fever resp distress
nausea
Adverse effects/toxicity: Teach
□ Do not stop
□ Erythema
abruptly –
multiforme,
withdrawal
□ angioedema,
symptoms will
□ anaphylaxis,
occur (insomnia,
□ dysrhythmia
nausea HA,
□ seizure
spasticity,
tachycardia).
□ No alcohol (will
increase CNS
depression)

contraindication
Do not use:
□ compromised
pulmonary
function,
□ hepatic disease,
□ impaired
myocardial
function,
□ acute alcohol
intoxication
□ infant < 6 months
□ narrow angle
glaucoma, open
angle glaucoma

□ Suicide prevention
precautions

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

29
Drug
Digoxin (Lanoxin)
□ Cardiac glycoside,
antiarrhythmic
drug.
□ Therapeutic range:
0.5-2.0ng/ml
□ Toxic level > 2
Antidote: digibind
(digoxin immune fab)

Use and dosage
□ Positive inotropic
effect
□ In heart failure it
Increase
contraction of the
heart muscle.
□ In atrial fib, it slows
the heart rate

Side effect
Side effects:
□ Nausea, HA, loss of
usual appetite.
Adverse effects/toxicity:
□ Toxicity may go
unrecognized since
it presents with
same symptoms as
flu (N/V, anorexia,
diarrhea, vomiting
visual disturbance).
□ Blurred green or
yellow vision or halo
effect**
□ In HF, early sign of
toxicity includes
dysrhythmias.
□ Children rarely show
signs of N/V,
diarrhea, visual
problem, anorexia
(could become dig toxic
without showing usual
s/s)

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ may give without
regard for food
□ IVP over 5 min, do
not give IM, it will
cause tissue
irritation.
□ Monitor apical
pulse, if <60/min.,
usually hold meds
and notify doctor.
□ Monitor labs (K,
calcium,
magnesium,
creatinine
clearance),
□ Monitor Dig level
every 6 months.
□ weigh daily and
report weight
greater than 2 lbs.
per day

contraindication
Avoid use with:
□ hypersensitivity to
dig
□ Caution with kidney
failure
Interaction:
□ IV calcium with dig
may increase risk of
cardiac
dysrhythmias,
□ erythromycin will
increase dig level,
□ quinidine,
verapamil and
amiodarone will
increase dig levels
and dig dose should
be decreased by
50%
□ Cyclophosphamide
combined with dig
cause dig toxicity

30
Drug
Disulfiram (Antabuse)
The only alcohol
antagonist in use.
□ Enzyme inhibitor
□ Anti-alcohol agent.

Half-life 24-36 hour
Onset up to 12 hrs.
Duration up to 2 wks.
Absorbed from the GI
excreted in feces or in
the breath as carbon
disulfide

Use and dosage
□ Adjunct treatment
of patient with
chronic alcoholism
who sincerely
wants to maintain
sobriety.
□ At least 12 hours
should elapse from
the time of last
alcohol intake and
the initial dose
□ Use only in people
with high physical
health.
□ Use for 1-2 wks.

Side effect
Side effects:
□ Rare in the absence
of alcohol

Adverse
effects/toxicity:
** Acetaldehyde
syndrome
□ hypotension to
shock level
arrhythmias,
□ acute congestive
failure,
□ marked respiratory
depression,
INTENDED Reaction
□ unconsciousness,
with alcohol ingestion: □ convulsions
□ flushing face, chest, □ sudden death
arms
□ pulsating HA
□ Nausea
□ violent vomiting
□ thirst
□ sweating
□ marked uneasiness

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ The effects of
disulfiram may
persist for 2 weeks
after last dose is
taken; alcohol must
not be consumed
until this interval is
over.
□ Give in the morning
when the resolve
not to drink is the
strongest. Give at
bedtime to
minimize the effect
of drug
□ avoid alcohol of all
forms include those
found in sauces,
cough mixture and
after shave lotions,
colognes and
liniments

contraindication
Do not use:
□ In people who do
not want to stop
drinking.
□ Severe cardiac
disease,
□ psychoses,
□ pregnancy,
□ multiple drug
dependence.

31
Drug
Epinephrine
(Adrenalin)
□ alpha and beta
adrenergic agonist
□ vasopressor
□ bronchodilator
□ If given IM, SQ result seen in 5 min
& lasts up to 4 hrs.,
□ Also available eye
drops and
intranasal

Use and dosage
□ Reverses
anaphylactic
reaction
□ Restores cardiac
rhythm in cardiac
arrest
□ Acute asthmatic
attack

Side effect
Side effects:
□ nervousness,
□ tremors,
□ increased HR, BP,
□ insomnia,
□ anorexia
□ cardiac stimulation
□ vascular HA.

Teaching and labs
Teach
□ Report nervousness
and sleeplessness dose should be
reduced.
□ Administer eye
drops at bedtime.
May experience
headache and
stinging but subside
□ Also use in
Adverse effects/toxicity:
with continued use.
ophthalmic
□ Tachyarrhythmias,
Report if continues.
decongestant,
□ chest pain,
manage open angle □ restlessness,
□ Monitor VS
glaucoma
□ agitation,
especially HR and
□ nervousness and
BP because of
□ insomnia.
cardio effect.
□ Nasal burning
stinging,
□ eye burning

D/C if hypersensitivity
develops (develops of
lids, itching, discharge,
crusting eyelid). Notify
doctor

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
If use with MOA
inhibitors may lead to
hypertensive crisis.
□ Narrow angle
glaucoma,
□ hemorrhagic
traumatic or
cardiogenic shock,
□ arrhythmias,
□ organic heart or
brain disease.
CAUTION in:
□ older adults,
□ HTN
□ TB, long standing
bronchial asthma
and emphysema
□ children < 6
□ No breastfeeding

32
Drug
Famotidine (Pepcid)
□ Histamine
□ H2 antagonist.
Onset 1 hr. Peak 1-3hr
Duration 10-12 hrs.
Half-life 2.5-4hr

Fluoxetine
hydrochloride (Prozac)

Use and dosage
□ Decreases output
of gastric acid
□ Short term
treatment in
duodenal ulcer or
benign gastric
ulcer.
□ Metabolized in
liver, excreted in
urine
□ Major depressive
disorder
□ Obsessive
compulsive
disorder,
□ bulimia,
□ panic disorder
□ obesity
□ alcoholism
□ chronic pain.

Side effect
Teaching and labs
Side effects:
□ May be taken with
□ diarrhea,
food.
constipation, dry
□ pain relief may not
mouth
be experienced for
Adverse effects/toxicity:
several days
□ thrombocytopenia

contraindication
□ Use cautiously with
impaired renal or
hepatic function.
□ Do not breastfeed

□ DO NOT stop
abruptly.
□ Give meds once a
day at about noon
because it causes
insomnia. If
prescribed 2 times
daily give dose in
the morning early
and 12 noon to
prevent insomnia
□ Teach side effects
of drugs
□ Therapeutic
response takes
some weeks to be
established.

□ MI, cerebrovascular
disease.
□ If suicide risk,
should not have
access to a large
quantity.
□ Do not take while
pregnant

Common side effects:
□ Orthostatic
hypotension
□ psych med.
□ sedation
□ Tricyclic
□ Anticholinergic
antidepressant.
□ Hypomania
□ Selective Serotonin
□ Sexual dysfunction
Reuptake inhibitors
Adverse effects/toxicity:
(SSRI)
□ Cardiac toxicity
□
Selective Serotonin
Half-life 1-6 days.
syndrome (early s/s:
Onset 2-3 weeks to be
diaphoresis, agitation,
Such as rash. Wait 4-6
effective.
weeks before switch to low grade temp.) Then
Peak 4-8hrs.
increase in BP, muscle
MAO Inhibitor
Metabolized in liver,
rigidity, temp, resp,
absorbed from GI tract,
pulse. Mental status
excreted in urine and
changes, tremors,
face.
hyperthermia, sweating
hypersalivation.
Notify dr ASAP.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

□ avoid antacid use
within 1 hour of
dose

□ ** The combination
of TCA and MAOI
can lead to
hypertensive crisis
from excessive
adrenergic
stimulation of the
heart and blood
vessels.

33
Drug
Fluphenazine (Prolixin)

Use and dosage
□ Potent medication
for treatment of
□ phenothiazine; Ends
antipsychotic
with azine
symptoms,
including
□ antipsychotic
schizophrenia.
Half-life > 24 hours
□ Treatment is not
Onset: 1 hr.,
curative.
peak 0. 5 hr. meds
□ Adjust dose to
symptoms.
effect can be seen 1-2
days but full effect
□ Use injectable form
several weeks
for long term
maintenance
- the rate of relapse is
usually reduced and is
more favorable

Side effect
□ Produces EPS which
are reversible.
** Treat EPS with
Cogentin, Artane,
Benadryl, Symmetrel
Side effects: ABCDE
□ Anticholingergic
(dry mouth), Blurred
vision, Constipation,
Drowsiness, EPS
□ Photosensitivity
□ may increase risk of
agranulocytosis
□ gynecomastia,
□ amenorrhea
□ weight gain
Adverse effects/toxicity:
Neuroleptic malignant
syndrome (NMS) a fatal
side effect. Presents
with catatonia, rigidity,
stupor, unstable blood
pressure, hyperthermia
profuse sweating,
dyspnea, incontinence.
Stop drug. Tx with
Dantrium and Parlodel.
Condition lasts for 5-10
days after stopping
med.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
Monitor LFTs
TEACH
□ Avoid alcohol use
and other CNS
depressants
□ Do not alter dose or
stop abruptly
□ Avoid sun exposure
□ With oral
concentrate, avoid
spills. Rinse skin
with warm water
immediately if there
is contact

contraindication
Avoid with:
□ Caution with
narrow angle
glaucoma, hepatic
or renal dysfunction
and seizure
disorder.
□ Do not breastfeed
□ Dose should be
reduced in the
elderly.

□ Dilute liquid drug
with fruit juice
water, carbonated
beverage, milk,
soup – avoid mixing
with caffeine, tea,
apple juice.

34
Drug
Furosemide (Lasix)

□ Loop diuretics,
□ Anti-hypertensive

Peak 60-70 min PO, 2060 min IV.
Onset 30-60 min PO, 5
min IV,
Duration 2 hrs.,
Half-life 30 min

Use and dosage
□ Rapid acting loop
diuretic
□ Inhibits
reabsorption of
sodium and water
(in Loop of Henle)
□ Lowers BP by
decreasing edema
and intravascular
fluid
Treat
□ acute pulmonary
edema, edema,
□ heart failure,
□ chronic renal
impairment,
□ hypertension,
□ hypercalcemia

Side effect
Side effects:
□ Ototoxicity
□ headache
□ Dizziness
□ Orthostatic
hypotension
□ weakness

Teaching and labs
TEACH
□ change position
slowly to avoid
dizziness and
orthostatic
hypotension
□ report ringing in the
ear immediately
□ Take with food or
milk
Adverse effects/toxicity:
□ Give early in day to
□ s/s hypokalemia –
avoid nocturia
□ Hyponatremia,
□ Replace potassium
□ hypochloremia,
(dietary or meds)
□ hypomagnesaemia
□ hypocalcemia
□ Monitor labs,
especially
electrolytes. Also
IV form:
hgb, hct, platelet as
□ Administer slowly;
these increase d/t
hearing loss can
hemoconcentration
occur if injected
rapidly (ototoxicity).
□ Monitor body
□ Give over 1-2
weight and I&O.
minutes to prevent
hypotension.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Avoid with:
□ anuria, electrolyte
depletion,
increasing oliguria,
anuria
□ hepatic coma,
□ pregnancy,
lactation
□ Interaction with
digitalis can
increase
arrhythmias.
□ Interaction with
aminoglycosides
increases risk of
ototoxicity.

35
Drug
Gentamicin
(Garamycin)
□ Aminoglycosides.
□ Antibiotic
Peak level:
□ Drawn 15-30 min
after the infusion is
completed.
□ Peak concentration
determines that
toxic level does not
occur.
□ If peak is too high,
may reduce dose.
Trough level:
□ Drawn immediately
(within 30 minutes)
before next IV dose
□ Assures that
therapeutic level of
drug is maintained.
Trough level is 1-2
g/ml between
doses.
□ Dose will be
adjusted if level is
not sustained
Peak 30-90 min
Half-life 2-4 hr.

Use and dosage
□ Broad-spectrum
antibiotic
□ Parenteral use
limited to severe
infections,
unresponsive to
other antibiotics.

Ophthalmic:
□ treat superficial
infection of the
eye.
□ Have pt. keep eyes
closed for 1-2 min
after instillation.
□ Vision will be
blurred initially

Side effect
Side effects:
□ HA, parenthesia,
skin rash fever

contraindication
Avoid with:
□ Maintain hydration
□ Pre-existing renal
to protect kidney
disease
damage. Fluid
□ Use caution with
Adverse effects/toxicity:
intake should be
pre-existing hearing
2,500-3000 ml/day
□ Nephrotoxicity
loss
□ give high protein
□ Ototoxicity.
□ Pregnancy,
foods
This may cause
lactation
LABS
irreversible auditory
□ Increased risk with
□ WBC to monitor the
impairment and
nephrotoxic drugs,
vestibular damage
effectiveness of
prolonged
Signs of ototoxicity
therapy
treatment with
include HA, NV unsteady □ Watch kidney
aminoglycosides,
gait, tinnitus, vertigo,
function tests (BUN,
impaired renal
high frequency, hearing
Creat) closely due to
function and other
loss and dizziness
toxicity risk
ototoxic drug such
□ Hypersensitivity
as Lasix, Vanco.
reactions
□ Report sore throat,
□ Superinfection: a
watery stools
secondary infection
greater than 4-6 per
caused by
day, severe nausea
eradication of
or vomiting,
normal flora:
indicating possible
Candidiasis, skin and
super infection
mucous membrane

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs

36
Drug
Glipizide (Glucotrol)
□ oral antidiabetic
□ Sulfonylurea
duration: 12-24 hours
Onset: 15-30 min
Peak: 1-2hr
Metabolized by the
liver

Glucagon
□ Anti-hypoglycemic
Onset 5-20 min,
Peak 30 min
Duration 1-1.5 hr.,
Half-Life; 3-10 minutes

Metabolizes in liver,
plasma and kidneys

Use and dosage
□ Stimulates
pancreatic beta
cells to secrete
insulin.
□ Type 2 diabetes
mellitus
□ Give dose 1-3 time
daily
□ may use alone or in
combination with
insulin
□ Emergency
treatment of
severe
hypoglycemia in
unconscious client
or those unable to
swallow
□ Comes in powder
form. Reconstitute
with provided
diluent.
□ Give IV, IM or SQ
immediately
□ Give IV through
D5W only, not NS

Side effect
Side effects:
□ GI distress
□ dizziness
□ drowsiness
□ headache

Teaching and labs
□ Monitor labs
including glucose,
Hgb A1C

TEACH
□ Take with first daily
meal.
Adverse effects/toxicity: □ Take any missed
dose as soon as
□ Severe skin rash,
remembered.
pruritus
□ Report s/s of
□ Hypoglycemia
hypoglycemia if
they occur
□ Avoid alcohol
Side effects:
□ Should awaken
□ Nausea/ vomiting
within 5-20 min
after giving.
Adverse effects/toxicity: □ Give 50% glucose if
□ Hypersensitivity
no response to
reaction,
glucagon
Teach
□ hyperglycemia
□ test blood sugar,
□ Hypokalemia
□ teach family how to
administer SQ or IM

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Avoid with:
□ Pregnancy,
lactation
□ Allergy to sulfa or
urea
□ Diabetic
ketoacidosis
Caution with:
□ impaired renal and
hepatic function
□ Adrenal or pituitary
insufficiency.
□ Incompatible with
sodium chloride
solution.

37
Drug
Glyburide
(Micronase, DiaBeta)
□ Oral antidiabetic,
□ more potent drug
□ Sulfonylurea
Onset 15-60 min
Peak 1-2 hrs.
Duration up to 24 hrs.
Half-life 10 hours
Metabolized in the
liver, excreted in urine
and feces.
Haloperidol (Haldol)
High potency drug
□ Antipsychotic
□ Butyrophenone
□ Antiemetic
Onset: 30-45 min IM
Effects can be seen in 12 days. Substantial
improvement 2-4 wks.
Full effect several
months.

Use and dosage
□ Lowers blood sugar
concentration in
diabetics and
nondiabetics by
sensitizing
pancreatic beta
cells to release
insulin in the
presence of serum
glucose.
□ Type 2 diabetes
□ Use as adjunct to
diet and exercise to
lower blood sugar
□ Psychotic disorders
□ Long acting drug
for maintenance –
to control
symptoms
□ Tourette’s
syndrome

Side effect
Side effects:
□ Hypoglycemia,
□ epigastric fullness
□ heartburn
□ pruritus

Teaching and labs
□ Give once in the
morning with
breakfast or with
first main meal
□ Monitor labs
including glucose,
HgbA1c
Adverse effects/toxicity:
Teach
□ hypoglycemia
□ Report reaction
□ Loss of control of
blood glucose level
may be due to
fever, surgery,
trauma, stress,
infection.
Side effects: ABCDE:
□ EPSE: usually first
□ Anticholinergic (dry
few days of tx, dose
mouth)
related, controlled
by dose or anti□ Blurred vision
Parkinson’s drugs
□ Constipation
□ Oral: Give with milk
□ Drowsiness
or food.
□ Extrapyramidal
□ Taper dose slowly
syndrome (such as
when stopping.
Parkinson’s s/s)
□ Injection: deep IM –
□ Photosensitivity
risk for orthostatic
Adverse effects/toxicity:
hypotension
□ Elderly patient may
develop Neuroleptic □ no alcohol or driving
until response
Malignant
known
Syndrome (NLMS)

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Avoid use with:
□ diabetic
ketoacidosis
□ Type I diabetes
Caution with:
□ renal or hepatic
insufficiency
□ older adult
□ malnourished pt.
□ adrenal or pituitary
insufficiency

Avoid with:
□ Parkinson’s disease
□ seizure disorder
□ severe mental
depression
Use caution:
□ older adults,
□ lithium therapy
□ HTN
□ Lactation

38
Drug
Heparin
□ Anticoagulant
Antidote = Protamine
sulfate (see separate
listing)

Hydrochlorothiazide
hydrochloride
(Hydrodiuril, HCTZ)
□ Electrolyte and
water balance
□ Thiazide diuretic
□ Effects noted 3-4
days; max effect
takes 3-4 weeks

Use and dosage
□ As anticoagulant –
given IV or SQ
□ Use as continuous
IV infusion for DVT,
Pulmonary
embolus, angina,
acute MI
□ SQ for prevention

Side effect
Side effects:
□ Bleeding
□ Heparin-induced
Thrombocytopenia
(HIT) – may appear
up to several weeks
later.

□ Hep-lock (flush) is
to maintain
patency of IV
catheters; not for
anticoagulant
therapy
Side effects:
□ Act on distal
tubules of nephron □ Glucose intolerance,
and increases
hyperglycemia
urinary excretion of □ Hypokalemia (low
sodium, chloride,
K+)
potassium, water,
bicarbonate
□ Decreases edema
and lowers blood
pressure

□ Most widely
prescribed diuretic
for HTN

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ Does not dissolve
clots – prevents
enlargement and
development of
new clots.
□ Use bleeding
precautions
□ Monitor labs: aPTT
Normal = 25-40
Coagulated = 1.5-2
times normal = 60-80

contraindication
Avoid use with:
□ Hemorrhage, active
bleeding
□ Do not give IM.

□ Adjust IV dose
based on labs.
□ Give with food or
mild to reduce GI
upset.
□ Give dose(s) early in
the day to avoid
nocturia
□ Limit Sodium intake
□ Eat foods high in K+.
– replacement med
usually not needed
□ photosensitivity
reaction occur 10-14
days after initial sun
exposure

Avoid with:
□ Anuria
□ Hypersensitivity to
thiazide
Use caution:
□ Bronchial asthma
□ hepatic cirrhosis
□ renal dysfunction
□ history of gout
□ diabetes
□ SLE
□ Lactation

39
Drug
Hydroxyzine HCl
(Atarax, Vistaril)
□ Anti-emetics
□ Anti-histamine (H1
receptor
antagonist)
□ antipruritic
Onset 15-30 min PO
Peak 4-6 hrs.
Duration
Absorbed form GI.
Metabolized in the liver
Ibuprofen
(Advil, Motrin)
□ Analgesic
□ Non-steroidal antiinflammatory
(NSAID)
□ For high dose
therapy:
therapeutic effect
may take up to one
month

Use and dosage
□ Treat N/V (use
anticipatorily)
□ Relieve anxiety
□ Reduce narcotic
requirement before
and after surgery.
□ Treat acute or
chronic alcoholism
with withdrawal
symptom or DTs
□ Pruritus

Side effect
Side effects:
□ CNS depression,
□ Drowsiness
□ Dizziness
□ dry mouth,
anticholinergic
effect
□ constipation
□ visual changes
□ photosensitivity

Teaching and labs
IM:
□ Administer deep IM,
Z-track – gluteus
maximum or vastus
lateralis in adults;
vastus lateralis in
children

Side effects:
□ CNS, renal system,
eyes
□ Nephrotoxicity
□ dysuria, hematuria,
oliguria, azotemia,
□ Blurred vision.
□ Ototoxicity
Children toxicity:
□ Rash, StevensJohnson syndrome

□

□
□
□

Usually PO for
maintenance
□ Treat mild to
moderate pain
□ absorbed in GI;
metabolized in liver

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

□

contraindication
Avoid with:
□ CNS depression and
coma.
□ Other CNS meds
Use caution with:
□ glaucoma
□ seizure
□ intestinal
monitor mouth daily
obstruction
no alcohol
□ prostatic
hard candy, ice
hyperplasia
chips or rinse mouth □ asthma
with warm water
□ cardiac, pulmonary
frequently to relieve
or hepatic disease
dry mouth
Increases toxicity of Avoid with:
□ GI bleed
anticoagulant,
lithium
□ Reaction to other
NSAIDs
Avoid alcohol, ASA, □ Children under 6
other NSAIDs
months

40
Drug
INSULINS
-

quick acting:
short acting
intermediate acting
long acting

Insulin is also available
in a premixed form of
Regular and NPH
(example: 70/30 = 30%
regular, 70% NPH).

Use and dosage
□ Diabetes mellitus,
type 1 or type 2
□ Could be made of:
pork/beef, pork or
human insulin type.
□ Short acting and
intermediate acting
insulin may be
given more than
once per day.

Side effect
Side effects:
□ Hypoglycemia
(anxiety, confusion,
nervousness,
hunger, diaphoresis,
cool, clammy skin)
□ Lipodystrophy
(abnormal deposits
of subcutaneous fat
at injection sites),
□ local allergic
reaction
Adverse effects/toxicity:
□ Somogyi
phenomenon: a
rebound response
with high blood
sugar in response to
low level at night.
□ Coma
□ Hyperosmolar
hyperglycemic state
(HHS)
□ Diabetic
ketoacidosis (DKA)

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ obtain med alert
bracelets
□ Open vial can be
stored at room
temp for up to one
month.
□ Rotate sites
□ Alcohol will increase
blood sugar

contraindication
□ Do not use
beef/pork insulin if
sensitivity

□ Requires long-term
monitoring of blood
sugar control and
potential
complications.

41
Drug
Insulin – Regular
(Humulin R)
**THIS IS THE ONLY TYPE
OF INSULIN WHICH CAN BE
GIVEN

IV. **

Isophane (NPH) insulin
(Humulin N)

Insulin – Glargine
(Lantus)
** LANTUS CANNOT BE
MIXED IN SAME SYRINGE

Use and dosage
Side effect
□ Short acting insulin □ hypoglycemia
□ Given IV or SQ
□ type 1 and type 2
diabetes mellitus
and ketoacidosis.
□ given before meals
according to blood
levels
□ Intermediate
□ If given before
acting insulin
breakfast,
hypoglycemic
□ Give 30 min before
episode is most
first meal of the
likely to occur
day. If necessary, a
between midsecond smaller
afternoon and
dose may be
dinner, when it
prescribed 30 min
peaks. Eat snack in
before bedtime.
midafternoon and
carry sugar candy.

Teaching and labs
□ Regular insulin is
clear and colorless.

□ Long acting insulin
□ Type 1 children &
adults; Type 2
adults
□ SQ injection

contraindication

□ With Type 2
diabetes, may or
may not be given
concurrently with
oral agents.

□ NPH Insulin is a
cloudy suspension.
□ Roll the bottle to
mix; do not shake.
□ NOTE: NPH may be
mixed with Regular
insulin injection
without altering
either solution.

WITH ANY OTHER
INSULIN.**

□ Usually given one
per day at bedtime.
May be given two
times per day.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

42
Drug
Iron

Use and dosage
□ Mineral
replacement

Ipecac Syrup

Adverse effects/toxicity: □ Use of this
□ For overdose on
□ Cardiotoxicity is
certain drug or
medication is not
poison
most serious if
automatic – verify
vomiting does not
appropriateness
□ stimulates vomiting
occur and the
with Poison control
within 20-30 min
substance is
center
retained.

□ Emetic
□ Antidote

Alternate: Activated
Charcoal (see separate
listing)

Side effect
Side effects:
□ Nausea/vomiting
□ Staining of teeth
□ Constipation
□ Black stools
(normal)

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ Taking on empty
stomach preferred
with full glass of
water or citrus juice
□ Calcium inhibits iron
absorption – do not
take with milk.
□ Vitamin C increases
iron absorption
□ Liquid form can
stain teeth

contraindication

Do not use:
□ With reduced level
of consciousness or
convulsions
□ poison by
Petroleum
distillates, strong
alkaline, acid or
strychnine

43
Drug
Lidocaine HCl
(Xylocaine)
□ Antiarrhythmic
□ Topical Anesthetic
Bolus dose – may
repeat – then start
continuous infusion –
stop when stable.
Therapeutic level: 1.56mcg/ml

Use and dosage
□ Treat VENTRICULAR
arrhythmias, PVC’s,
V-Tach.
□ Use for rapid
control of
ventricular
dysrhythmias
during acute MI or
Cardiac cath
□ Use microdrip
tubing and infusion
pump.

Side effect
Side effects:
□ Drowsiness,
headache, dizziness,
mild hypotension.
Adverse effects/toxicity:
□ convulsions,
respiratory
depression
□ CV: hypotension,
bradycardia, heart
block CV collapse,
and arrest

Teaching and labs
LAB
□ Monitor Lidocaine
levels assess,
therapeutic level is
1.5 -6mcg/ml
□ Assess electrolyte,
check baseline liver
and renal blood
studies.
Report:
□ lightheadedness,
□ dizziness, confusion,
□ numbness or
□ Stop infusion with
tingling of lips,
EKG changes such as
tongue or fingers
prolonged PR,
□ visual changes or
widened QRS, heart □ ringing in ears
block.
□ Correct
hypokalemia before
giving Lidocaine

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Avoid with:
□ Sinus bradycardia
□ Severe degrees of
SA, AV and
intraventricular
heart block.
Use caution:
□ hepatic or renal
disease
□ CHF
□ Hypovolemia
□ shock
□ hyperthermia
□ elderly
□ BETA BLOCKERS
increase the effect
of lidocaine

44
Drug
Lithium carbonate
(Eskalith)
□ Mood stabilizer
□ Antipsychotic
□ Therapeutic level
0.8-1.5meq/L.
□ Toxic level >2.
□ Lithium has short
half-life (about 1
day) and high
toxicity.

Lorazepam (Ativan)
□ Anxiolytic
□ Sedative-hypnotic
□ Benzodiazepines.
Onset
1-5 min IV, 15-30 IM,
Peak
60-90 min IM, 2 hrs. PO
Duration 12-24 hrs.

Use and dosage
□ Drug of choice to
control manic
episodes in bipolar
disorder
□ Anti manic effects
are usually seen in
5-7 days after initial
doses, but full
effect does not
occur for 2-3 wks.
□ Lithium is a salt;
exact action
uncertain

□
□

□

□

Side effect
□ This med does not
cause sedation.
Mild Side effects:
□ fine tremor, nausea,
thirst, polyuria,
Adverse effects/toxicity:
□ Vomiting, diarrhea,
slurred speech, lack
of coordination,
drowsiness, muscle
weakness, or
twitching) –
withhold dose and
notify provider but
DO NOT stop
abruptly.
Side effects:
anxiety disorder
short term for relief □ Drowsiness
□ sedation
of symptoms of
anxiety
□ Mild medication
Pre-anesthetic
with limited toxic
medication to
potential
produce sedation
□ respiratory
and reduce anxiety.
depression is rate
Status epilepticus
Paradoxical reactions
(nightmares, mania,
etc.) may occur in
children, psych patients
and the elderly.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ Give with meals
□ Hydration is
essential –
dehydration will
increase levels
□ Watch for weight
gain (fluid
retention)
□ Avoid NSAIDs and
diuretics.
□ Essential to monitor
mood and behaviors
□ Labs: Lithium level
every 3 months
initially, then every
6 months.
□ Avoid alcohol
□ Taper dose when
stopping to avoid
withdrawal
symptoms
□ Watch for suicidal
risk

contraindication
Do not use with:
□ Dehydration,
severe debilitating,
severe
cardiovascular.
Use caution:
□ elderly,
□ pt. with cardiac,
renal, thyroid or
diabetes
□ pregnancy

Do not use with:
□ Acute narrow-angle
glaucoma,
□ Primary depression
□ acute alcohol
intoxication.
□ Pregnancy and
Lactation
Use caution:
□ renal or hepatic
impairment
□ myasthenia gravis
□ suicidal tendencies

45
Drug
Magnesium Sulfate
iron(Epsom salt – oral
form)

Onset 1-2 hrs. PO; 1 hr.
IM.
Duration 30 min IV, 3-4
hr. PO
Eliminated by kidneys

Use and dosage
□ Oral: laxative (by
osmotic retention
of fluid which
distend the colon,
increase content of
feces and cause
bowel stimulation)
□ Parenteral: CNS
depressant; used in
seizures of
toxemia; for
hypomagnesemia

Normal Magnesium
level: 1.8-3 mEq/L
□ 4 gm. loading dose
is give over 20-20
min via pump.

Side effect
Side effects:
□ Flushed warm
feeling
□ fluid and electrolyte
imbalance
□ hyponatremia
□ N/V
Adverse effects/toxicity:
Early indication of
magnesium toxicity
□ Respiratory
depression
□ Cathartic effect
□ profound thirst
□ feeling of warmth
□ sedation
□ confusion
□ depressed deep
tendon reflexes
□ muscle weakness
□ can lead to cardiac
arrest

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
s/s hypomagnesemia:
□ irritability
□ tremors, tetany
□ tachycardia
□ hypertension
□ psychotic behavior
□ Monitor urinary
output and hydrate
adequately with
parenteral
administration.

contraindication
Avoid with:
□ MI, heart block,
cardiac arrest
except for certain
arrhythmias.
Use caution:
□ impaired kidney
function
□ other cardiac
glycosides
□ Lactating moms
and children

46
Drug
Mannitol (Osmitrol)

Use and dosage
□ Use in oliguria and
acute renal failure.
□ Electrolyte and
Help to prevent
water balance
renal failure and
agent
reduce increased
intracranial or
□ osmotic diuretic
intraocular
pressure
Onset
1-3 hr. diuresis; 30 to 60 □ It acts by increasing
min IOP, 15 min. for ICP
the osmolality of
Duration
plasma, glomerular
4-6 hr. IOP,
filtrate, and tubular
3-8 hr. ICP
fluid. This
decreases the
Serum osmolality is 275reabsorption of
300 mmol/kg.
fluid and
electrolytes, which
increases excretion
of water, chloride
Give IV.
and sodium and
Usually give test dose
slightly increase the
which should result in
excretion of
Output of 30 to 50
Potassium.
ml/hr. and is produced □ In intraocular (IOP)
2-3 hrs. after
and CSF (ICP), it
administration.
pulls the fluid and
sends it to the
plasma and
extravascular
systems

Side effect
Side effects:
□ HA, confusion,
syncope
□ fluid and electrolyte
imbalance, esp.
hyponatremia
□ pulmonary
congestion, rhinitis
□ Water intoxication

Teaching and labs
□ Use filter needle
and/or filter in
infusion tubing
because crystals
may form in the
solution.
□ Mannitol is held if
serum osmolality
exceeds 310 -320.
□ Daily weights
Adverse effects/toxicity: Teach
□ Non-narcotics such
□ Seizure,
as Tylenol if there is
□ thrombophlebitis,
headache
□ CHF, Cardiovascular
□ Therapy is based on
collapse
urine flow rate.
□ Hyponatremia
□ Reassure pt. that
excessive thirst,
Warning: There may be
blurred vision,
a rebound increase in
rhinitis should
ICP about 12 hours after
subside when
administration of med.
Mannitol is
Pt may complain of HA,
discontinued
or confusion.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Do not use:
□ severely impaired
renal function
□ marked
dehydration
□ breast feeding
□ hepatic failure,
□ active ICP
□ anuria
□ Intracranial bleed
shock
□ Question the
administration of
mannitol if the
patient has cor
pulmonae (right
sided heart failure)
because Mannitol
pulls fluid and it
may lead to
circulatory overload
which the heart
could not handle.
This client would
need loop diuretic
to prevent serious
complications

47
Drug
Meperidine HCl
(Demerol)
□ Narcotic analgesic
(opioid agonist)

Use and dosage
□ Given for moderate
to severe pain.
□ Potent, long acting

Give Narcan for
toxicity - It is use to
reverse respiratory
depression induced by
overdose
Onset: 15 mins. PO, 10
mins. IM, 5 mins IV
duration 2-4 hours
Metoprolol tartrate
(Lopressor, Toprol)
□ Beta adrenergic
antagonist
(beta blocker)
□ Antihypertensive
□ Antianginal = same
action as with
propanolol

Side effect
Side effects:
□ N/V, Anorexia
□ Sedation, dizziness
□ elevated BP
□ rash, urticaria
□ tremors
□ hyperventilation
Adverse effects/toxicity:
□ Resp depression,
□ respiratory arrest,
□ circulatory
depression,
□ increased
intracranial pressure

□ Decreases heart
rate and cardiac
output
□ Lowers BP
□
□
□
□

Side effects:
□ Usually well
tolerated
□ Nausea, vomiting
□ Weight gain
Mild to severe HTN □ worsening CHF
angina pectoris
□ insomnia
**Post - acute MI** Adverse effects/toxicity:
□ profound
Max effect may
bradycardia
take 1 week
□ heart block
□ acute CHF,
□ bronchospasm
□ laryngospasm

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
Assess:
□ LOC
□ rash, urticaria
□ respiratory rate.
If respirations < 12 per
minute – withhold
meds.

contraindication
Avoid use with:
□ acute bronchial
asthma, upper
airway obstruction
□ increased
intracranial
pressure
□ convulsive disorder
□ pancreatitis, acute
ulcerative colitis
□ severe liver or
kidney insufficiency
Caution with:
□ children and elderly

□ Give with or w/o
food, but consistent
□ Do not stop
abruptly; may cause
rebound effect.
Gradually decrease
over 1-2 wks.
□ Hold meds if BP < 90
or pulse < 60
□ Watch for s/s heart
failure
□ Can lead to elevated
BUN, creat.
□ May mask
hypoglycemia

Avoid use with:
□ Heart block greater
than 1st degree
□ Sinus brady,
□ cardiogenic shock
Use caution:
□ hyperactive airway
syndrome ( asthma
or bronchospasm)
□ Increases chance of
both Dig and
Lithium toxicity

48
Drug
Morphine Sulfate
(MS Contin = sustained
release form)
□ Narcotic analgesic
(Opioid agonist)

Use and dosage
□ Produces effect by
binding to opioid
receptors
throughout the
CNS.
□ Schedule II drug,
major drug abuse.
□

Give Narcan for
toxicity.

□

Onset, Peak, Duration
depend on route of
□
medication.
Onset: Immediate IV,
rapid if given IM or oral,
except MS Contin
□

Side effect
Side effects:
□ Nausea vomiting
anorexia, GI,
□ pruritus,
□ light headedness
□ constipation
Adverse effects/toxicity:
□ Classic triad of
symptoms:
For severe, chronic
respiratory
or acute pain.
depression, coma,
Most commonly
pinpoint pupils.
use in post□ Withdrawal begins
operative setting.
6-8 hrs. After the
mild bronchodilator
last dose, reach
to improve
peak intensity within
breathing
48-72 hrs. S/S
include craving,
MS Contin is
chills, sweating
sustained release;
piloerection (goose
it will not control
flesh), abdominal
break-through pain
pain and cramps,
because it is time
diarrhea, runny
release.
nose, irritability.
□ Morphine induced
CNS stimulation –
paradoxical reaction
common in women
and older adults.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs

contraindication
Avoid use with:
□ Avoid alcohol use
□ Hypersensitivity to
opiates)
□ Hold medication if
□ acute bronchial
respirations < 12/min
asthma or upper
airway obstruction,
□ Hydrate adequately □ ICP
to prevent
□ convulsive
constipation
disorders
□ pancreatitis, acute
ulcerative colitis
□ severe liver or
kidney disease
□ Do not give
morphine to
children

49
Drug
Use and dosage
Naloxone HCl (Narcan) □ Competes with
opioids at the
opiate receptor
□ Opioid antagonist.
sites, blocking the
effects of the
Onset
opioids
1-2 min IV;
□ Reverses effects of
2-5 mins. SQ or IM
opiates, including
respiratory
Duration
depression,
1 hr. IV; up to 4 hrs. IM
sedation and
but start to diminish
hypotension.
after 20 mins.
□ May need given
every few hours
until the opioids
has dropped to a
nontoxic level
Nedocromil (Tilade)
□ asthma prophylaxis
NOT for acute
□ Inhaled nonasthma attacks
steroidal
□ up to a week for
medication
full effectiveness
□ anti-inflammatory
□ Must be taken
and antiasthmatic.
regularly to be
effective

Side effect
Side effects:
□ Increased BP, HR,
hyperpnea
□ tremors,
□ hyperventilation,
□ drowsiness,
□ nervousness
□ N/V

Teaching and labs
□ Watch vital signs
and respiratory
function closely
with administration
of medication

contraindication
Avoid use with:
□ Known allergy
□ Respiratory
depression d/t nonopioids
□ Substance abuse
□ Titrate dose slowly (may lead to
if too much is given
withdrawal
the client will swing
symptoms)
from a state of
Adverse effects/toxicity:
intoxication to one
□ Hypotension,
of withdrawal
□ V-tach and V-fib
□ convulsion,
□ hepatitis
□ pulmonary edema,

Adverse effect:
□ abnormal bitter
taste
□ N/V, HA, dizziness,
sore throat.

□ Rinse mouth after
taking medication
to avoid dry mouth
□ Do not use for
acute attack
□ Non-compliance is a
concern due to
bitter taste

Avoid use with:
□ acute
bronchospasm or
status asthmaticus.
□ Hypersensitivity
Use with caution:
□ hepatic or renal
function

(also available as optic
form – for ocular
allergic conjunctivitis)

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

50
Drug
Neomycin sulfate
(Mycifradin)
□ ORAL
aminoglycoside
□ antibiotic

Nifedipine (Procardia)
□ Calcium Channel
Blocker
□ Antianginal
□ Antihypertensive
□ Negative inotropic

Use and dosage
Antibacterial – ORAL
□ GI tract
□ Hepatic coma

Side effect
Side effects: skin rash
(esp. topical)

Teaching and labs
□ Poorly tolerated GI
so it is usually for
bowel cleansing.

contraindication

Adverse effects/toxicity:
Main form is topical for □ Nephrotoxicity
eye, ear and skin
□ Ototoxicity.
infection.
NEOMYCIN IS NOT GIVEN IV
□ angina
□ mild to moderate
HTN (sustained
release form)
□

□

□

□

□ Do not give 1-2 wks.
after an acute MI.
□ Do not give with
grapefruit juice
(could lead to
toxicity)
Dilates coronary
□ Report gradual
arteries and relaxes
coronary spasm
weight gain and
evidence of edema;
Increases cardiac
may indicate onset
output; decreases
of CHF.
peripheral vascular Adverse effects/toxicity:
□ Do not stop
resistance.
□ Gingival hyperplasia
suddenly (will have
Blocks calcium ion
rebound symptoms)
flow into cells of
□ Smoking decreases
myocardial and
arterial smooth
efficacy of med
muscle (cardiac and
□ Monitor pulse rate –
peripheral blood
report irregular or
vessels)
slower than normal
Slows HR;
rate. Hold for BP
decreases O2 need
below 90/60.
Side effects:
□ Usually well
tolerated
□ Headache
□ fatigue
□ Dizziness
□ Postural
hypotension
□ peripheral edema

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Avoid use with:
□ Known
hypersensitivity
□ Unstable angina
□ Lactation

51
Drug
Oxytocin (Pitocin)
□ Oxytocic
Labor and delivery.
Onset is immediate.
After stopping med,
contractions should
stop in 2-3 minutes
Half-life 3-5 min

Pancrelipase
(Creon, Pancrease)
□ Pancreatic enzyme
replacement
therapy

Use and dosage
□ To initiate or
improve uterine
contractions at
term
□ Induce labor
□ Management of
incomplete or
missed abortion
(miscarriage)
□ reduce postpartum
bleeding

□ Help to breakdown
fat, proteins and
carbs for better
absorption.
□ cystic fibrosis
□ chronic
pancreatitis, post
pancretectomy
□ steatorrhea
□ malabsorption
syndrome

Side effect
Teaching and labs
Side effects:
□ Careful monitoring
□ subarachnoid bleed
of uterine
contraction pattern,
□ fetal trauma
fetal heart rate and
□ seizure, coma
maternal BP.
Adverse effects/toxicity:
Hypertensive crisis.
□ Postpartum;
monitor lochia and
For fetal anoxia:
BP.
□ stop infusion, turn

contraindication
Avoid use with:
□ Hypersensitivity
□ Cepahalopelvic
disproportion
□ Obstetric
emergencies

mom on left side,
oxygen prn
Stop infusion for:
□ Contractions which
occur more often
than every 2 mins.
or last over 90 sec.

□ Do not increase
dose after desired
contraction pattern
is achieved
(contraction
frequency of 2-3 min
lasting 60 sec).
Side effects:
□ Take with or just
□ Nausea, diarrhea,
prior to eating
and cramps
□ Do not mix brand
names; there is a
Adverse effects/toxicity:
variance in
Hyperuricemia.
concentration of
□ Report joint or
enzymes
swelling pain (high
□ Swallow tablet or
uric acid level)
capsule whole; do
not crush or chew.
□ Can mix powder or
open capsule with
food.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Drug interaction:
□ Allergy to med or
pork
□ Do not give with
magnesiumcontaining antacid.
May be ordered
with H2 blockers or
with proton pump
inhibitors.
□ Iron will decrease
effectiveness of
med.

52
Drug
Phenobartial
(Phenobarbital Sodium
= Luminal) – this is the
short-acting form.
For status epilepticus:
Administer slow IV
□ Anticonvulsant
□ Sedative-hypnotic

Pilocarpine
hydrochloride (Pilocar)
□ Eye preparation.
□ Miotic (Antiglaucoma agent).
□ Direct acting
cholinergic agent
for ophthalmic use.
□ It is an antidote to
Atropine

Use and dosage
□ Long-term
management of
grand mal, partial
seizure and status
epilepticus.
□ Sedative effect to
decrease anxiety
and tension.
□ No analgesic effect

□ For acute or
chronic Glaucoma –
decreases
intraocular
pressure
□ Will reverse the
effects of Atropine
(and Atropine will
reverse the effects
of Pilocarpine).

Side effect
Side effects:
□ Somnolence,
hangover effect
Adverse effects/toxicity:
□ CNS depression,
□ Stevens-Johnson
□ Blood dyscrasias
□ Paradoxical
reactions may occur
in children, older
adults and
debilitated people

Teaching and labs
□ Okay to crush and
mix with food or
fluids
□ Monitor IV infusion
closely.
□ Do not stop
abruptly
□ Avoid alcohol and
other CNS
depressants

Side effects:
□ Apply gentle
□ Visual blurring,
pressure for 1-2
myopia, irritation,
mins. to
brow pain and HA.
nasolacrimal
(with ophthalmic)
drainage area after
administering eye
□ Normal: Increased
gtts
pigmentation of iris
□ Eye therapy will
and eyelids; long
eyelashes.
continue long term
Adverse effects/toxicity:
□ Retinal detachment
□ Ataxia
□ Confusion
□ seizure

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Avoid use with:
□ Hypersensitivity
□ Resp or kidney
failure
□ Pregnancy and
lactation

Avoid use with:
□ Asthma, COPD
□ HTN
□ Acute eye
infections, retinal
detachment,
contact lens use

53
Drug
Prazosin hydrochloride
(Minipress)
□ Antihypertensive
□ Alpha-adrenergic
receptor antagonist
□ vasodilator
□ Treat benign
prosthetic
hyperplasia (BPH)

Use and dosage
□ Mild to moderate
HTN – mainly
diastolic
□ little effect on
cardiac output and
HR
□ BPH (due to
vasodilator effects)

Optimal effects may
take 4-6 weeks

Prochlorperazine
(Compazine)
□ Antiemetic
□ Antipsychotic
□ Phenothiazine

□
□

□

□

Side effect
Side effects:
□ Dizziness,
drowsiness
□ Fatigue, weakness.
□ Priapism, impotence
□ Orthostatic
hypotension
Adverse effects/toxicity:
□ First-dose
phenomenon:
syncope within 30
min to 1 hr. Effect is
transient, may
diminish by giving
at bedtime.
Severe nausea and Side effects:
□ drowsiness,
vomiting
dizziness,
Management of
□ EPSE
psychotic
disorders,
Adverse effects/toxicity:
excessive anxiety
□ Persistent tardive
and agitation
dyskinesia
□ Tremor, twitching
Take 30-60 min
□ Agranulocytosis,
before any activity □ thrombocytopenia
that causes nausea □ After 1-2 months:
for best effect.
Akathisia (inner
restless, inability to
Start doses low and
sit still) – may tx
increase slowly
with propranolol.

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ monitor for
decreased BP,
especially with
initial administration
□ Monitor urine vol.
□ change position
slowly to prevent
orthostatic
hypotension
□ stop smoking and
avoid alcohol intake
□ avoid driving and
hazardous tasks
until effect of med
is known
□ Avoid excessive
sunlight – may turn
skin gray-blue
□ Urine may turn
reddish brown
□ Use sugarless hard
candy or ice chips to
avoid dry mouth.
□ Avoid skin contact
with concentrate
□ Do not crush or
chew – swallow
whole
□ Deep IM, not SQ
injection

contraindication
Avoid use with:
□ Prior sensitivity
□ hypotension
Use caution with:
□ impaired hepatic
function
□ older adults

Avoid use with:
□ Hypersensitivity
□ Blood dyscrasias
□ Dementia related
psychosis in elderly
□ Young children
□ Seizures
□ Lactation

54
Drug
Promethazine
(Phenergan)
□ Antiemetic
□ Antihistamine
□ Anti-vertigo

Protamine sulfate
□ Antidote for
Heparin toxicity.
□ Heparin antagonist
Onset = 5 minutes
Duration = 2 hours
Longer half-life than
heparin
Ranitidine
hydrochloride (Zantac)
□ H2-receptor
antagonist.
□ Higher potency
than cimetidine
(Tagamet)

Use and dosage
□ Long-acting med
□ motion sickness
□ nausea

Side effect
Side effects:
□ Resp depression,
□ drowsiness,
confusion
□ IM route: Give deep □ agranulocytosis
□ blurred vision
IM; not SQ (can
cause necrosis)
□ dry mouth
□ Avoid intra-arterial □ EPSE
injection – can
cause necrosis.

Teaching and labs
□ Decrease GI distress
by giving oral dose
with milk or food.
□ May crush and mix
with food.
□ Avoid sunlight
exposure
□ Avoid alcohol and
other CNS
depressants

contraindication
Avoid use with:
□ Acute MI, angina,
atrial fib
Use caution with:
□ Narrow angle
glaucoma
□ peptic ulcer
□ duodenal
obstruction

□ Antidote for
Heparin overdose
□ Given IV; maximum
dose of 50 mg in 10
min time period;
should be titrated
according to the
time and length of
time the heparin
was administered
□ Reduce gastric
secretion.
□ Active duodenal
ulcer, maintenance
after healing
□ GERD
□ benign gastric ulcer
(short-term)

□ Monitor vital signs
and labs closely
(aPTT)

Avoid use with:
□ Hemorrhage not
induced by heparin
overdose.

Side effect:
□ Abrupt drop in BP if
administered too
rapidly.

See listing for HEPARIN

Side effects:
□ headache
□ taste disorder,
diarrhea,
constipation
□ dry mouth
Adverse effects/toxicity:
□ hepatotoxicity
□ thrombocytopenia

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

□ Give without regard
to meals
□ Usually give 1 x day
□ reduce dose in renal
patient
□ avoid smoking to
□ avoid antacid within
1 hour of dose

Avoid use with:
□ Hypersensitivity
Use caution with:
□ Impaired renal of
hepatic function.
□ May increase
effects of alcohol,
aspirin, Coumadin
and sulfonylureas

55
Drug
Rh0(D) immune
globulin (RhoGAM)
□ Biological response
modifier
□ Immunoglobulin
(IgG)
Peak 2 hour
Half-life 25 days

Use and dosage
□ Given to Rhnegative moms
with RH positive
babies.
□ Provides passive
immunity by
suppressing active
antibody response
and formation of
anti-RHo when (1)
positive fetal RBC
enters maternal
circulation during
the third stage of
labor; (2) there is
fetal maternal
hemorrhage or other
trauma during
pregnancy; (3)
termination of
pregnancy or
miscarriage; or (4)
following a Rh+
transfusion.

Side effect
Side effects:
□ Injection site
irritation
□ slight fever
□ myalgia
□ lethargy

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
contraindication
Avoid use with:
□ Send sample of
newborn cord blood □ Known sensitivity
to lab for cross
to human
match and typing
immunoglobulins.
immediately after
delivery before
administer RHo (D)
□ Give to mom IM via
deltoid. (Only a few
forms can be given
IV).
□ Give immediately
after reconstitution
□ Recommended at
28 weeks gestation
and then within 72
hours after delivery
or 3 hrs. of
termination of
pregnancy or
miscarriage.
□ Keep epinephrine
available; systemic
allergic reactions
sometimes occur.
□ TEACH it will
prevent hemolytic
disease in a
subsequent
pregnancy

56
Drug
Setraline
hydrochloride (Zoloft)
□ Antidepressant
□ SSRI (selective
serotonin reuptake
inhibitor)

Spironolactone
(Aldactone)
□ Fluid & electrolyte
balance
□ antihypertensive
□ Potassium sparing
diuretic

Use and dosage
□ panic disorders
□ Anxiety disorders
□ OCD
□ PTSD
□ 2-3 wks. to be
effective

□ Increases sodium
excretion; does not
decrease
potassium
□ treatment of
primary
aldosteronism
□ Use for edema and
HTN associated
with heart failure.

Side effect
Side effects:
□ Cause fewer
disorders than other
antidepressants
□ fewer side effects
on HR and HTN
□ Sexual dysfunction
□ Weight gain
Major complication
□ (Selective Serotonin
Syndrome): Pt. can
die from it. Elevated
temp up to 105.
Every speed up. BP,
HR, Temp. May
progress to coma.
Side effects:
□ Headache
□ dizziness, weakness
□ orthostatic
hypotension
Adverse effects/toxicity:
□ Hyperkalemia
(nausea, vomiting,
diarrhea, cramps,
tachycardia then
bradycardia)
□ aplastic anemia
□ thrombocytopenia

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

Teaching and labs
□ Give with food in
the morning to
prevent insomnia
□ Watch for suicide
risk
□ Increases effect of
Coumadin
□ Avoid grapefruit
juice

contraindication
Avoid use:
□ Within 14 days of
using MAO inhibitor
□ Seizure disorder

□ Take with food
□ avoid salt substitute
high in K+
□ Avoid excessive
ingestion of foods
high in potassium.
□ no potassium
supplement needed
□ Monitor VS and
urine output
□ Avoid direct
sunlight

Avoid use with:
□ Serum K+ level > 5.5
□ anuria, acute and
chronic renal
insufficiency
□ diabetic
nephropathy
□ hypersensitivity
□ impaired hepatic
function
□ Decreases effect of
Dig;
□ increases chance of
lithium toxicity

57
Drug
Sucralfate (Carafate)
□ Antiulcer
□ Gastro-protective
agent

Theophylline
(Theo-dur)
□ Bronchodilator
(resp. smooth
muscle relaxant)
□ xanthines
□ Normal level 10-20.
toxic level (> 20)
may develop
quickly

Use and dosage
□ Protects the ulcer
from gastric acid by
forming an
adherent coating; it
absorbs pepsin
decreasing its
activity.
□ Duodenal ulcer
□ Short term with
gastric ulcer
□ esophageal ulcer
related to radiation
or chemotherapy
□ bronchospasms
□ asthma
□ bronchitis
□ emphysema

Side effect
Side effects:
□ constipation
□ nausea

WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013)

contraindication
Avoid use with:
□ Chronic kidney
failure

□ Avoid gastric
irritants such as
caffeine, alcohol,
smoking and spicy
foods.

Side effects:
□ Tachycardia
□ Seizures
□ N/V, anorexia,
Adverse effects/toxicity:
□ restlessness,
agitation, HA, and
insomnia
□ note: restlessness
could be due to
toxicity or hypoxia
so close assessment
is required

Teaching and labs
□ No antacid use
within ½ hour of
this medication

□ Decreases
absorption of Cipro,
Dig, Dilantin,
Tetracycline (so take
these med 2 hours
apart from Sucralfate)

□ PO: take with water
and after meals.
□ Wait 4-6 hours after
IV to start PO.
□ Take same time
each day

Avoid use with:
□ CAD, angina
□ Renal or liver
disease
□ Pregnancy,
lactation
□ children
□ CHF and acute viral
□ can cause seizure
(with high
doses/levels) so
avoid with seizure
disorder unless
bronchospasm is
unresponsive to
other treatments

□ Limit caffeine
□ Smoking decreases
effect of med
□ Increases lithium
excretion

58
Nln pharmacology study guide final 6 3-2013
Nln pharmacology study guide final 6 3-2013
Nln pharmacology study guide final 6 3-2013
Nln pharmacology study guide final 6 3-2013
Nln pharmacology study guide final 6 3-2013
Nln pharmacology study guide final 6 3-2013
Nln pharmacology study guide final 6 3-2013

More Related Content

What's hot

Injection Technique
Injection TechniqueInjection Technique
Injection TechniquePaolo Zabat
 
1 care of postpartum
1 care of postpartum1 care of postpartum
1 care of postpartumHishgeeubuns
 
Normal labour and delivery ppt
Normal labour and delivery pptNormal labour and delivery ppt
Normal labour and delivery pptRhea Marcano
 
Introduction to midwifery
Introduction to midwiferyIntroduction to midwifery
Introduction to midwiferyJAYDIP NINAMA
 
Drugs used in pregnancy, labor and puerperium
Drugs used in pregnancy, labor and puerperiumDrugs used in pregnancy, labor and puerperium
Drugs used in pregnancy, labor and puerperiumAnamika Ramawat
 
Intramuscular Injection -common sites, procedure, complications
Intramuscular Injection -common sites, procedure, complicationsIntramuscular Injection -common sites, procedure, complications
Intramuscular Injection -common sites, procedure, complicationsGanga Tiwari
 
Postpartum hemorrhage
Postpartum hemorrhagePostpartum hemorrhage
Postpartum hemorrhageSeif Said
 
Chest Drains
Chest DrainsChest Drains
Chest Drainsnishad
 
Lesson plan on perineal care procedure use in OBG and Nursing foundation Assi...
Lesson plan on perineal care procedure use in OBG and Nursing foundation Assi...Lesson plan on perineal care procedure use in OBG and Nursing foundation Assi...
Lesson plan on perineal care procedure use in OBG and Nursing foundation Assi...sonal patel
 
Intravenous cannulation
Intravenous cannulationIntravenous cannulation
Intravenous cannulationAYM NAZIM
 
Nursing case study Appendectomy
Nursing case study AppendectomyNursing case study Appendectomy
Nursing case study Appendectomypinoy nurze
 
pediatric Drug administration
pediatric Drug administrationpediatric Drug administration
pediatric Drug administrationRia Saira
 

What's hot (20)

Intravenous infusion
Intravenous infusionIntravenous infusion
Intravenous infusion
 
Injection Technique
Injection TechniqueInjection Technique
Injection Technique
 
9. drugs used in critical
9. drugs used in critical9. drugs used in critical
9. drugs used in critical
 
IV CANNULA INSERTION
IV CANNULA INSERTIONIV CANNULA INSERTION
IV CANNULA INSERTION
 
1 care of postpartum
1 care of postpartum1 care of postpartum
1 care of postpartum
 
Nursing care of_hyperbilirubinemia
Nursing care of_hyperbilirubinemiaNursing care of_hyperbilirubinemia
Nursing care of_hyperbilirubinemia
 
Labetalol HCl
Labetalol HClLabetalol HCl
Labetalol HCl
 
Normal labour and delivery ppt
Normal labour and delivery pptNormal labour and delivery ppt
Normal labour and delivery ppt
 
Oxygen therapy
Oxygen therapyOxygen therapy
Oxygen therapy
 
Introduction to midwifery
Introduction to midwiferyIntroduction to midwifery
Introduction to midwifery
 
Drugs used in pregnancy, labor and puerperium
Drugs used in pregnancy, labor and puerperiumDrugs used in pregnancy, labor and puerperium
Drugs used in pregnancy, labor and puerperium
 
Intramuscular Injection -common sites, procedure, complications
Intramuscular Injection -common sites, procedure, complicationsIntramuscular Injection -common sites, procedure, complications
Intramuscular Injection -common sites, procedure, complications
 
Postpartum hemorrhage
Postpartum hemorrhagePostpartum hemorrhage
Postpartum hemorrhage
 
Chest Drains
Chest DrainsChest Drains
Chest Drains
 
Intake Output Chart Guidelines
Intake Output Chart GuidelinesIntake Output Chart Guidelines
Intake Output Chart Guidelines
 
Lesson plan on perineal care procedure use in OBG and Nursing foundation Assi...
Lesson plan on perineal care procedure use in OBG and Nursing foundation Assi...Lesson plan on perineal care procedure use in OBG and Nursing foundation Assi...
Lesson plan on perineal care procedure use in OBG and Nursing foundation Assi...
 
Intravenous cannulation
Intravenous cannulationIntravenous cannulation
Intravenous cannulation
 
Perineal care
Perineal carePerineal care
Perineal care
 
Nursing case study Appendectomy
Nursing case study AppendectomyNursing case study Appendectomy
Nursing case study Appendectomy
 
pediatric Drug administration
pediatric Drug administrationpediatric Drug administration
pediatric Drug administration
 

Viewers also liked

241603963 drug-study-final
241603963 drug-study-final241603963 drug-study-final
241603963 drug-study-finalhomeworkping4
 
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
82085243 case-study-on-pregnancy-induced-hypertension-eclampsiahomeworkping3
 
Second year anatomy exam 6-2013
Second year anatomy exam 6-2013Second year anatomy exam 6-2013
Second year anatomy exam 6-2013Fathy AbdElhamed
 
Abdul wajid seminar
Abdul wajid seminarAbdul wajid seminar
Abdul wajid seminarismailzai
 
Second y final-exam malaysean 9-2013
Second y final-exam malaysean 9-2013Second y final-exam malaysean 9-2013
Second y final-exam malaysean 9-2013Fathy AbdElhamed
 
Second year anatomy exam 9-2013 المتخلفين
Second year anatomy exam 9-2013 المتخلفينSecond year anatomy exam 9-2013 المتخلفين
Second year anatomy exam 9-2013 المتخلفينFathy AbdElhamed
 
Medications
MedicationsMedications
Medicationsstudent
 
Rabies presentation
Rabies presentationRabies presentation
Rabies presentationismailzai
 
Oesophagus
OesophagusOesophagus
Oesophagusafiqzh
 
Medication remediation template for pharmacology
Medication remediation template for pharmacologyMedication remediation template for pharmacology
Medication remediation template for pharmacologyAllison Shamblin-Padua
 
Med chem lecture on Antihistaminicdrugs
Med chem lecture on AntihistaminicdrugsMed chem lecture on Antihistaminicdrugs
Med chem lecture on Antihistaminicdrugssagar joshi
 
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
Emergency contraception, Combination Birth Control Pill, Progestogen-Only PillsEmergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pillsmaria may dizon
 
Sedative hypnotics
Sedative hypnoticsSedative hypnotics
Sedative hypnoticsmmbakhaitan
 
Mcq pharmacology - july 2001 v3 (answers)
Mcq    pharmacology - july 2001 v3 (answers)Mcq    pharmacology - july 2001 v3 (answers)
Mcq pharmacology - july 2001 v3 (answers)Azhar Sherazi
 
Surgical infections and antibiotics selections
Surgical infections and antibiotics selectionsSurgical infections and antibiotics selections
Surgical infections and antibiotics selectionsmasoud salaran
 
Nursing and pharmacology topics 1 10
Nursing and pharmacology topics 1 10Nursing and pharmacology topics 1 10
Nursing and pharmacology topics 1 10Jack Frost
 

Viewers also liked (20)

241603963 drug-study-final
241603963 drug-study-final241603963 drug-study-final
241603963 drug-study-final
 
Lecture6
Lecture6Lecture6
Lecture6
 
Pharmacology .. Anit-migraine Drugs
Pharmacology .. Anit-migraine DrugsPharmacology .. Anit-migraine Drugs
Pharmacology .. Anit-migraine Drugs
 
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
 
Second year anatomy exam 6-2013
Second year anatomy exam 6-2013Second year anatomy exam 6-2013
Second year anatomy exam 6-2013
 
Abdul wajid seminar
Abdul wajid seminarAbdul wajid seminar
Abdul wajid seminar
 
A&e mcq
A&e mcqA&e mcq
A&e mcq
 
Second y final-exam malaysean 9-2013
Second y final-exam malaysean 9-2013Second y final-exam malaysean 9-2013
Second y final-exam malaysean 9-2013
 
Second year anatomy exam 9-2013 المتخلفين
Second year anatomy exam 9-2013 المتخلفينSecond year anatomy exam 9-2013 المتخلفين
Second year anatomy exam 9-2013 المتخلفين
 
Medications
MedicationsMedications
Medications
 
Rabies presentation
Rabies presentationRabies presentation
Rabies presentation
 
Oesophagus
OesophagusOesophagus
Oesophagus
 
Anticoagulants 22
Anticoagulants 22Anticoagulants 22
Anticoagulants 22
 
Medication remediation template for pharmacology
Medication remediation template for pharmacologyMedication remediation template for pharmacology
Medication remediation template for pharmacology
 
Med chem lecture on Antihistaminicdrugs
Med chem lecture on AntihistaminicdrugsMed chem lecture on Antihistaminicdrugs
Med chem lecture on Antihistaminicdrugs
 
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
Emergency contraception, Combination Birth Control Pill, Progestogen-Only PillsEmergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
 
Sedative hypnotics
Sedative hypnoticsSedative hypnotics
Sedative hypnotics
 
Mcq pharmacology - july 2001 v3 (answers)
Mcq    pharmacology - july 2001 v3 (answers)Mcq    pharmacology - july 2001 v3 (answers)
Mcq pharmacology - july 2001 v3 (answers)
 
Surgical infections and antibiotics selections
Surgical infections and antibiotics selectionsSurgical infections and antibiotics selections
Surgical infections and antibiotics selections
 
Nursing and pharmacology topics 1 10
Nursing and pharmacology topics 1 10Nursing and pharmacology topics 1 10
Nursing and pharmacology topics 1 10
 

Similar to Nln pharmacology study guide final 6 3-2013

De-challenge and Rechallenge
De-challenge and RechallengeDe-challenge and Rechallenge
De-challenge and RechallengeClinosolIndia
 
Approach to Neurogenic Dysphagia (1) 24_07.pptx
Approach to Neurogenic Dysphagia (1) 24_07.pptxApproach to Neurogenic Dysphagia (1) 24_07.pptx
Approach to Neurogenic Dysphagia (1) 24_07.pptxNeurologyKota
 
Advances in the management of pediatric septic shock
Advances in the management of pediatric septic shockAdvances in the management of pediatric septic shock
Advances in the management of pediatric septic shockDr. Vinaykumar S Appannavar
 
Pediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasPediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasNEHA MALIK
 
Assessment of knowledge and practice of diabetic patients towards insulin t...
 Assessment of knowledge and practice of diabetic patients towards  insulin t... Assessment of knowledge and practice of diabetic patients towards  insulin t...
Assessment of knowledge and practice of diabetic patients towards insulin t...AfrahAwad1
 
Surviving sepsis campaign international guidelines for the management
Surviving sepsis campaign international guidelines for the managementSurviving sepsis campaign international guidelines for the management
Surviving sepsis campaign international guidelines for the managementRavi Jeengar
 
Esophageal cancer NOV 20
Esophageal cancer NOV 20Esophageal cancer NOV 20
Esophageal cancer NOV 20Carolina chaves
 
EPIQNewsletter_2016_02Feb
EPIQNewsletter_2016_02FebEPIQNewsletter_2016_02Feb
EPIQNewsletter_2016_02FebJennifer McCoy
 
CASE REPORT ON osteomyelitis.pptx
CASE REPORT ON osteomyelitis.pptxCASE REPORT ON osteomyelitis.pptx
CASE REPORT ON osteomyelitis.pptxnirbhay katiyar
 
110445675-Drugs-Used-in-Pediatric-Dentistry.pptx
110445675-Drugs-Used-in-Pediatric-Dentistry.pptx110445675-Drugs-Used-in-Pediatric-Dentistry.pptx
110445675-Drugs-Used-in-Pediatric-Dentistry.pptxnonaaryan2
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist Lifecare Centre
 
Total Parenteral Nutrition.pptx
Total Parenteral Nutrition.pptxTotal Parenteral Nutrition.pptx
Total Parenteral Nutrition.pptxNikethana1
 
Unit 4 Review Assignment Please write in complete sentences. You.docx
Unit 4 Review Assignment Please write in complete sentences. You.docxUnit 4 Review Assignment Please write in complete sentences. You.docx
Unit 4 Review Assignment Please write in complete sentences. You.docxmarilucorr
 
Hypertrophic_Pyloric_Stenosis.ppt
Hypertrophic_Pyloric_Stenosis.pptHypertrophic_Pyloric_Stenosis.ppt
Hypertrophic_Pyloric_Stenosis.pptbosccofrengky
 
Guideline_Hypertrophic_Pyloric_Stenosis.ppt
Guideline_Hypertrophic_Pyloric_Stenosis.pptGuideline_Hypertrophic_Pyloric_Stenosis.ppt
Guideline_Hypertrophic_Pyloric_Stenosis.pptslimansliman3
 
MANAGEMENT OF STROKE
MANAGEMENT OF STROKEMANAGEMENT OF STROKE
MANAGEMENT OF STROKEtahav kershio
 
Severe Pediatric Status Asthmaticus
Severe Pediatric Status AsthmaticusSevere Pediatric Status Asthmaticus
Severe Pediatric Status AsthmaticusRobert Parker
 

Similar to Nln pharmacology study guide final 6 3-2013 (20)

De-challenge and Rechallenge
De-challenge and RechallengeDe-challenge and Rechallenge
De-challenge and Rechallenge
 
Approach to Neurogenic Dysphagia (1) 24_07.pptx
Approach to Neurogenic Dysphagia (1) 24_07.pptxApproach to Neurogenic Dysphagia (1) 24_07.pptx
Approach to Neurogenic Dysphagia (1) 24_07.pptx
 
59499957 case
59499957 case59499957 case
59499957 case
 
Advances in the management of pediatric septic shock
Advances in the management of pediatric septic shockAdvances in the management of pediatric septic shock
Advances in the management of pediatric septic shock
 
Pediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulasPediatric Drug calculations |drug calculation formulas
Pediatric Drug calculations |drug calculation formulas
 
Assessment of knowledge and practice of diabetic patients towards insulin t...
 Assessment of knowledge and practice of diabetic patients towards  insulin t... Assessment of knowledge and practice of diabetic patients towards  insulin t...
Assessment of knowledge and practice of diabetic patients towards insulin t...
 
management of SLE.pptx
management of SLE.pptxmanagement of SLE.pptx
management of SLE.pptx
 
Surviving sepsis campaign international guidelines for the management
Surviving sepsis campaign international guidelines for the managementSurviving sepsis campaign international guidelines for the management
Surviving sepsis campaign international guidelines for the management
 
Esophageal cancer NOV 20
Esophageal cancer NOV 20Esophageal cancer NOV 20
Esophageal cancer NOV 20
 
EPIQNewsletter_2016_02Feb
EPIQNewsletter_2016_02FebEPIQNewsletter_2016_02Feb
EPIQNewsletter_2016_02Feb
 
Iv therapy training
Iv therapy trainingIv therapy training
Iv therapy training
 
CASE REPORT ON osteomyelitis.pptx
CASE REPORT ON osteomyelitis.pptxCASE REPORT ON osteomyelitis.pptx
CASE REPORT ON osteomyelitis.pptx
 
110445675-Drugs-Used-in-Pediatric-Dentistry.pptx
110445675-Drugs-Used-in-Pediatric-Dentistry.pptx110445675-Drugs-Used-in-Pediatric-Dentistry.pptx
110445675-Drugs-Used-in-Pediatric-Dentistry.pptx
 
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN  Consultant Pathologist
A.B.C. of Paps Smear Update (2016) ,DR. SUDHIR JAIN Consultant Pathologist
 
Total Parenteral Nutrition.pptx
Total Parenteral Nutrition.pptxTotal Parenteral Nutrition.pptx
Total Parenteral Nutrition.pptx
 
Unit 4 Review Assignment Please write in complete sentences. You.docx
Unit 4 Review Assignment Please write in complete sentences. You.docxUnit 4 Review Assignment Please write in complete sentences. You.docx
Unit 4 Review Assignment Please write in complete sentences. You.docx
 
Hypertrophic_Pyloric_Stenosis.ppt
Hypertrophic_Pyloric_Stenosis.pptHypertrophic_Pyloric_Stenosis.ppt
Hypertrophic_Pyloric_Stenosis.ppt
 
Guideline_Hypertrophic_Pyloric_Stenosis.ppt
Guideline_Hypertrophic_Pyloric_Stenosis.pptGuideline_Hypertrophic_Pyloric_Stenosis.ppt
Guideline_Hypertrophic_Pyloric_Stenosis.ppt
 
MANAGEMENT OF STROKE
MANAGEMENT OF STROKEMANAGEMENT OF STROKE
MANAGEMENT OF STROKE
 
Severe Pediatric Status Asthmaticus
Severe Pediatric Status AsthmaticusSevere Pediatric Status Asthmaticus
Severe Pediatric Status Asthmaticus
 

More from Dr P Deepak

Differentiating trigeminal neuropathy from trigeminal neuralgia
Differentiating trigeminal neuropathy from trigeminal neuralgiaDifferentiating trigeminal neuropathy from trigeminal neuralgia
Differentiating trigeminal neuropathy from trigeminal neuralgiaDr P Deepak
 
Beck depression-inventory-real-time-report
Beck depression-inventory-real-time-reportBeck depression-inventory-real-time-report
Beck depression-inventory-real-time-reportDr P Deepak
 
Antihistamines and-asthma-patients-2002
Antihistamines and-asthma-patients-2002Antihistamines and-asthma-patients-2002
Antihistamines and-asthma-patients-2002Dr P Deepak
 
Review anti-cancer agents in medicinal chemistry, 2013
Review anti-cancer agents in medicinal chemistry, 2013Review anti-cancer agents in medicinal chemistry, 2013
Review anti-cancer agents in medicinal chemistry, 2013Dr P Deepak
 
Ctg underlying pathophysiology
Ctg underlying pathophysiologyCtg underlying pathophysiology
Ctg underlying pathophysiologyDr P Deepak
 
Occipitalneuralgia
OccipitalneuralgiaOccipitalneuralgia
OccipitalneuralgiaDr P Deepak
 
6122 htn lp_01.12.06
6122 htn lp_01.12.066122 htn lp_01.12.06
6122 htn lp_01.12.06Dr P Deepak
 
En atbantibiotics
En atbantibioticsEn atbantibiotics
En atbantibioticsDr P Deepak
 
Hypertension guidelines2008to2010update
Hypertension guidelines2008to2010updateHypertension guidelines2008to2010update
Hypertension guidelines2008to2010updateDr P Deepak
 
Htn pharmacotherapy
Htn pharmacotherapyHtn pharmacotherapy
Htn pharmacotherapyDr P Deepak
 
Malaria treatment protocol
Malaria treatment protocolMalaria treatment protocol
Malaria treatment protocolDr P Deepak
 
Studying drug induced-disease
Studying drug induced-diseaseStudying drug induced-disease
Studying drug induced-diseaseDr P Deepak
 
Ad hoc reporting
Ad hoc reportingAd hoc reporting
Ad hoc reportingDr P Deepak
 
2010 cv pharm slp
2010 cv pharm slp2010 cv pharm slp
2010 cv pharm slpDr P Deepak
 

More from Dr P Deepak (20)

Mal3
Mal3Mal3
Mal3
 
Malabsorption
MalabsorptionMalabsorption
Malabsorption
 
Differentiating trigeminal neuropathy from trigeminal neuralgia
Differentiating trigeminal neuropathy from trigeminal neuralgiaDifferentiating trigeminal neuropathy from trigeminal neuralgia
Differentiating trigeminal neuropathy from trigeminal neuralgia
 
Beck depression-inventory-real-time-report
Beck depression-inventory-real-time-reportBeck depression-inventory-real-time-report
Beck depression-inventory-real-time-report
 
Audit
AuditAudit
Audit
 
Antihistamines and-asthma-patients-2002
Antihistamines and-asthma-patients-2002Antihistamines and-asthma-patients-2002
Antihistamines and-asthma-patients-2002
 
Corticosteriods
CorticosteriodsCorticosteriods
Corticosteriods
 
Review anti-cancer agents in medicinal chemistry, 2013
Review anti-cancer agents in medicinal chemistry, 2013Review anti-cancer agents in medicinal chemistry, 2013
Review anti-cancer agents in medicinal chemistry, 2013
 
Ctg underlying pathophysiology
Ctg underlying pathophysiologyCtg underlying pathophysiology
Ctg underlying pathophysiology
 
Ichdii cranial
Ichdii cranialIchdii cranial
Ichdii cranial
 
Occipitalneuralgia
OccipitalneuralgiaOccipitalneuralgia
Occipitalneuralgia
 
6122 htn lp_01.12.06
6122 htn lp_01.12.066122 htn lp_01.12.06
6122 htn lp_01.12.06
 
En atbantibiotics
En atbantibioticsEn atbantibiotics
En atbantibiotics
 
Hypertension guidelines2008to2010update
Hypertension guidelines2008to2010updateHypertension guidelines2008to2010update
Hypertension guidelines2008to2010update
 
Htn pharmacotherapy
Htn pharmacotherapyHtn pharmacotherapy
Htn pharmacotherapy
 
Malaria treatment protocol
Malaria treatment protocolMalaria treatment protocol
Malaria treatment protocol
 
Studying drug induced-disease
Studying drug induced-diseaseStudying drug induced-disease
Studying drug induced-disease
 
Strom11206
Strom11206Strom11206
Strom11206
 
Ad hoc reporting
Ad hoc reportingAd hoc reporting
Ad hoc reporting
 
2010 cv pharm slp
2010 cv pharm slp2010 cv pharm slp
2010 cv pharm slp
 

Recently uploaded

Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinojohnmickonozaleda
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 

Recently uploaded (20)

Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipino
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 

Nln pharmacology study guide final 6 3-2013

  • 1. NLN Pharmacology Study Guide There is no official study guide for the NLN Pharmacology Exam. This guide is not meant to be all-inclusive of the information you will need to know to successfully pass the NLN Pharmacology exam. You should utilize other resources as necessary to prepare for the exam. Please note that after taking the exam, NLN provides access to review resources on-line. The test is composed of 100 scored questions plus some trial questions (about 25). You will not know which are which. All are multiple choice questions, including calculations. Content is divided in three areas on the exam: calculations, principles of medication administration and medication effects. They are pretty evenly divided. The questions are very similar to the NCLEX questions. You should also use traditional NCLEX testtaking tips to prepare for this exam also. References: Pearson nurses’s drug guide. (2013). Upper Saddle River, NJ: Pearson. Silvestri, L. A. (2011). Saunders comprehensive review for the NCLEX-RN® examination. St. Louis, MO: Mosby. Adams, M. P. & Urban, C. Q. (2013). Pharmacology: Connections to nursing practice (2nd ed.). Upper Saddle River, NJ: Pearson. Calculations Please remember this is about 1/3 of the pharmacology exam. It may be beneficial for you to practice calculations and/or review a nursing math book to help prep. You may not have used all the calculation methods recently. Questions may include one or more type of calculation. Tips: 1. READ CAREFULLY. Always be sure you know what the end result should be (mg, pills, ml, etc.). This can help you select the correct formula and eliminate unnecessary information. 2. Double (and triple) check actual math. Did you clear the calculator correctly? 3. Does the answer make sense? 4. There are both adult and pediatric calculations. 5. Watch ‘per dose’, ‘per day’. 6. How you calculate the answer does not matter (desired over have, ratio : proportion, etc.); accuracy does. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 1
  • 2. 2Common calculations include (but are not limited to): 1. Kg to mg to mcg conversion (any which way) L K H D M D C M mcg G liter (kilo – hecto – deca – meter – deci – centi – milli – skip – skip – micro) gram 2. Dosage calculations a. Tablets b. mg. to tablets c. mg. to ml d. units to ml e. kg to ml f. Half-life calculation g. IV rate calculation (hourly infusion rate) AND adjustment h. IV rate dosage calculation (based on units per ml, etc.) i. Macro- vs. micro-drop tubing j. Calculating drops/minute (gtts/min) Examples: (abbreviated to type of question; exam will add extra information) 1. Have 5 mg tablets; ordered dose 2.5 mg. How many tablets will the nurse administer? 2. Have 2 mg/2 ml; order is 1 mg. How many milliliters will the nurse administer? 3. Prepare a 20 mEq dose of a medication. Available solution is 40 mEq/10 ml. How many ml will be administered? Note: calculation method is not different in examples 1 - 3, just the unit of measure (mg, units, mEq, etc.). BE SURE AVAILABLE AND HAVE ARE THE SAME UNIT OF MEASURE. 4. Half-life conversion: Half-life is known to be 2 hours. What percentage will be left in the body after six hours? 5. A person weighs 165 lbs. How many kg does the person weigh? WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 2
  • 3. 6. The available medication has been reconstituted to 250 mg/5 ml. The order is 5 mg/kg/daily in two evenly divided doses. Child weight 44 pounds. How many milliliters will be administered per dose? NOTE: More than one calculation method must be used to answer this question. 7. IV was ordered at 1000 ml over 8 hour period. After two hours, only 900 ml has infused. Calculate the new infusion rate for the medication to be administered within the original 8 hour period. 8. Order is for 3000 cc over a 24-hour period. What is the hourly flow rate? OR: What will the pump be set at per hour? 9. Order is for antibiotic to be mixed in 50 ml NS and administered over 45 minutes. What is the hourly flow rate? OR: What will the pump be set at per hour? 10. Volume is 1000 ml. Ordered infusion time is 8 hours. Have tubing of 15 drops/ml. How many drops need to be counted to deliver the identified milliliters per minute? 11. Available solution = 25,000 units in 250 ml NS. Order is to administer at 22 ml/hour. How many units will be given per hour? 12. Available solution = 25,000 units in 250 ml NS. Administer at 2000 units/hour. How many ml will be given be hour? OR: What will the pump be set at per hour? Principles of Pharmacology These include the basics! Review: 1. Routes of administration – benefits and problems 2. Sizes of needles and syringes for injections 3. Six Rights of Medication Administration; Three Checks 4. Side effects; adverse effects; paradoxical reactions; toxicity; antagonists 5. Half-life calculation 6. Allergic or hypersensitivity reactions 7. Absorption, metabolism, distribution and excretion 8. There may be questions on lab values as relevant. 9. There are pediatric and adult questions. 10. Immunosuppression precautions (due to meds for cancer, HIV/AIDS, etc.) WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 3
  • 4. Administration routes: some key points Sublingual administration □ absorbed in mucosa of oral cavities □ rapid onset of action □ Place tablet on floor of mouth, close mouth. Do not swallow, hold under tongue until dissolve. □ Use spray on floor of mouth under tongue and close mouth. Buccal □ place tablet between gum and cheek near back of mouth, close mouth and keep in place until dissolve □ slower to dissolve and absorb than sublingual Intramuscular injections □ Given in the vastus lateralis in children up to 3 □ Spread skin taught to bring muscle near surface of skin, with dart-like motion insert needle at 90 degrees □ Aspirate to determine if needle enter a blood vessel. If there is blood return discard the needle and meds and start procedure over. NGtube / Gtube □ NG usually temporary; G-tube for longer term □ Follow instructions re crushing, dissolving medication – no sustained release meds Eye drop administration □ Clean exudates from eye; (2) tilt head toward side of affected eye; (3) pull lower eyelid down; (4) have pt. look up; (5) instill drops in conjunctival sac formed by lower lid (not onto the eye); (6) Apply gentle pressure for 30 sec to 1 min over inner cantus next to nose (this prevents absorption through the tear duct and drainage of the medication). Close eyes gently massage the eyes to distribute the meds. □ Slow absorption except in infants where they readily absorb EYE OINTMENT □ Same as eye drop except it is expressed directly into the conjunctival sac from the inner canthus to the outer canthus. Close eyes and gently massage to distribute the medication WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 4
  • 5. Definitions: Agranulocytosis / Neutropenia / agranulocytopenia □ Definition: Acute decrease in the number of granulocytes/leukopenia (WBC) in peripheral blood □ Causes include: treatment with broad spectrum PCN, sulfonamides or cephalosporin (piperacillin, tazobactam, cetazidime, ticarcillin, gentamycin), bone marrow transplant, chemotherapy, radiation. □ Generally is impaired resulting from bone marrow depression by drugs and chemicals or replacement by a neoplasm(oral lesion, ulcer necrotic, gingivitis, buccal mucosa □ Lymphadenopathy, lymphadenitis may be prevalent. □ Could lead to respiratory infection, ulceration of mouth colon, high fever, UTI. But may be asymptomatic Chelating agents □ A form of detoxification □ Chelating therapy involves an injection or oral administration of ethylene diamine Tetra acetic avide (a synthetic amino acid which attaches to toxic substance such as lead, cadmium, aluminum and other metal in the blood to facilitate their removal from the body.) □ May be used to treat hardening of the arteries, heart attack, stroke, arthritis and gangrene because of its ability to remove excess calcium from the body. EDTA: Ethylenediaminetetraacetic acid □ Use in children with lead level between 45&70 micron/dl. □ EDTA binds to lead in blood and excreted by the bowel and kidney. EDTA may be toxic to kidney. Monitor urine output. □ Give this by IV. Dose depends on weight of child, severity of the poison. Agent is given every 4 hours for 5 days. A second course may be needed if there is a rebound in the blood level. Give oral and IV fluid to enhance excretion □ Do not use EDTA with hypocalcemia or hypokalemia. OTHER AGENTS □ British antiLewisite (BAL) does not give with iron supplement and avoid in pt. with plant allergy. Give this by IM □ Succimer (Chemer) □ Chemet – oral medication - Do not give in pt. with encephalopathy Epistaxis □ Nose bleed. Can be anterior or posterior. Posterior is more serious. □ due to rupture of blood vessels within richly perfuse nasal mucosa spontaneous or initiated by trauma □ blood can come up through the eye, can also flow down the stomach causing nausea, vomiting WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 5
  • 6. Treat epistaxis □ cauterization with silver nitrate, calcium alginate mesh, nasal cavity packed with sterile dressing ribbon gauze, absorbent dressing or saline sprayed into the nose □ Ice pack to forehead or back of the neck □ pinch septum of nose for 5 minutes □ Do not pack nose with tissue or gauze Half-life □ The time it takes for a medication to lose half of its pharmacologic or physiologic effect □ To calculate half-life: There is a formula but the easiest way to decrease count. □ Example: half- life is 1 hour. Start 100% 1 hr. 50% 2 hrs. 25% 3 hrs. 12.5% 4 hrs. 6.25% Question – Half-life of ‘xyz’ medication is 1 hour. After 3 hours, what percentage of the medication will be left? A = 12.5% Osmotic agent - see entry under Mannitol Paradoxical reaction □ A response to a drug (or medical treatment) that is the opposite to the usual response, such as agitation produced in an individual patient by a drug which is ordered to sedate or calm a person. Sustained release / time released / extended release / controlled release □ Pills or capsule formulated to dissolve slowly and release drug over time. □ They can often be taken less frequently, keep steadier levels of the drug in the bloodstream □ Contain in a matrix of insoluble substance (e.g. Acrylics) the drug swells up to form a gel so that the drug has first to dissolve in matrix then exit through the outer surface. □ Cannot be crushed, dissolved or opened WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 6
  • 7. Medication Effects There is a bit of an overlap here with Principles of Pharmacology. These questions tend to be medication (or classification) specific. There are many medications on the test and many could be. As applicable, both brand and generic names are used. We recognize the attached grid is very lengthy, but have included some of the key components as identified below. Most medications addressed are either high usage or high risk. Please note that auto-corrections will change generic names to starting with caps. In the grid, we have tried to list generic first, then brand names. Areas to know: 1. Use, dose, side effects, contraindications 2. Since there are a limited number of questions, not all medications are addressed. You may be asked to select which medication would be given for a particular diagnosis. When studying, focus on the classifications – this may enable you to answer without knowing the actual medication. 3. Focus on what are the major side effects of a medication or class? What makes it high risk? Why might one particular med be used other than another? 4. Patient teaching is a major focus. What would you tell the patient about the medication? What would indicate understanding? What would indicate need for further teaching? Common classification of medications Note letters in medication name and look for those letters that identify a particular classification: ◊ Androgens: end with –terone: testosterone (Testoderm) ◊ ACE Inhibitors: end with –pril: enalapril (Vasotec) ◊ Antidiuretic hormones: end with –pressin: desmopressin (DDAVP) ◊ Antilipidemic: end with –statin: atorvastatin (Lipitor) ◊ Antiviral: contain -vir: ritonavir (Norvir) WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 7
  • 8. ◊ Benzodiazepines: include alprazolam (Xanax), chlordiazepoxide (Librium), clorazepate (Tranxene), estazolam (ProSom), and triazolam (Halcion). Most others end with –pam: diazepam (Valium) ◊ Beta Blockers: end with –lol: atenolol (Tenormin) ◊ CCB: end with –pine: amlodipine (Norvasc); some exceptions include diltiazem (Cardizem), verapamil (Isoptin) ◊ Carbonic anhydrase inhibitors: end with –mide: acetazolamide (Diamox) ◊ Estrogens: contain est: conjugated estrogen (Premarin) ◊ Glucocorticoids and corticosteroids: end with –sone: prednisone (Deltasone) ◊ Histamine H2 receptor antagonists: end with –dine: cimetidine (Tagamet) ◊ Nitrates: contain nitr: nitroglycerin (Nitrostat) ◊ Pancreatic enzyme replacements: contain pancre: pancrelipase (Pancrease) ◊ Phenothiazines: end with –zine: chlorpromazine (Thorazine) ◊ Proton Pump Inhibitors: end with –zole: lansoprazole (Prevacid) ◊ Sulfonamides: include –sulf: sulfasalazine (Azulfidine) ◊ Thiazide diuretics: end with –zide: hydrochlorothiazide (HydroDIURIL) ◊ Thrombolytics: end with -ase: alteplase (Activase) ◊ Thyroid hormones: contain –thy: levothyroxine (Synthroid) ◊ Xanthine bronchodialators: end with –line: theophylline WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 8
  • 9. Specific Diseases or treatments: Aminoglycoside □ antibiotics - Treats serious life threatening gram negative (and some positive) infections All aminoglycoside ends Mycin but not all drugs that ends in Mycin are aminoglycosides such as (Erythromycin and azithromycin) Examples: □ Gentamycin □ Tobramycin □ Vancomycin □ Neomycin □ Generally IM or IV. □ Oral route is not recommended. It is only use for bowel prep prior to surgery (see Neomycin) Adverse effects/toxicity: Two most common MAJOR adverse effects: Nephrotoxicity and ototoxicity. Also: □ Photosensitivity □ risk for superinfections □ Pseudomembranous colitis (c-diff): stop med and treat with PO Flagyl Peak level: □ Drawn 15-30 min after the infusion is completed. □ Peak concentration determines that toxic level does not occur. □ If peak is too high, may reduce dose. Trough level: □ Drawn immediately (within 30 minutes) before next IV dose □ Assures that therapeutic level of drug is maintained. Trough level is 1-2 g/ml between doses. □ Dose will be adjusted if level is not sustained □ WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 9
  • 10. Blood administration □ Start blood transfusion slow 2 ml/min. Remain with pt. for the first 15-30 min. if there is no sign of side effect, increase rate to the desired rate □ Administer using largest gauge IV access as possible. □ Observe for acute reaction such as: allergic s/s – rash, itching, localized edema; febrile (even low grade); septic; air embolism; circulatory overload. □ Observe for delayed reaction: Graft vs. host; hepatitis; hemolysis Crack abuse effect on newborns □ Crack crosses the placenta and enters the fetus. □ Common presentation: Infant may appear normal or develop neurological problem. Child may develop depression or excitability, they may be lethargy, have poor suck; weak cry and difficulty in arousing, hypotonicity, rigidity, irritability, inability to console and intolerance to change, small head, decreased birth length □ Late symptoms: Some infant showed late symptoms 2-8 wks. There may be growth retardation - head growth is one of the best indication Diabetes treatment in children □ Hypoglycemic reaction takes place most time before meals or when insulin effect is peaking. □ First teaching: (1) let child wear bracelet or tag; (2) Teach how to give injection. Inject at 90 degree angle. □ Teach only the essentials on the first few visits and intense later. Keep session for children to 14-20 min and adult may go up to 45-60 □ Have same meal as normal child time intake of food. Eat at the same time each day. □ Children can start learn to assume responsibility for self-management as soon as age 4-5. At age 9, they can start giving their own insulin with supervision. □ Exercise: do not restrict exercise. Have extra snack before and after exercise. Exercise very regularly as it decreases the need for insulin □ Carry a source of glucose at all times (hard candy, sugar cubes glucose tablets, insta glucose). The rapid releasing sugar is followed by complex CHO and protein such as slice of bread or cracker spread with peanut butter □ After glucagon injection, vomiting may occur. Place child on the side to prevent aspiration. □ Preferred way of treating ketoacidosis is by insulin IV of low dosing. Note. Run a mixture of insulin through the tubing before starting the drip because the insulin can chemically bind to plastic. Replace fluid over 24-48 hrs. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 10
  • 11. Diabetes – Intravenous insulin administration □ Can only be done with regular insulin in management of DKA, HHNK. □ Premature discontinuation can cause prolongation of DKA. □ Begin SQ insulin therapy before stopping the infusion. If not, there might be prolonged hyperglycemia. Hepatitis – see below HIV treatment – antiretinoviral therapy Side effects: START therapy: Common meds: (1) all symptomatic HIV people □ Assess for opportunistic infection (presenting with a AIDS-defining illness) □ abacavir (ziagen) (cancer, neurological disease); HA, or fatigue, nausea, vomiting, diarrhea, □ stavudine (Zerit) abdominal discomfort, anemia, taste (2) with a CD4 count less than 350 mm3. □ zidovudine (AZT) (3) also start pregnant women (AZT is perversion, asthenia, circumoral used to prevent maternal transmission paresthesia with ritonivair, Antiviral protease inhibitor. End in AVIR of HIV) Adverse/toxicity □ Use prophylactically. STOP if severe rash or other □ Hepatoxicity, Hepatotoxicity: AST, □ Use in combination to decrease viral hypersensitivity reaction occurs. ALT, bilirubin; observe for nausea, load and increase CD4. Excluding reaction to medications vomiting jaundice upper right Reverse transcriptase inhibitors: Ends in and/or ineffectiveness of medication, abdominal quad enlargement and INE treatment will be long-term. tenderness. Reduce dose in liver □ Stop replication/growth. Reduces dysfunction. viral load. TEACH □ One major advantage is that they do □ Nephrotoxicity; creatinine, BUN, creatinine clearance, urinalysis, keep □ Use neutropenic precautions not affect adversely affect □ Eat small frequent meals with accurate I& O, monitor for SE of development of blood cells. complete or complementary proteins neutropenic, observe occult signs of □ Use in combination with other meds infection. (lower back, flank or because resistant strains may rapidly suprapubic pain, normal temp or low evolve if used as single agent grade fever related to UTI therapy. □ Inhibit cell protein synthesis that interfere with viral replication; block protease activity in HIV. □ Treat AIDS and AIDS-related complex to decrease viral load WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 11
  • 12. Inotropic medications: Positive inotropic meds increase cardiac contractility – examples: epinephrine, norepinephrine, dopamine Negative inotropic meds decrease cardiac contractility, lower BP: examples – quinidine; betablockers (most end in ‘olol”) Sulfonamides Side effects: CAUTION: do not use: □ Rash common; most are urticaria and □ known allergies to sulfa drugs □ Anti-infective. maculopapular. □ In polyuria, advanced renal or hepatic □ Bacteriostatic which action on □ GI symptoms dysfunction bacteria results from interference □ Bone marrow depression □ with intestinal and urinary blockage, with the functioning of enzyme □ Headache, dizziness, vertigo, ataxia, □ asthma systems necessary for normal convulsion, depression metabolism, growth and Adverse effects/toxicity: □ Take adequate amount to fluid 3000multiplication □ Hepatotoxicity 4000ml/day to promote urinary □ Treat: UTI, Chlamydia causing output, at least 1500ml/d to prevent □ Nephrotoxicity blindness, pneumonia, brain abscess, □ Stevens Johnson syndrome (an crystalluria/stone formation ulcerative colitis, active Crohn’s □ May be taken after meals to prolong adverse reaction of skin that disease, rheumatoid arthritis time in intestine. resembles appearance of partial Examples: □ Collect C&S prior to beginning thickness burns) □ Bactrim therapy Thiazide diuretics: Side effects: □ Take early in the day to avoid Examples: □ Dizziness, vertigo, HA, weakness, nocturia chlorothiazide (Hydrodiuril), dehydration, orthostatic hypotension □ Take with food to avoid GI upset. hydrochlorothiazide (HCTZ, Diuril) □ N/V, abdominal pain, diarrhea, □ Thiazide is ineffective if creatinine Name ends in ZIDE constipation, frequent urination clearance is < 30ml/min □ non-potassium sparing diuretic. □ dermatitis and rash □ Eat foods high in potassium, restrict □ Acts on distal tubes, blocks □ Electrolyte imbalance sodium, do not use salt substitute if reabsorption of sodium, chloride and □ impaired glucose tolerance taking potassium supplement water. Leads to increased loss of Adverse effects/toxicity: □ weigh self daily, report sudden Potassium. weight gains or losses □ Renal failure, □ Use for edema and mild to moderate □ aplastic anemia, agranulocytosis, Avoid use with: hypertension □ Children thrombocytopenia □ will see effect of within 1-4 wks. □ anuria □ anaphylactic reaction WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 12
  • 13. Tricyclic Antidepressants □ Initial mechanism of TCA takes 1-3 weeks to develop. □ Maximum response is achieved in 6-8 wks. □ Has long half-life. Most Tricyclics ends in INE □ nortriptyline (Pamelor) □ amitriptyline (Elavil) □ doxepin (sinequan) □ imipramine (tofranil) □ Block the reuptake of norepinephrine or serotonins or both, leaving more available in the CNS. It intensifies the effect of norepinephrine and serotonin which can elevate mood, increase activity and alertness, decrease preoccupation with morbidity, improve appetite and regulate sleep pattern. □ It is used to treat insomnia, attention deficit/hyperactivity and panic disorder. Side effects: □ orthostatic hypotension, □ sedation and anticholinergic effects. Adverse effects/toxicity: □ Most serious adverse effect is cardiac toxicity; in the absence of overdose or preexisting cardiac impairment, serious cardiotoxicity is rare. □ URINARY RETENTION IS URGENT □ Overdose may cause convulsions □ Take at nights, it causes sedation. □ Do not take with MAO it will cause hypertensive crisis from excessive adrenergic stimulation of the heart and blood vessels, □ monitor orthostatic BP of pt. in hospital Use with caution: □ Glaucoma □ Elderly □ constipation, prostatic hyperplasia, as they are more sensitive to anticholinergic effect Avoid use with: □ hypersensitivity, □ MI, Cardiovascular disease Vesicant – Chemotherapy □ See precautions under “Vincristine” Hepatitis: inflammation of liver caused by virus, bacteria or exposure to meds or hepatotoxins Stages of viral hepatitis: (1) Pre-icteric – precedes appearance of jaundice, may have flulike symptoms (2) Icteric – appearance of jaundice, elevated bilirubin, dark or tea colored urine, clay-colored stools (3) Post-icteric – convalescent stage; jaundice improves; color of urine and stool returns to normal WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 13
  • 14. Hepatitis A (formerly “infectious hepatitis”) Cause: enterovirus At risk: □ Young children □ Institutionalized people □ Health care personnel Transmission: □ fecal-oral □ ingestion of food or liquids contaminated with the virus. □ person by person contact Incubation: 3-5 wks. Infectious: usually 2 wks. before the onset of jaundice and 1 wk. after onset of jaundice. s/s: May have no symptoms initially. Complications: □ Fulminant hepatitis Hepatitis B. Hepatitis C Hepatitis D Hepatitis E At risk: □ IV drug users □ People on Hemodialysis □ Health care personnel At risk: □ IV drug users □ People receiving frequent transfusions □ Healthcare personnel Cause: Occurs only with Hepatitis B and only causes problems with an acute HepB infection. Cause: waterborne virus Transmission: □ blood and body fluids □ contaminated needles, parenteral □ sexual activity Incubation: 6-24 weeks s/s: □ progression of symptoms is more insidious and prolonged than Hep A virus. □ Initially may be asymptomatic. □ 1 week -2 months of Prodromal symptoms: fatigue, anorexia, transient fever, abdominal Transmission: □ Same as Hep B □ Blood and body fluids Incubation period: 5-10 weeks s/s: similar to HBV but often less severe. Complications: □ chronic liver disease □ Cirrhosis. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) At risk: □ common in Middle east, south Africa and Mediterranean □ same as HepB Transmission: □ same as Hepatitis B. Incubation period: 7-8 weeks HepD along with HepB causes superinfection and worsening of condition and rapid progression of cirrhosis Complications: As per Hep B At risk: □ Travel to areas where sewage disposal is inadequate and/or people bathe in contaminated rivers □ At higher risk with higher mortality: women in third trimester of pregnancy Transmission: □ Same as HepA Incubation: 2-9 weeks Complications: □ Maternal and fetal demise 14
  • 15. □ death discomfort N/V, HA. □ Then expanding to: Hepatic S/S, photophobia, angioedema, rash, vasculitis, jaundice in Icteric phase Complication: □ Cirrhosis □ Fulminant hepatitis A grid follows with a listing of medications that may be on the exam. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 15
  • 16. Drug Acetylsalicylic acid (Aspirin) □ Non-narcotic analgesic □ Antipyretic □ Antiplatelets Activated charcoal (Actidose) □ Antidote □ Adsorbent Use and dosage □ Blocks pain impulse in peripheral and some CNS; □ antipyretic result; □ inhibit platelets aggregation □ □ □ □ □ □ Side effect □ Increases coagulation times □ Reye’s syndrome (encephalopathy and fatty liver), □ GI bleed, □ tinnitus, Treat TIA, Post MI, □ liver toxicity (dark Stroke, angina urine, clay stool, itching, yellowing sclera and skin), □ visual changes Treat poison and □ Vomiting with rapid overdose following administration oral ingestion. □ pulmonary Binds to poison and aspiration prevent its absorption by the GI tract and then eliminates in the feces. Administer within 60 minutes of ingestion. Give once or twice depending on the level of toxin. May come premixed with water 12.5-25 grams WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ Monitor coagulation studies □ Take with full glass of water, milk for food to prevent stomach upset □ Do not crush enteric coated □ given daily (81-325 mg) for cardiac prophylaxis post MI, stents, strokes, etc. □ Binding is irreversible so cathartic such as sorbitol may be added as well. □ It allows certain drugs/toxins to be drawn out of the blood and bind to charcoal in the intestine a kind of “gut dialysis” □ Stools will be black □ Charcoal does not change the stomach PH. contraindication Do not use with: □ children under 12 and/or children or teenagers with chicken pox or flu like symptoms (because of risk of Reye’s syndrome); □ pregnancy in 3rd trimester; and □ vitamin K deficiency Do not administer with Ingestion of: □ caustic alkali agent, □ high viscosity petroleum products OR when: □ convulsions are occurring, □ cardiac dysrhythmias are present, or □ there is emesis of blood Implement antidote supportive care and prevent aspiration are if gastric lavage is not to be performed. 16
  • 17. Drug Acyclovir (Zovirax) □ Antiviral - Herpes simplex virus – HSV - Herpes zoster - varicella Alteplase recombinant (Activase) Streptokinase is similar. Urokinase is given mostly in emergency situation. □ Thrombolytic agent Cath-flo Activase – is for occluded catheters Use and dosage □ Used for herpes simplex. Does not eradicate latent herpes. It reduces viral shedding and formation of new lesions and speeds healing time. (oral, IV and topical) □ To decrease symptoms with varicella zoster (chicken pox/ shingles). □ Dissolves or break down clots to reestablish perfusion. □ Indicated for clients at risk for developing thrombus with resultant ischemia such as MI, ischemic stroke, arterial thrombosis, DVT, PE □ occlusion of IV catheters. Side effect Side effects: □ Headache, dizziness □ seizure □ nausea, vomiting, diarrhea □ acute renal failure □ thrombocytopenia □ purpura hemolytic □ uremia syndrome Teaching and labs □ Even after HSV infection is controlled, latent virus can be activated by stress, trauma, fever exposure to sunlight, sexual intercourse. □ Refrain from sex if S/S of herpes. Adverse effects/toxicity: □ nephrotoxicity contraindication □ □ □ □ Do not give with: □ pregnancy, □ active bleeding, □ recent Hx of CVA, □ Uncontrolled HTN, Hemorrhage, N/V, hypotension cardiac dysrhythmias. □ Dose related is the highest problem WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) □ Watch for s/s bleeding; VS changes, s/s of impending shock □ If bleeding is occurring stop treatment and notify doctor. May start on FFP and PRBC. □ Aminocaprionic acid (Amicar) may be ordered for overdose or excessive bleeding. IM medication route is contraindicated when using thrombolytics. □ Do not take NSAIDs or Aspirin because of enhanced bleeding. 17
  • 18. Drug Aluminum hydroxide (Amphogel) □ Antacid Ampicillin (Ampicin) IV, PO, IM. □ Antibiotic □ Aminopenicillin Similar side effects, allergic reaction, etc. for all Penicillins (PCN) Use and dosage □ Neutralizes gastric acid, □ antflatulent to alleviate symptoms of gas and bloating Treat bacterial infection Commonly used with: □ Shigella, □ salmonella, Escherichia coli, □ haemophilus influenza, □ Neisseria gonorrhea, □ Neisseria meningitis, □ gram positive organism Side effect □ Increases gastric pH, □ □ Decreases absorption of other drugs such as dig, □ antibiotic, iron supplement. □ Toxicity causes dementia, Hypercalcemia, □ metabolic alkalosis, worsening of HTN, heart failure from increased intake. □ allergic reaction: Skin rash, urticaria, swelling, pruritus, angioedema. □ Severe allergy: hives, wheezing, anaphylactic reaction. Medical emergency requires immediate tx or can lead to death. □ side effects: GI, N/V, diarrhea, abdominal pain. □ Pruritic rash like measles is not a true allergic reaction WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs Given 2 hrs. apart from other drugs where interaction may occur. Observe for signs and symptoms of altered phosphate levels; anorexia, muscle weakness and malaise. Increase fluid, exercise and fiber to prevent constipation. contraindication Do not use: □ abdominal pain, N/V, diarrhea, □ severe renal dysfunction, □ fecal impaction, rectal bleeding, □ colostomy, ileostomy □ dehydration □ hypercalcemia and hypercalciuria □ Do not give with fruit juice, milk or carbonated beverages because of poor absorption. □ Watch for hypokalemia □ Take on empty stomach. □ May not be necessary to stop treatment if mild diarrhea develops. □ Give yogurt or buttermilk to restore normal flora (or probiotics) Avoid with: □ Hypersensitivity to any penicillins; use cautiously if history of hypersensitivity to cephalosporins; □ Exfoliated dermatitis □ Loop diuretic may exacerbate hypokalemia and rash. □ Potassium-sparing diuretic may contribute to hyperkalemia 18
  • 19. Drug Atropine Sulfate. Use and dosage □ Use to increase heart rate (not Two different uses: necessarily first drug of choice). □ Anticholinergic □ Decreases (such as for involuntary Parkinson’s disease) movement and □ For ophthalmic use rigidity in Parkinson’s disease □ Pre-op to decrease secretions and prevent aspiration Systemic effect is more of secretions while pronounced in infant under anesthesia and children with blue eyes and blond hair. □ Use for Also increased risk of inflammation of the toxicity with Down iris and uveal tract. syndrome Side effect □ Dry mouth, constipation, urinary retention or hesitancy headache, dizziness Adverse effects/toxicity: □ Paralytic ileus. □ Treat overdose (resp. depression and circulatory collapse) symptomatically. Adverse effect when used for the eye □ Transient stinging, □ increase IOP, photophobia, WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs contraindication □ Monitor dosage of □ Increased meds carefully, even anticholinergic slight overdose can effect with lead to toxicity. phenothiazine, antidepressant, □ Assess for MAO’s amantadine. constipation and urinary retention; increase fluids, bulk □ Contraindicated in and exercise, assess pt. with narrow bowel sound to rule angle glaucoma, out paralytic ileus, myasthenia gravis, or GI obstruction. □ Avoid driving or other hazardous activities, drowsiness may occur. For the Eye □ Acute glaucoma can be precipitated by papillary dilation; if not recognized and treat, acute glaucoma can result in blindness. □ Wear dark sunglass and avoid bright light for photophobia, □ Monitor intraocular pressure and vision 19
  • 20. Drug Beclomethasone diproprionate (Beclovent) □ inhaled corticosteroid medication note: also nasal inhalant as Beconase Use and dosage □ Used in bronchial asthma, allergic rhinitis Side effect Side Effects: □ Pharyngeal irritation and sore throat, coughing, dry mouth, oral fungal infections, and sinusitis. Teaching and labs □ Decrease dose if pt. is on systematic corticosteroid. □ Assess for impaired bone growth in children receiving inhaled □ Increased corticosteroid susceptibility to Considerations: infection, □ Monitor for dermatologic effects hyperglycemia and osteoporosis, □ Rinse mouth after diarrhea, N/V, HA, use for medication; fever, dizziness oropharyngeal angioedema rash candidiasis and/or urticaria and hoarseness can paradoxical occur. bronchospasm □ Use bronchodilator inhalant before Adverse effects/toxicity corticosteroid when □ Adrenocortical both are ordered. insufficiency □ Do not abruptly □ fluid and electrolyte stop meds taper disturbances, over 2 weeks. □ nervous system □ Be aware of steroids effects and symptoms - Moon endocrine effects if face, acne, edema, absorbed increased fat pads systemically. - notify doctor. □ Report weight gain WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Do not use with: □ children under □ Clients with known allergy □ May require adjustment of antidiabetic agent as there is a potential for elevated blood glucose levels with corticosteroids are administered orally. □ Not use in bronchospasm or status asthmaticus. 20
  • 21. Drug Benztropine mesylate (Cogentin) □ Anticholinergic (cholinergic receptor antagonist) □ Anti-Parkinson Use and dosage □ Treat Parkinson symptoms: Suppresses tremors and rigidity, not tardive dyskinesia □ Decreases hypersalivation and irregular movement related to Parkinson disease. □ Reduces extrapyramidal side effects Buspirone (Buspar) □ Anxiety □ anxiolytic □ Desired response 710 days; Make take 3-4 weeks for full effect Side effect Side effects: □ dry mouth, □ urinary retention/hesitancy, □ HA, □ dizziness. Teaching and labs □ Monitor dose carefully; even slight overdose can lead to toxicity. Nursing considerations: □ Monitor I&O’s, Adverse effects/toxicity: Education: □ paralytic ileus □ Avoid driving, or other hazardous activities; drowsiness may occur. □ Avoid cough OTC medication unless prescribed. Side effects: □ When switching to □ Dizziness Buspar, taper off benzodiazepines □ headache □ Less likely to have □ drowsiness cognitive impairment than other CNS meds □ Does not cause withdrawal s/s and thus does not need to be tapered off when stopping WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Avoid use with: □ narrow-angle glaucoma, □ myasthenia gravis, □ GI obstruction Avoid use with: □ MAO Inhibitors □ Lactation □ Caution with: moderate to severe renal impairment 21
  • 22. Drug Chlordiazepoxide hydrochloride (Librium) □ Anxiolytic □ Sedative-hypnotic benzodiazepine IM & tablet form Peak: □ 1-4 hours PO, □ 15-30 min IM. Half-life 5-30hr Use and dosage □ To relieve tension and/or anxiety □ To manage alcohol withdrawal Side effect Adverse effect: □ respiratory distress, drowsy, dizziness, lethargy, orthostatic hypotension □ photosensitivity □ do not to stop taking drug abruptly – will have withdrawal symptoms (usually in 5-7 days) Suicidal tendencies may be present and protective measures may be necessary. □ Monitor closely for paradoxical reactions – excitement, stimulation, acute rage – usually early in tx – withhold drug and notify dr. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ Give with milk or food to prevent GI upset. □ Check BP and pulse early in tx. If BP falls delay medication and notify dr. □ Labs: Monitor CBC, renal and hepatic enzyme levels □ watch for dependency Education: □ Avoid alcohol □ no OTC meds unless prescribed □ Avoid driving and other hazardous activities until effects known. contraindication Avoid use with: □ Narrow angle glaucoma, □ under 12 year old □ lactation Use cautiously with: □ impending depression, □ impaired hepatic or renal function, □ COPD 22
  • 23. Drug Chloramphenicol (Chloromycetin) Oral, injection, ophthalmic drops and ointment □ Anti-bacterial Chlorothiazide (Diuril) □ Thiazide diuretic, non-Potassium sparing □ Anti-hypertensive Use and dosage □ severe infection for susceptible organisms when other anti-infective are ineffective. □ Sty, conjunctivitis, uveitis Side effect Side effects: dermatitis, itching, stinging, swelling Adverse effects/toxicity (oral and injection) □ edema □ super infection, □ aplastic anemia. □ Stevens-Johnson syndrome Teaching and labs □ obtain culture specimen from eye before initiation of treatment □ remove exudates. □ Monitor for pain, drainage, redness, swelling. □ Monitor for bleeding or bruising contraindication Avoid use with: □ hypersensitivity □ Increases urinary excretion sodium and water by inhibiting sodium reabsorption. □ Use for edema and HTN, HF, cirrhosis, corticosteroid and estrogen therapy, diabetes insipidus, Side effects: □ Dizziness, vertigo, frequent urination, electrolyte imbalance, impaired glucose tolerance, hyperuricemia, photosensitivity Adverse effects/toxicity: □ Renal failure, aplastic anemia, and anaphylaxis □ Take early in the morning to avoid nocturia. □ Give with food, □ allow for 3-4 weeks for maximum effect, □ Will not be effective if creatinine clearance Is less than 30ml/min Avoid use: □ Client with anuria. □ Use cautiously with impaired renal or hepatic function. □ If pregnant. □ Will increase serum lithium level WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 23
  • 24. Drug Chlorpromazine hydrochloride (Thorazine) □ □ □ □ Use and dosage □ Block dopamine receptor in CNS to □ Use: treat psychotic disorder phenothiazine (schizophrenia, Antipsychotic bipolar, and other medication mental illnesses); prevent acute Anti-emetic exacerbation and maintain highest possible level of function Give bromocripitine □ Use to control (Parlodel) and manic phase dantrolene (bipolar) (Dantrium) for □ intractable hiccups NMS. □ nausea/vomiting □ Low potency antipsychotic which can reduce the risk of EPSE (extrapyramidal side effects) Side effect Side effects: □ Sedation, orthostatic hypotension, □ anticholinergic effect (dry mouth, blurred vision, urinary retention, photophobia, constipation, tachycardia) □ liver damage, tremor are two major side effects. □ photosensitivity Adverse effects/toxicity: □ Neuroleptic malignant syndrome (NMS), catatonia, rigidity, stupor, unstable blood pressure profuse sweating, dyspnea. Can be toxic effect and MAY last for 5-10 days after discontinuation of the med. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ get baseline ECG, thorough baseline evaluation lab tests before treatment. □ Give bromocripitine (Parlodel) and dantrolene (Dantrium) for NMS. □ Withdrawal of drug is necessary □ Take measures to protect eyes exposed to sunlight contraindication □ Monitor diabetics closely for glucose intolerance 24
  • 25. Drug Cimetidine (Tagamet) □ GI meds, □ H2 receptor antagonist Cisplatin (Platinol) Half-life 20-30 minutes □ Antineoplastic medication □ Alkylating agent ** Major allergic reaction can occur within first 15 mins. of administration. Anaphylaxis may occur within minutes of drug initiation. Use and dosage □ Works against histamine receptors, decreases gastric secretion. □ Use short term for duodenal ulcer, benign gastric ulcer, acute upper GI bleed □ Treat ovarian and testicular cancer by interfering with DNA replication Side effect Side effects: □ Cardiac dysrhythmia, diarrhea, dry mouth, constipation Adverse effects/toxicity: □ Rare but may include agranulocytosis neutropenia , thrombocytopenia aplastic anemia, anaphylaxis Side effects: □ anorexia, uncontrolled N/V, fluid retention, weight gain Adverse effects/toxicity: □ Major toxicities occur in the blood, GI, and reproductive system. □ Watch urine output and specific gravitynephrotoxicity may occur within 2 wks. □ ototoxicity (tinnitus or difficulty hearing in the high frequency range) WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ May be given with meals and at bedtime □ Avoid smoking which cause gastric stimulation □ Avoid antacid use within one hour of dose contraindication Avoid use: □ hypersensitivity Use caution: □ impaired renal or hepatic function □ maintain fluid at least 3000 ml in 24 hr. ; report reduced urine output □ Avoid food high in thiamine (beer, wine cheese, brewer’s yeast, chicken liver & banana) - may lead to hypertension & intracranial hemorrhage Avoid use: □ Hx of sensitivity to platinum-containing compounds, □ impaired renal function and hearing, □ Hx of gout, renal stones. Incompatible with □ dextrose and Reglan, Vanco □ Lasix may increase otoxicity □ other nephrotoxic drugs may increase nephrotoxicity and renal failure. 25
  • 26. Drug Codeine sulfate □ Opioid analgesic (agonist) □ Antitussive (cough suppressant) Use and dosage □ To treat mild to severe pain □ most oral preparations combined with ASA or acetaminophen □ hyperactive cough Rapid onset if IM or IV. Peak 1-2 hrs., Duration up to 7 hours. Cyanocobalamin (Vitamin B12) Half- life: 6 days □ Vitamin B12 helps in the formation of red blood cells essential for the proper production of blood platelets and red and white blood cells and the nervous system □ Malabsorption syndrome □ Pernicious anemia Side effect Side effects: □ Constipation, urinary retention, dizziness, lightheadedness. Adverse effects/toxicity: □ Respiratory depression, respiratory arrest, circulatory depression, ICP. □ Long term use may cause withdrawal symptoms when stopped Adverse effects/toxicity: □ Anaphylactic shock, sudden death, □ severe optic nerve atrophy (may develop after years of use or with Leber’s disease) □ water-soluble vitamin that is stored in the liver. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs Assess for: □ respiration and usually hold <12 breaths per minute, □ CNS changes (LOC), □ allergic reaction TEACH: □ no alcohol □ no OTC pain meds unless ordered □ Avoid driving until drug response is known. contraindication Do not use: □ Hypersensitivity □ Increased ICP, head injury □ Acute alcoholism □ labor Teach: □ Injection is once per month for life with pernicious anemia . □ Oral preps may be mixed with fruit juice but give immediately since ascorbic acid (Vit. C) affects stability of B12. □ Dietary B12: best are organ meats, egg yolk, clams, oysters, crabs, sardines, salmon Do not use: □ Hypersensitivity □ Lactation 26
  • 27. Drug Cyclosporine (Sandimmune) □ Immunosuppressant medication Metabolized in the liver. Peak 4-5hr, Duration 20-54 hrs. Half-life 19-27 hrs. Use and dosage □ Inhibit T helper and T suppressor cells. □ Prevent rejection of kidney, liver and heart transplants. □ Treat chronic rejection in people who have received immunosuppressive agent, rheumatoid arthritis, recalcitrant plaque psoriasis Side effect Side effects: □ Hypertension, □ increased risk of infection □ Tremor is an expected side effect Teaching and labs □ Monitor labs: AST, ALT, BUN, creat, platelet count, K, TEACH: □ Take with food to reduce GI upset □ mix with milk, Adverse effects/toxicity: chocolate milk or orange juice but not □ Renal toxicity, with Grapefruit juice □ hepatotoxicity □ Mix in glass, not plastic □ Avoid use of live vaccine □ Prevention of infection and report signs of infections contraindication □ Do not use: Pregnant/lactating mom, □ Use cautiously in renal and hepatic impairment □ Antiepileptic medications decrease cyclosporine levels □ oral contraceptive increase levels □ Immunosuppressed precautions WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 27
  • 28. Drug Debrox drops □ Ear drops to dewax Use and dosage □ used to soften and loosen ear wax, making it easier to remove. Side effect Side effects: □ temporary decrease in hearing after using the ear drops □ mild feeling of fullness in the ear □ mild itching inside the ear. Adverse effects/toxicity: □ Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs Use: □ Tilt head with ear facing upward. Pull back on ear to open up the ear canal. Drop the correct number of ear drops into the ear. □ After using the ear drops, stay lying down or with your head tilted for at least 5 minutes. You may use a small piece of cotton ball to plug the ear and keep the medicine from draining out. □ A bubbling sound inside may be heard after putting in the drops. This is caused by the foaming action of carbamide peroxide, which helps break up the wax □ May come with bulb syringe. contraindication Do not use: □ With a ruptured ear drum. □ any signs of ear infection or injury □ Do not use this medication in a child younger than 12 years old without the advice of a doctor. □ Do not use for longer than 4 days in a row. 28
  • 29. Drug Diazepam (Valium) □ Benzodiazepine (have zep and zap in them) □ minor tranquilizers, □ anticonvulsant, □ anxiolytic □ Absorbed from GI, metabolize in liver Onset 30 min IM, 60 PO, 15 IV. Works quickly. Peak 1-2hr PO, Duration 15 min to 1hr IV; up to 3 hrs. PO. Half-life 20-50 min Use and dosage □ Relieve pain and discomfort from musculoskeletal disorders, □ manage anxiety, □ Manage acute alcohol withdrawal Maximum effect will be seen in 1-2 weeks. Can take 2-4 wks. It has addictive effect. Side effect Side effects: ABCD. □ Anticholinergic (dry mouth), □ Blurred vision, □ Constipation, & □ Drowsiness, Teaching and labs □ Watch for CNS effect. □ Monitor CBC WBC with diff. □ notify dr. if drop in BP of 20 mm Hg □ Assess for allergic reaction including □ cardiovascular idiosyncratic collapse, reaction, laryngospasm, anaphylaxis, rash dizzy, weakness, fever resp distress nausea Adverse effects/toxicity: Teach □ Do not stop □ Erythema abruptly – multiforme, withdrawal □ angioedema, symptoms will □ anaphylaxis, occur (insomnia, □ dysrhythmia nausea HA, □ seizure spasticity, tachycardia). □ No alcohol (will increase CNS depression) contraindication Do not use: □ compromised pulmonary function, □ hepatic disease, □ impaired myocardial function, □ acute alcohol intoxication □ infant < 6 months □ narrow angle glaucoma, open angle glaucoma □ Suicide prevention precautions WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 29
  • 30. Drug Digoxin (Lanoxin) □ Cardiac glycoside, antiarrhythmic drug. □ Therapeutic range: 0.5-2.0ng/ml □ Toxic level > 2 Antidote: digibind (digoxin immune fab) Use and dosage □ Positive inotropic effect □ In heart failure it Increase contraction of the heart muscle. □ In atrial fib, it slows the heart rate Side effect Side effects: □ Nausea, HA, loss of usual appetite. Adverse effects/toxicity: □ Toxicity may go unrecognized since it presents with same symptoms as flu (N/V, anorexia, diarrhea, vomiting visual disturbance). □ Blurred green or yellow vision or halo effect** □ In HF, early sign of toxicity includes dysrhythmias. □ Children rarely show signs of N/V, diarrhea, visual problem, anorexia (could become dig toxic without showing usual s/s) WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ may give without regard for food □ IVP over 5 min, do not give IM, it will cause tissue irritation. □ Monitor apical pulse, if <60/min., usually hold meds and notify doctor. □ Monitor labs (K, calcium, magnesium, creatinine clearance), □ Monitor Dig level every 6 months. □ weigh daily and report weight greater than 2 lbs. per day contraindication Avoid use with: □ hypersensitivity to dig □ Caution with kidney failure Interaction: □ IV calcium with dig may increase risk of cardiac dysrhythmias, □ erythromycin will increase dig level, □ quinidine, verapamil and amiodarone will increase dig levels and dig dose should be decreased by 50% □ Cyclophosphamide combined with dig cause dig toxicity 30
  • 31. Drug Disulfiram (Antabuse) The only alcohol antagonist in use. □ Enzyme inhibitor □ Anti-alcohol agent. Half-life 24-36 hour Onset up to 12 hrs. Duration up to 2 wks. Absorbed from the GI excreted in feces or in the breath as carbon disulfide Use and dosage □ Adjunct treatment of patient with chronic alcoholism who sincerely wants to maintain sobriety. □ At least 12 hours should elapse from the time of last alcohol intake and the initial dose □ Use only in people with high physical health. □ Use for 1-2 wks. Side effect Side effects: □ Rare in the absence of alcohol Adverse effects/toxicity: ** Acetaldehyde syndrome □ hypotension to shock level arrhythmias, □ acute congestive failure, □ marked respiratory depression, INTENDED Reaction □ unconsciousness, with alcohol ingestion: □ convulsions □ flushing face, chest, □ sudden death arms □ pulsating HA □ Nausea □ violent vomiting □ thirst □ sweating □ marked uneasiness WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ The effects of disulfiram may persist for 2 weeks after last dose is taken; alcohol must not be consumed until this interval is over. □ Give in the morning when the resolve not to drink is the strongest. Give at bedtime to minimize the effect of drug □ avoid alcohol of all forms include those found in sauces, cough mixture and after shave lotions, colognes and liniments contraindication Do not use: □ In people who do not want to stop drinking. □ Severe cardiac disease, □ psychoses, □ pregnancy, □ multiple drug dependence. 31
  • 32. Drug Epinephrine (Adrenalin) □ alpha and beta adrenergic agonist □ vasopressor □ bronchodilator □ If given IM, SQ result seen in 5 min & lasts up to 4 hrs., □ Also available eye drops and intranasal Use and dosage □ Reverses anaphylactic reaction □ Restores cardiac rhythm in cardiac arrest □ Acute asthmatic attack Side effect Side effects: □ nervousness, □ tremors, □ increased HR, BP, □ insomnia, □ anorexia □ cardiac stimulation □ vascular HA. Teaching and labs Teach □ Report nervousness and sleeplessness dose should be reduced. □ Administer eye drops at bedtime. May experience headache and stinging but subside □ Also use in Adverse effects/toxicity: with continued use. ophthalmic □ Tachyarrhythmias, Report if continues. decongestant, □ chest pain, manage open angle □ restlessness, □ Monitor VS glaucoma □ agitation, especially HR and □ nervousness and BP because of □ insomnia. cardio effect. □ Nasal burning stinging, □ eye burning D/C if hypersensitivity develops (develops of lids, itching, discharge, crusting eyelid). Notify doctor WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication If use with MOA inhibitors may lead to hypertensive crisis. □ Narrow angle glaucoma, □ hemorrhagic traumatic or cardiogenic shock, □ arrhythmias, □ organic heart or brain disease. CAUTION in: □ older adults, □ HTN □ TB, long standing bronchial asthma and emphysema □ children < 6 □ No breastfeeding 32
  • 33. Drug Famotidine (Pepcid) □ Histamine □ H2 antagonist. Onset 1 hr. Peak 1-3hr Duration 10-12 hrs. Half-life 2.5-4hr Fluoxetine hydrochloride (Prozac) Use and dosage □ Decreases output of gastric acid □ Short term treatment in duodenal ulcer or benign gastric ulcer. □ Metabolized in liver, excreted in urine □ Major depressive disorder □ Obsessive compulsive disorder, □ bulimia, □ panic disorder □ obesity □ alcoholism □ chronic pain. Side effect Teaching and labs Side effects: □ May be taken with □ diarrhea, food. constipation, dry □ pain relief may not mouth be experienced for Adverse effects/toxicity: several days □ thrombocytopenia contraindication □ Use cautiously with impaired renal or hepatic function. □ Do not breastfeed □ DO NOT stop abruptly. □ Give meds once a day at about noon because it causes insomnia. If prescribed 2 times daily give dose in the morning early and 12 noon to prevent insomnia □ Teach side effects of drugs □ Therapeutic response takes some weeks to be established. □ MI, cerebrovascular disease. □ If suicide risk, should not have access to a large quantity. □ Do not take while pregnant Common side effects: □ Orthostatic hypotension □ psych med. □ sedation □ Tricyclic □ Anticholinergic antidepressant. □ Hypomania □ Selective Serotonin □ Sexual dysfunction Reuptake inhibitors Adverse effects/toxicity: (SSRI) □ Cardiac toxicity □ Selective Serotonin Half-life 1-6 days. syndrome (early s/s: Onset 2-3 weeks to be diaphoresis, agitation, Such as rash. Wait 4-6 effective. weeks before switch to low grade temp.) Then Peak 4-8hrs. increase in BP, muscle MAO Inhibitor Metabolized in liver, rigidity, temp, resp, absorbed from GI tract, pulse. Mental status excreted in urine and changes, tremors, face. hyperthermia, sweating hypersalivation. Notify dr ASAP. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) □ avoid antacid use within 1 hour of dose □ ** The combination of TCA and MAOI can lead to hypertensive crisis from excessive adrenergic stimulation of the heart and blood vessels. 33
  • 34. Drug Fluphenazine (Prolixin) Use and dosage □ Potent medication for treatment of □ phenothiazine; Ends antipsychotic with azine symptoms, including □ antipsychotic schizophrenia. Half-life > 24 hours □ Treatment is not Onset: 1 hr., curative. peak 0. 5 hr. meds □ Adjust dose to symptoms. effect can be seen 1-2 days but full effect □ Use injectable form several weeks for long term maintenance - the rate of relapse is usually reduced and is more favorable Side effect □ Produces EPS which are reversible. ** Treat EPS with Cogentin, Artane, Benadryl, Symmetrel Side effects: ABCDE □ Anticholingergic (dry mouth), Blurred vision, Constipation, Drowsiness, EPS □ Photosensitivity □ may increase risk of agranulocytosis □ gynecomastia, □ amenorrhea □ weight gain Adverse effects/toxicity: Neuroleptic malignant syndrome (NMS) a fatal side effect. Presents with catatonia, rigidity, stupor, unstable blood pressure, hyperthermia profuse sweating, dyspnea, incontinence. Stop drug. Tx with Dantrium and Parlodel. Condition lasts for 5-10 days after stopping med. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs Monitor LFTs TEACH □ Avoid alcohol use and other CNS depressants □ Do not alter dose or stop abruptly □ Avoid sun exposure □ With oral concentrate, avoid spills. Rinse skin with warm water immediately if there is contact contraindication Avoid with: □ Caution with narrow angle glaucoma, hepatic or renal dysfunction and seizure disorder. □ Do not breastfeed □ Dose should be reduced in the elderly. □ Dilute liquid drug with fruit juice water, carbonated beverage, milk, soup – avoid mixing with caffeine, tea, apple juice. 34
  • 35. Drug Furosemide (Lasix) □ Loop diuretics, □ Anti-hypertensive Peak 60-70 min PO, 2060 min IV. Onset 30-60 min PO, 5 min IV, Duration 2 hrs., Half-life 30 min Use and dosage □ Rapid acting loop diuretic □ Inhibits reabsorption of sodium and water (in Loop of Henle) □ Lowers BP by decreasing edema and intravascular fluid Treat □ acute pulmonary edema, edema, □ heart failure, □ chronic renal impairment, □ hypertension, □ hypercalcemia Side effect Side effects: □ Ototoxicity □ headache □ Dizziness □ Orthostatic hypotension □ weakness Teaching and labs TEACH □ change position slowly to avoid dizziness and orthostatic hypotension □ report ringing in the ear immediately □ Take with food or milk Adverse effects/toxicity: □ Give early in day to □ s/s hypokalemia – avoid nocturia □ Hyponatremia, □ Replace potassium □ hypochloremia, (dietary or meds) □ hypomagnesaemia □ hypocalcemia □ Monitor labs, especially electrolytes. Also IV form: hgb, hct, platelet as □ Administer slowly; these increase d/t hearing loss can hemoconcentration occur if injected rapidly (ototoxicity). □ Monitor body □ Give over 1-2 weight and I&O. minutes to prevent hypotension. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Avoid with: □ anuria, electrolyte depletion, increasing oliguria, anuria □ hepatic coma, □ pregnancy, lactation □ Interaction with digitalis can increase arrhythmias. □ Interaction with aminoglycosides increases risk of ototoxicity. 35
  • 36. Drug Gentamicin (Garamycin) □ Aminoglycosides. □ Antibiotic Peak level: □ Drawn 15-30 min after the infusion is completed. □ Peak concentration determines that toxic level does not occur. □ If peak is too high, may reduce dose. Trough level: □ Drawn immediately (within 30 minutes) before next IV dose □ Assures that therapeutic level of drug is maintained. Trough level is 1-2 g/ml between doses. □ Dose will be adjusted if level is not sustained Peak 30-90 min Half-life 2-4 hr. Use and dosage □ Broad-spectrum antibiotic □ Parenteral use limited to severe infections, unresponsive to other antibiotics. Ophthalmic: □ treat superficial infection of the eye. □ Have pt. keep eyes closed for 1-2 min after instillation. □ Vision will be blurred initially Side effect Side effects: □ HA, parenthesia, skin rash fever contraindication Avoid with: □ Maintain hydration □ Pre-existing renal to protect kidney disease damage. Fluid □ Use caution with Adverse effects/toxicity: intake should be pre-existing hearing 2,500-3000 ml/day □ Nephrotoxicity loss □ give high protein □ Ototoxicity. □ Pregnancy, foods This may cause lactation LABS irreversible auditory □ Increased risk with □ WBC to monitor the impairment and nephrotoxic drugs, vestibular damage effectiveness of prolonged Signs of ototoxicity therapy treatment with include HA, NV unsteady □ Watch kidney aminoglycosides, gait, tinnitus, vertigo, function tests (BUN, impaired renal high frequency, hearing Creat) closely due to function and other loss and dizziness toxicity risk ototoxic drug such □ Hypersensitivity as Lasix, Vanco. reactions □ Report sore throat, □ Superinfection: a watery stools secondary infection greater than 4-6 per caused by day, severe nausea eradication of or vomiting, normal flora: indicating possible Candidiasis, skin and super infection mucous membrane WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs 36
  • 37. Drug Glipizide (Glucotrol) □ oral antidiabetic □ Sulfonylurea duration: 12-24 hours Onset: 15-30 min Peak: 1-2hr Metabolized by the liver Glucagon □ Anti-hypoglycemic Onset 5-20 min, Peak 30 min Duration 1-1.5 hr., Half-Life; 3-10 minutes Metabolizes in liver, plasma and kidneys Use and dosage □ Stimulates pancreatic beta cells to secrete insulin. □ Type 2 diabetes mellitus □ Give dose 1-3 time daily □ may use alone or in combination with insulin □ Emergency treatment of severe hypoglycemia in unconscious client or those unable to swallow □ Comes in powder form. Reconstitute with provided diluent. □ Give IV, IM or SQ immediately □ Give IV through D5W only, not NS Side effect Side effects: □ GI distress □ dizziness □ drowsiness □ headache Teaching and labs □ Monitor labs including glucose, Hgb A1C TEACH □ Take with first daily meal. Adverse effects/toxicity: □ Take any missed dose as soon as □ Severe skin rash, remembered. pruritus □ Report s/s of □ Hypoglycemia hypoglycemia if they occur □ Avoid alcohol Side effects: □ Should awaken □ Nausea/ vomiting within 5-20 min after giving. Adverse effects/toxicity: □ Give 50% glucose if □ Hypersensitivity no response to reaction, glucagon Teach □ hyperglycemia □ test blood sugar, □ Hypokalemia □ teach family how to administer SQ or IM WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Avoid with: □ Pregnancy, lactation □ Allergy to sulfa or urea □ Diabetic ketoacidosis Caution with: □ impaired renal and hepatic function □ Adrenal or pituitary insufficiency. □ Incompatible with sodium chloride solution. 37
  • 38. Drug Glyburide (Micronase, DiaBeta) □ Oral antidiabetic, □ more potent drug □ Sulfonylurea Onset 15-60 min Peak 1-2 hrs. Duration up to 24 hrs. Half-life 10 hours Metabolized in the liver, excreted in urine and feces. Haloperidol (Haldol) High potency drug □ Antipsychotic □ Butyrophenone □ Antiemetic Onset: 30-45 min IM Effects can be seen in 12 days. Substantial improvement 2-4 wks. Full effect several months. Use and dosage □ Lowers blood sugar concentration in diabetics and nondiabetics by sensitizing pancreatic beta cells to release insulin in the presence of serum glucose. □ Type 2 diabetes □ Use as adjunct to diet and exercise to lower blood sugar □ Psychotic disorders □ Long acting drug for maintenance – to control symptoms □ Tourette’s syndrome Side effect Side effects: □ Hypoglycemia, □ epigastric fullness □ heartburn □ pruritus Teaching and labs □ Give once in the morning with breakfast or with first main meal □ Monitor labs including glucose, HgbA1c Adverse effects/toxicity: Teach □ hypoglycemia □ Report reaction □ Loss of control of blood glucose level may be due to fever, surgery, trauma, stress, infection. Side effects: ABCDE: □ EPSE: usually first □ Anticholinergic (dry few days of tx, dose mouth) related, controlled by dose or anti□ Blurred vision Parkinson’s drugs □ Constipation □ Oral: Give with milk □ Drowsiness or food. □ Extrapyramidal □ Taper dose slowly syndrome (such as when stopping. Parkinson’s s/s) □ Injection: deep IM – □ Photosensitivity risk for orthostatic Adverse effects/toxicity: hypotension □ Elderly patient may develop Neuroleptic □ no alcohol or driving until response Malignant known Syndrome (NLMS) WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Avoid use with: □ diabetic ketoacidosis □ Type I diabetes Caution with: □ renal or hepatic insufficiency □ older adult □ malnourished pt. □ adrenal or pituitary insufficiency Avoid with: □ Parkinson’s disease □ seizure disorder □ severe mental depression Use caution: □ older adults, □ lithium therapy □ HTN □ Lactation 38
  • 39. Drug Heparin □ Anticoagulant Antidote = Protamine sulfate (see separate listing) Hydrochlorothiazide hydrochloride (Hydrodiuril, HCTZ) □ Electrolyte and water balance □ Thiazide diuretic □ Effects noted 3-4 days; max effect takes 3-4 weeks Use and dosage □ As anticoagulant – given IV or SQ □ Use as continuous IV infusion for DVT, Pulmonary embolus, angina, acute MI □ SQ for prevention Side effect Side effects: □ Bleeding □ Heparin-induced Thrombocytopenia (HIT) – may appear up to several weeks later. □ Hep-lock (flush) is to maintain patency of IV catheters; not for anticoagulant therapy Side effects: □ Act on distal tubules of nephron □ Glucose intolerance, and increases hyperglycemia urinary excretion of □ Hypokalemia (low sodium, chloride, K+) potassium, water, bicarbonate □ Decreases edema and lowers blood pressure □ Most widely prescribed diuretic for HTN WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ Does not dissolve clots – prevents enlargement and development of new clots. □ Use bleeding precautions □ Monitor labs: aPTT Normal = 25-40 Coagulated = 1.5-2 times normal = 60-80 contraindication Avoid use with: □ Hemorrhage, active bleeding □ Do not give IM. □ Adjust IV dose based on labs. □ Give with food or mild to reduce GI upset. □ Give dose(s) early in the day to avoid nocturia □ Limit Sodium intake □ Eat foods high in K+. – replacement med usually not needed □ photosensitivity reaction occur 10-14 days after initial sun exposure Avoid with: □ Anuria □ Hypersensitivity to thiazide Use caution: □ Bronchial asthma □ hepatic cirrhosis □ renal dysfunction □ history of gout □ diabetes □ SLE □ Lactation 39
  • 40. Drug Hydroxyzine HCl (Atarax, Vistaril) □ Anti-emetics □ Anti-histamine (H1 receptor antagonist) □ antipruritic Onset 15-30 min PO Peak 4-6 hrs. Duration Absorbed form GI. Metabolized in the liver Ibuprofen (Advil, Motrin) □ Analgesic □ Non-steroidal antiinflammatory (NSAID) □ For high dose therapy: therapeutic effect may take up to one month Use and dosage □ Treat N/V (use anticipatorily) □ Relieve anxiety □ Reduce narcotic requirement before and after surgery. □ Treat acute or chronic alcoholism with withdrawal symptom or DTs □ Pruritus Side effect Side effects: □ CNS depression, □ Drowsiness □ Dizziness □ dry mouth, anticholinergic effect □ constipation □ visual changes □ photosensitivity Teaching and labs IM: □ Administer deep IM, Z-track – gluteus maximum or vastus lateralis in adults; vastus lateralis in children Side effects: □ CNS, renal system, eyes □ Nephrotoxicity □ dysuria, hematuria, oliguria, azotemia, □ Blurred vision. □ Ototoxicity Children toxicity: □ Rash, StevensJohnson syndrome □ □ □ □ Usually PO for maintenance □ Treat mild to moderate pain □ absorbed in GI; metabolized in liver WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) □ contraindication Avoid with: □ CNS depression and coma. □ Other CNS meds Use caution with: □ glaucoma □ seizure □ intestinal monitor mouth daily obstruction no alcohol □ prostatic hard candy, ice hyperplasia chips or rinse mouth □ asthma with warm water □ cardiac, pulmonary frequently to relieve or hepatic disease dry mouth Increases toxicity of Avoid with: □ GI bleed anticoagulant, lithium □ Reaction to other NSAIDs Avoid alcohol, ASA, □ Children under 6 other NSAIDs months 40
  • 41. Drug INSULINS - quick acting: short acting intermediate acting long acting Insulin is also available in a premixed form of Regular and NPH (example: 70/30 = 30% regular, 70% NPH). Use and dosage □ Diabetes mellitus, type 1 or type 2 □ Could be made of: pork/beef, pork or human insulin type. □ Short acting and intermediate acting insulin may be given more than once per day. Side effect Side effects: □ Hypoglycemia (anxiety, confusion, nervousness, hunger, diaphoresis, cool, clammy skin) □ Lipodystrophy (abnormal deposits of subcutaneous fat at injection sites), □ local allergic reaction Adverse effects/toxicity: □ Somogyi phenomenon: a rebound response with high blood sugar in response to low level at night. □ Coma □ Hyperosmolar hyperglycemic state (HHS) □ Diabetic ketoacidosis (DKA) WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ obtain med alert bracelets □ Open vial can be stored at room temp for up to one month. □ Rotate sites □ Alcohol will increase blood sugar contraindication □ Do not use beef/pork insulin if sensitivity □ Requires long-term monitoring of blood sugar control and potential complications. 41
  • 42. Drug Insulin – Regular (Humulin R) **THIS IS THE ONLY TYPE OF INSULIN WHICH CAN BE GIVEN IV. ** Isophane (NPH) insulin (Humulin N) Insulin – Glargine (Lantus) ** LANTUS CANNOT BE MIXED IN SAME SYRINGE Use and dosage Side effect □ Short acting insulin □ hypoglycemia □ Given IV or SQ □ type 1 and type 2 diabetes mellitus and ketoacidosis. □ given before meals according to blood levels □ Intermediate □ If given before acting insulin breakfast, hypoglycemic □ Give 30 min before episode is most first meal of the likely to occur day. If necessary, a between midsecond smaller afternoon and dose may be dinner, when it prescribed 30 min peaks. Eat snack in before bedtime. midafternoon and carry sugar candy. Teaching and labs □ Regular insulin is clear and colorless. □ Long acting insulin □ Type 1 children & adults; Type 2 adults □ SQ injection contraindication □ With Type 2 diabetes, may or may not be given concurrently with oral agents. □ NPH Insulin is a cloudy suspension. □ Roll the bottle to mix; do not shake. □ NOTE: NPH may be mixed with Regular insulin injection without altering either solution. WITH ANY OTHER INSULIN.** □ Usually given one per day at bedtime. May be given two times per day. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 42
  • 43. Drug Iron Use and dosage □ Mineral replacement Ipecac Syrup Adverse effects/toxicity: □ Use of this □ For overdose on □ Cardiotoxicity is certain drug or medication is not poison most serious if automatic – verify vomiting does not appropriateness □ stimulates vomiting occur and the with Poison control within 20-30 min substance is center retained. □ Emetic □ Antidote Alternate: Activated Charcoal (see separate listing) Side effect Side effects: □ Nausea/vomiting □ Staining of teeth □ Constipation □ Black stools (normal) WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ Taking on empty stomach preferred with full glass of water or citrus juice □ Calcium inhibits iron absorption – do not take with milk. □ Vitamin C increases iron absorption □ Liquid form can stain teeth contraindication Do not use: □ With reduced level of consciousness or convulsions □ poison by Petroleum distillates, strong alkaline, acid or strychnine 43
  • 44. Drug Lidocaine HCl (Xylocaine) □ Antiarrhythmic □ Topical Anesthetic Bolus dose – may repeat – then start continuous infusion – stop when stable. Therapeutic level: 1.56mcg/ml Use and dosage □ Treat VENTRICULAR arrhythmias, PVC’s, V-Tach. □ Use for rapid control of ventricular dysrhythmias during acute MI or Cardiac cath □ Use microdrip tubing and infusion pump. Side effect Side effects: □ Drowsiness, headache, dizziness, mild hypotension. Adverse effects/toxicity: □ convulsions, respiratory depression □ CV: hypotension, bradycardia, heart block CV collapse, and arrest Teaching and labs LAB □ Monitor Lidocaine levels assess, therapeutic level is 1.5 -6mcg/ml □ Assess electrolyte, check baseline liver and renal blood studies. Report: □ lightheadedness, □ dizziness, confusion, □ numbness or □ Stop infusion with tingling of lips, EKG changes such as tongue or fingers prolonged PR, □ visual changes or widened QRS, heart □ ringing in ears block. □ Correct hypokalemia before giving Lidocaine WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Avoid with: □ Sinus bradycardia □ Severe degrees of SA, AV and intraventricular heart block. Use caution: □ hepatic or renal disease □ CHF □ Hypovolemia □ shock □ hyperthermia □ elderly □ BETA BLOCKERS increase the effect of lidocaine 44
  • 45. Drug Lithium carbonate (Eskalith) □ Mood stabilizer □ Antipsychotic □ Therapeutic level 0.8-1.5meq/L. □ Toxic level >2. □ Lithium has short half-life (about 1 day) and high toxicity. Lorazepam (Ativan) □ Anxiolytic □ Sedative-hypnotic □ Benzodiazepines. Onset 1-5 min IV, 15-30 IM, Peak 60-90 min IM, 2 hrs. PO Duration 12-24 hrs. Use and dosage □ Drug of choice to control manic episodes in bipolar disorder □ Anti manic effects are usually seen in 5-7 days after initial doses, but full effect does not occur for 2-3 wks. □ Lithium is a salt; exact action uncertain □ □ □ □ Side effect □ This med does not cause sedation. Mild Side effects: □ fine tremor, nausea, thirst, polyuria, Adverse effects/toxicity: □ Vomiting, diarrhea, slurred speech, lack of coordination, drowsiness, muscle weakness, or twitching) – withhold dose and notify provider but DO NOT stop abruptly. Side effects: anxiety disorder short term for relief □ Drowsiness □ sedation of symptoms of anxiety □ Mild medication Pre-anesthetic with limited toxic medication to potential produce sedation □ respiratory and reduce anxiety. depression is rate Status epilepticus Paradoxical reactions (nightmares, mania, etc.) may occur in children, psych patients and the elderly. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ Give with meals □ Hydration is essential – dehydration will increase levels □ Watch for weight gain (fluid retention) □ Avoid NSAIDs and diuretics. □ Essential to monitor mood and behaviors □ Labs: Lithium level every 3 months initially, then every 6 months. □ Avoid alcohol □ Taper dose when stopping to avoid withdrawal symptoms □ Watch for suicidal risk contraindication Do not use with: □ Dehydration, severe debilitating, severe cardiovascular. Use caution: □ elderly, □ pt. with cardiac, renal, thyroid or diabetes □ pregnancy Do not use with: □ Acute narrow-angle glaucoma, □ Primary depression □ acute alcohol intoxication. □ Pregnancy and Lactation Use caution: □ renal or hepatic impairment □ myasthenia gravis □ suicidal tendencies 45
  • 46. Drug Magnesium Sulfate iron(Epsom salt – oral form) Onset 1-2 hrs. PO; 1 hr. IM. Duration 30 min IV, 3-4 hr. PO Eliminated by kidneys Use and dosage □ Oral: laxative (by osmotic retention of fluid which distend the colon, increase content of feces and cause bowel stimulation) □ Parenteral: CNS depressant; used in seizures of toxemia; for hypomagnesemia Normal Magnesium level: 1.8-3 mEq/L □ 4 gm. loading dose is give over 20-20 min via pump. Side effect Side effects: □ Flushed warm feeling □ fluid and electrolyte imbalance □ hyponatremia □ N/V Adverse effects/toxicity: Early indication of magnesium toxicity □ Respiratory depression □ Cathartic effect □ profound thirst □ feeling of warmth □ sedation □ confusion □ depressed deep tendon reflexes □ muscle weakness □ can lead to cardiac arrest WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs s/s hypomagnesemia: □ irritability □ tremors, tetany □ tachycardia □ hypertension □ psychotic behavior □ Monitor urinary output and hydrate adequately with parenteral administration. contraindication Avoid with: □ MI, heart block, cardiac arrest except for certain arrhythmias. Use caution: □ impaired kidney function □ other cardiac glycosides □ Lactating moms and children 46
  • 47. Drug Mannitol (Osmitrol) Use and dosage □ Use in oliguria and acute renal failure. □ Electrolyte and Help to prevent water balance renal failure and agent reduce increased intracranial or □ osmotic diuretic intraocular pressure Onset 1-3 hr. diuresis; 30 to 60 □ It acts by increasing min IOP, 15 min. for ICP the osmolality of Duration plasma, glomerular 4-6 hr. IOP, filtrate, and tubular 3-8 hr. ICP fluid. This decreases the Serum osmolality is 275reabsorption of 300 mmol/kg. fluid and electrolytes, which increases excretion of water, chloride Give IV. and sodium and Usually give test dose slightly increase the which should result in excretion of Output of 30 to 50 Potassium. ml/hr. and is produced □ In intraocular (IOP) 2-3 hrs. after and CSF (ICP), it administration. pulls the fluid and sends it to the plasma and extravascular systems Side effect Side effects: □ HA, confusion, syncope □ fluid and electrolyte imbalance, esp. hyponatremia □ pulmonary congestion, rhinitis □ Water intoxication Teaching and labs □ Use filter needle and/or filter in infusion tubing because crystals may form in the solution. □ Mannitol is held if serum osmolality exceeds 310 -320. □ Daily weights Adverse effects/toxicity: Teach □ Non-narcotics such □ Seizure, as Tylenol if there is □ thrombophlebitis, headache □ CHF, Cardiovascular □ Therapy is based on collapse urine flow rate. □ Hyponatremia □ Reassure pt. that excessive thirst, Warning: There may be blurred vision, a rebound increase in rhinitis should ICP about 12 hours after subside when administration of med. Mannitol is Pt may complain of HA, discontinued or confusion. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Do not use: □ severely impaired renal function □ marked dehydration □ breast feeding □ hepatic failure, □ active ICP □ anuria □ Intracranial bleed shock □ Question the administration of mannitol if the patient has cor pulmonae (right sided heart failure) because Mannitol pulls fluid and it may lead to circulatory overload which the heart could not handle. This client would need loop diuretic to prevent serious complications 47
  • 48. Drug Meperidine HCl (Demerol) □ Narcotic analgesic (opioid agonist) Use and dosage □ Given for moderate to severe pain. □ Potent, long acting Give Narcan for toxicity - It is use to reverse respiratory depression induced by overdose Onset: 15 mins. PO, 10 mins. IM, 5 mins IV duration 2-4 hours Metoprolol tartrate (Lopressor, Toprol) □ Beta adrenergic antagonist (beta blocker) □ Antihypertensive □ Antianginal = same action as with propanolol Side effect Side effects: □ N/V, Anorexia □ Sedation, dizziness □ elevated BP □ rash, urticaria □ tremors □ hyperventilation Adverse effects/toxicity: □ Resp depression, □ respiratory arrest, □ circulatory depression, □ increased intracranial pressure □ Decreases heart rate and cardiac output □ Lowers BP □ □ □ □ Side effects: □ Usually well tolerated □ Nausea, vomiting □ Weight gain Mild to severe HTN □ worsening CHF angina pectoris □ insomnia **Post - acute MI** Adverse effects/toxicity: □ profound Max effect may bradycardia take 1 week □ heart block □ acute CHF, □ bronchospasm □ laryngospasm WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs Assess: □ LOC □ rash, urticaria □ respiratory rate. If respirations < 12 per minute – withhold meds. contraindication Avoid use with: □ acute bronchial asthma, upper airway obstruction □ increased intracranial pressure □ convulsive disorder □ pancreatitis, acute ulcerative colitis □ severe liver or kidney insufficiency Caution with: □ children and elderly □ Give with or w/o food, but consistent □ Do not stop abruptly; may cause rebound effect. Gradually decrease over 1-2 wks. □ Hold meds if BP < 90 or pulse < 60 □ Watch for s/s heart failure □ Can lead to elevated BUN, creat. □ May mask hypoglycemia Avoid use with: □ Heart block greater than 1st degree □ Sinus brady, □ cardiogenic shock Use caution: □ hyperactive airway syndrome ( asthma or bronchospasm) □ Increases chance of both Dig and Lithium toxicity 48
  • 49. Drug Morphine Sulfate (MS Contin = sustained release form) □ Narcotic analgesic (Opioid agonist) Use and dosage □ Produces effect by binding to opioid receptors throughout the CNS. □ Schedule II drug, major drug abuse. □ Give Narcan for toxicity. □ Onset, Peak, Duration depend on route of □ medication. Onset: Immediate IV, rapid if given IM or oral, except MS Contin □ Side effect Side effects: □ Nausea vomiting anorexia, GI, □ pruritus, □ light headedness □ constipation Adverse effects/toxicity: □ Classic triad of symptoms: For severe, chronic respiratory or acute pain. depression, coma, Most commonly pinpoint pupils. use in post□ Withdrawal begins operative setting. 6-8 hrs. After the mild bronchodilator last dose, reach to improve peak intensity within breathing 48-72 hrs. S/S include craving, MS Contin is chills, sweating sustained release; piloerection (goose it will not control flesh), abdominal break-through pain pain and cramps, because it is time diarrhea, runny release. nose, irritability. □ Morphine induced CNS stimulation – paradoxical reaction common in women and older adults. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs contraindication Avoid use with: □ Avoid alcohol use □ Hypersensitivity to opiates) □ Hold medication if □ acute bronchial respirations < 12/min asthma or upper airway obstruction, □ Hydrate adequately □ ICP to prevent □ convulsive constipation disorders □ pancreatitis, acute ulcerative colitis □ severe liver or kidney disease □ Do not give morphine to children 49
  • 50. Drug Use and dosage Naloxone HCl (Narcan) □ Competes with opioids at the opiate receptor □ Opioid antagonist. sites, blocking the effects of the Onset opioids 1-2 min IV; □ Reverses effects of 2-5 mins. SQ or IM opiates, including respiratory Duration depression, 1 hr. IV; up to 4 hrs. IM sedation and but start to diminish hypotension. after 20 mins. □ May need given every few hours until the opioids has dropped to a nontoxic level Nedocromil (Tilade) □ asthma prophylaxis NOT for acute □ Inhaled nonasthma attacks steroidal □ up to a week for medication full effectiveness □ anti-inflammatory □ Must be taken and antiasthmatic. regularly to be effective Side effect Side effects: □ Increased BP, HR, hyperpnea □ tremors, □ hyperventilation, □ drowsiness, □ nervousness □ N/V Teaching and labs □ Watch vital signs and respiratory function closely with administration of medication contraindication Avoid use with: □ Known allergy □ Respiratory depression d/t nonopioids □ Substance abuse □ Titrate dose slowly (may lead to if too much is given withdrawal the client will swing symptoms) from a state of Adverse effects/toxicity: intoxication to one □ Hypotension, of withdrawal □ V-tach and V-fib □ convulsion, □ hepatitis □ pulmonary edema, Adverse effect: □ abnormal bitter taste □ N/V, HA, dizziness, sore throat. □ Rinse mouth after taking medication to avoid dry mouth □ Do not use for acute attack □ Non-compliance is a concern due to bitter taste Avoid use with: □ acute bronchospasm or status asthmaticus. □ Hypersensitivity Use with caution: □ hepatic or renal function (also available as optic form – for ocular allergic conjunctivitis) WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) 50
  • 51. Drug Neomycin sulfate (Mycifradin) □ ORAL aminoglycoside □ antibiotic Nifedipine (Procardia) □ Calcium Channel Blocker □ Antianginal □ Antihypertensive □ Negative inotropic Use and dosage Antibacterial – ORAL □ GI tract □ Hepatic coma Side effect Side effects: skin rash (esp. topical) Teaching and labs □ Poorly tolerated GI so it is usually for bowel cleansing. contraindication Adverse effects/toxicity: Main form is topical for □ Nephrotoxicity eye, ear and skin □ Ototoxicity. infection. NEOMYCIN IS NOT GIVEN IV □ angina □ mild to moderate HTN (sustained release form) □ □ □ □ □ Do not give 1-2 wks. after an acute MI. □ Do not give with grapefruit juice (could lead to toxicity) Dilates coronary □ Report gradual arteries and relaxes coronary spasm weight gain and evidence of edema; Increases cardiac may indicate onset output; decreases of CHF. peripheral vascular Adverse effects/toxicity: □ Do not stop resistance. □ Gingival hyperplasia suddenly (will have Blocks calcium ion rebound symptoms) flow into cells of □ Smoking decreases myocardial and arterial smooth efficacy of med muscle (cardiac and □ Monitor pulse rate – peripheral blood report irregular or vessels) slower than normal Slows HR; rate. Hold for BP decreases O2 need below 90/60. Side effects: □ Usually well tolerated □ Headache □ fatigue □ Dizziness □ Postural hypotension □ peripheral edema WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Avoid use with: □ Known hypersensitivity □ Unstable angina □ Lactation 51
  • 52. Drug Oxytocin (Pitocin) □ Oxytocic Labor and delivery. Onset is immediate. After stopping med, contractions should stop in 2-3 minutes Half-life 3-5 min Pancrelipase (Creon, Pancrease) □ Pancreatic enzyme replacement therapy Use and dosage □ To initiate or improve uterine contractions at term □ Induce labor □ Management of incomplete or missed abortion (miscarriage) □ reduce postpartum bleeding □ Help to breakdown fat, proteins and carbs for better absorption. □ cystic fibrosis □ chronic pancreatitis, post pancretectomy □ steatorrhea □ malabsorption syndrome Side effect Teaching and labs Side effects: □ Careful monitoring □ subarachnoid bleed of uterine contraction pattern, □ fetal trauma fetal heart rate and □ seizure, coma maternal BP. Adverse effects/toxicity: Hypertensive crisis. □ Postpartum; monitor lochia and For fetal anoxia: BP. □ stop infusion, turn contraindication Avoid use with: □ Hypersensitivity □ Cepahalopelvic disproportion □ Obstetric emergencies mom on left side, oxygen prn Stop infusion for: □ Contractions which occur more often than every 2 mins. or last over 90 sec. □ Do not increase dose after desired contraction pattern is achieved (contraction frequency of 2-3 min lasting 60 sec). Side effects: □ Take with or just □ Nausea, diarrhea, prior to eating and cramps □ Do not mix brand names; there is a Adverse effects/toxicity: variance in Hyperuricemia. concentration of □ Report joint or enzymes swelling pain (high □ Swallow tablet or uric acid level) capsule whole; do not crush or chew. □ Can mix powder or open capsule with food. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Drug interaction: □ Allergy to med or pork □ Do not give with magnesiumcontaining antacid. May be ordered with H2 blockers or with proton pump inhibitors. □ Iron will decrease effectiveness of med. 52
  • 53. Drug Phenobartial (Phenobarbital Sodium = Luminal) – this is the short-acting form. For status epilepticus: Administer slow IV □ Anticonvulsant □ Sedative-hypnotic Pilocarpine hydrochloride (Pilocar) □ Eye preparation. □ Miotic (Antiglaucoma agent). □ Direct acting cholinergic agent for ophthalmic use. □ It is an antidote to Atropine Use and dosage □ Long-term management of grand mal, partial seizure and status epilepticus. □ Sedative effect to decrease anxiety and tension. □ No analgesic effect □ For acute or chronic Glaucoma – decreases intraocular pressure □ Will reverse the effects of Atropine (and Atropine will reverse the effects of Pilocarpine). Side effect Side effects: □ Somnolence, hangover effect Adverse effects/toxicity: □ CNS depression, □ Stevens-Johnson □ Blood dyscrasias □ Paradoxical reactions may occur in children, older adults and debilitated people Teaching and labs □ Okay to crush and mix with food or fluids □ Monitor IV infusion closely. □ Do not stop abruptly □ Avoid alcohol and other CNS depressants Side effects: □ Apply gentle □ Visual blurring, pressure for 1-2 myopia, irritation, mins. to brow pain and HA. nasolacrimal (with ophthalmic) drainage area after administering eye □ Normal: Increased gtts pigmentation of iris □ Eye therapy will and eyelids; long eyelashes. continue long term Adverse effects/toxicity: □ Retinal detachment □ Ataxia □ Confusion □ seizure WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Avoid use with: □ Hypersensitivity □ Resp or kidney failure □ Pregnancy and lactation Avoid use with: □ Asthma, COPD □ HTN □ Acute eye infections, retinal detachment, contact lens use 53
  • 54. Drug Prazosin hydrochloride (Minipress) □ Antihypertensive □ Alpha-adrenergic receptor antagonist □ vasodilator □ Treat benign prosthetic hyperplasia (BPH) Use and dosage □ Mild to moderate HTN – mainly diastolic □ little effect on cardiac output and HR □ BPH (due to vasodilator effects) Optimal effects may take 4-6 weeks Prochlorperazine (Compazine) □ Antiemetic □ Antipsychotic □ Phenothiazine □ □ □ □ Side effect Side effects: □ Dizziness, drowsiness □ Fatigue, weakness. □ Priapism, impotence □ Orthostatic hypotension Adverse effects/toxicity: □ First-dose phenomenon: syncope within 30 min to 1 hr. Effect is transient, may diminish by giving at bedtime. Severe nausea and Side effects: □ drowsiness, vomiting dizziness, Management of □ EPSE psychotic disorders, Adverse effects/toxicity: excessive anxiety □ Persistent tardive and agitation dyskinesia □ Tremor, twitching Take 30-60 min □ Agranulocytosis, before any activity □ thrombocytopenia that causes nausea □ After 1-2 months: for best effect. Akathisia (inner restless, inability to Start doses low and sit still) – may tx increase slowly with propranolol. WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ monitor for decreased BP, especially with initial administration □ Monitor urine vol. □ change position slowly to prevent orthostatic hypotension □ stop smoking and avoid alcohol intake □ avoid driving and hazardous tasks until effect of med is known □ Avoid excessive sunlight – may turn skin gray-blue □ Urine may turn reddish brown □ Use sugarless hard candy or ice chips to avoid dry mouth. □ Avoid skin contact with concentrate □ Do not crush or chew – swallow whole □ Deep IM, not SQ injection contraindication Avoid use with: □ Prior sensitivity □ hypotension Use caution with: □ impaired hepatic function □ older adults Avoid use with: □ Hypersensitivity □ Blood dyscrasias □ Dementia related psychosis in elderly □ Young children □ Seizures □ Lactation 54
  • 55. Drug Promethazine (Phenergan) □ Antiemetic □ Antihistamine □ Anti-vertigo Protamine sulfate □ Antidote for Heparin toxicity. □ Heparin antagonist Onset = 5 minutes Duration = 2 hours Longer half-life than heparin Ranitidine hydrochloride (Zantac) □ H2-receptor antagonist. □ Higher potency than cimetidine (Tagamet) Use and dosage □ Long-acting med □ motion sickness □ nausea Side effect Side effects: □ Resp depression, □ drowsiness, confusion □ IM route: Give deep □ agranulocytosis □ blurred vision IM; not SQ (can cause necrosis) □ dry mouth □ Avoid intra-arterial □ EPSE injection – can cause necrosis. Teaching and labs □ Decrease GI distress by giving oral dose with milk or food. □ May crush and mix with food. □ Avoid sunlight exposure □ Avoid alcohol and other CNS depressants contraindication Avoid use with: □ Acute MI, angina, atrial fib Use caution with: □ Narrow angle glaucoma □ peptic ulcer □ duodenal obstruction □ Antidote for Heparin overdose □ Given IV; maximum dose of 50 mg in 10 min time period; should be titrated according to the time and length of time the heparin was administered □ Reduce gastric secretion. □ Active duodenal ulcer, maintenance after healing □ GERD □ benign gastric ulcer (short-term) □ Monitor vital signs and labs closely (aPTT) Avoid use with: □ Hemorrhage not induced by heparin overdose. Side effect: □ Abrupt drop in BP if administered too rapidly. See listing for HEPARIN Side effects: □ headache □ taste disorder, diarrhea, constipation □ dry mouth Adverse effects/toxicity: □ hepatotoxicity □ thrombocytopenia WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) □ Give without regard to meals □ Usually give 1 x day □ reduce dose in renal patient □ avoid smoking to □ avoid antacid within 1 hour of dose Avoid use with: □ Hypersensitivity Use caution with: □ Impaired renal of hepatic function. □ May increase effects of alcohol, aspirin, Coumadin and sulfonylureas 55
  • 56. Drug Rh0(D) immune globulin (RhoGAM) □ Biological response modifier □ Immunoglobulin (IgG) Peak 2 hour Half-life 25 days Use and dosage □ Given to Rhnegative moms with RH positive babies. □ Provides passive immunity by suppressing active antibody response and formation of anti-RHo when (1) positive fetal RBC enters maternal circulation during the third stage of labor; (2) there is fetal maternal hemorrhage or other trauma during pregnancy; (3) termination of pregnancy or miscarriage; or (4) following a Rh+ transfusion. Side effect Side effects: □ Injection site irritation □ slight fever □ myalgia □ lethargy WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs contraindication Avoid use with: □ Send sample of newborn cord blood □ Known sensitivity to lab for cross to human match and typing immunoglobulins. immediately after delivery before administer RHo (D) □ Give to mom IM via deltoid. (Only a few forms can be given IV). □ Give immediately after reconstitution □ Recommended at 28 weeks gestation and then within 72 hours after delivery or 3 hrs. of termination of pregnancy or miscarriage. □ Keep epinephrine available; systemic allergic reactions sometimes occur. □ TEACH it will prevent hemolytic disease in a subsequent pregnancy 56
  • 57. Drug Setraline hydrochloride (Zoloft) □ Antidepressant □ SSRI (selective serotonin reuptake inhibitor) Spironolactone (Aldactone) □ Fluid & electrolyte balance □ antihypertensive □ Potassium sparing diuretic Use and dosage □ panic disorders □ Anxiety disorders □ OCD □ PTSD □ 2-3 wks. to be effective □ Increases sodium excretion; does not decrease potassium □ treatment of primary aldosteronism □ Use for edema and HTN associated with heart failure. Side effect Side effects: □ Cause fewer disorders than other antidepressants □ fewer side effects on HR and HTN □ Sexual dysfunction □ Weight gain Major complication □ (Selective Serotonin Syndrome): Pt. can die from it. Elevated temp up to 105. Every speed up. BP, HR, Temp. May progress to coma. Side effects: □ Headache □ dizziness, weakness □ orthostatic hypotension Adverse effects/toxicity: □ Hyperkalemia (nausea, vomiting, diarrhea, cramps, tachycardia then bradycardia) □ aplastic anemia □ thrombocytopenia WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) Teaching and labs □ Give with food in the morning to prevent insomnia □ Watch for suicide risk □ Increases effect of Coumadin □ Avoid grapefruit juice contraindication Avoid use: □ Within 14 days of using MAO inhibitor □ Seizure disorder □ Take with food □ avoid salt substitute high in K+ □ Avoid excessive ingestion of foods high in potassium. □ no potassium supplement needed □ Monitor VS and urine output □ Avoid direct sunlight Avoid use with: □ Serum K+ level > 5.5 □ anuria, acute and chronic renal insufficiency □ diabetic nephropathy □ hypersensitivity □ impaired hepatic function □ Decreases effect of Dig; □ increases chance of lithium toxicity 57
  • 58. Drug Sucralfate (Carafate) □ Antiulcer □ Gastro-protective agent Theophylline (Theo-dur) □ Bronchodilator (resp. smooth muscle relaxant) □ xanthines □ Normal level 10-20. toxic level (> 20) may develop quickly Use and dosage □ Protects the ulcer from gastric acid by forming an adherent coating; it absorbs pepsin decreasing its activity. □ Duodenal ulcer □ Short term with gastric ulcer □ esophageal ulcer related to radiation or chemotherapy □ bronchospasms □ asthma □ bronchitis □ emphysema Side effect Side effects: □ constipation □ nausea WSU – CONH STUDY GUIDE FOR NLN PHARMACOLOGY EXAM (REVISED 6/3/2013) contraindication Avoid use with: □ Chronic kidney failure □ Avoid gastric irritants such as caffeine, alcohol, smoking and spicy foods. Side effects: □ Tachycardia □ Seizures □ N/V, anorexia, Adverse effects/toxicity: □ restlessness, agitation, HA, and insomnia □ note: restlessness could be due to toxicity or hypoxia so close assessment is required Teaching and labs □ No antacid use within ½ hour of this medication □ Decreases absorption of Cipro, Dig, Dilantin, Tetracycline (so take these med 2 hours apart from Sucralfate) □ PO: take with water and after meals. □ Wait 4-6 hours after IV to start PO. □ Take same time each day Avoid use with: □ CAD, angina □ Renal or liver disease □ Pregnancy, lactation □ children □ CHF and acute viral □ can cause seizure (with high doses/levels) so avoid with seizure disorder unless bronchospasm is unresponsive to other treatments □ Limit caffeine □ Smoking decreases effect of med □ Increases lithium excretion 58